Source,Text,Link,Verb,Original_Form,Context
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,refer,refers,'secondary glioblastoma' refers to a minority of glioblastomas that evolve
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,evolve,evolve,minority of glioblastomas that evolve from previously diagnosed who grade ii or
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,include,include,changes in glioblastoma include mutations in genes regulating receptor tyrosine kinase (
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,include,includes,"treatment of glioblastoma includes surgery, radiotherapy, and alkylating chemotherapy."
Abstract,"""Molecular targeted therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31541850,think,thought,glioblastomas are intrinsic brain tumors thought to originate from neuroglial
Abstract,"""Molecular targeted therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31541850,exhibit,exhibit,", uncommon glioblastoma subsets may exhibit specific vulnerabilities amenable to targeted interventions"
Abstract,"""A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/31883794,exhibit,exhibit,"glioblastomas exhibit vast inter- and intra-tumoral heterogeneity,"
Abstract,"""A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/31883794,recapitulate,recapitulate,-derived glioblastoma organoids (gbos) that recapitulate the histological features
Abstract,"""A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/31883794,deploy,deployed,features of glioblastomas and can be rapidly deployed to investigate patient-
Abstract,"""Glioblastoma and other malignant gliomas: a clinical review.""",https://pubmed.ncbi.nlm.nih.gov/24193082,base,based,newly diagnosed glioblastoma is based on radiotherapy combined with temozolomide.
Abstract,"""Glioblastoma and other malignant gliomas: a clinical review.""",https://pubmed.ncbi.nlm.nih.gov/24193082,remain,remains,"relevance: glioblastoma remains a difficult cancer to treat, although therapeutic"
Title,"""Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.""",https://pubmed.ncbi.nlm.nih.gov/36851761,emerge,emerging,developments in glioblastoma therapy: oncolytic viruses and emerging future strategies.
Abstract,"""Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.""",https://pubmed.ncbi.nlm.nih.gov/36851761,describe,describe,virotherapy for glioblastomas and describe several ovs and their combination with other
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,rank,ranks,glioblastoma ranks among the most lethal of all human cancers
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,display,display,"glioblastomas display striking cellular heterogeneity, with stem-like"
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,induce,induce,glioblastomas induce a systemic immunosuppression with mixed responses to oncoimmunologic
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,offer,offers,"collectively, glioblastoma offers a reliable cancer to study cancer stem cells"
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,recur,recur,", primary glioblastomas invariably recur as aggressive, therapy-resistant relapses"
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,emerge,emerging,of recurrent glioblastoma is just slowly emerging.
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,ask,ask,on recurrent glioblastoma and ask whether and how therapies change intra-
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,determine,determine,"in recurrent glioblastoma will determine, whether, one day, glioblastoma"
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,contain,contained,"day, glioblastoma can be contained in a state of chronic disease"
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,develop,develop,majority of glioblastomas (~90%) develop rapidly de novo in
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,differ,differ,"and secondary glioblastomas are largely indistinguishable, but they differ in their"
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,associate,associated,in primary glioblastomas and which are associated with a hypermethylation phenotype.
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,originate,originate,and secondary glioblastomas are distinct tumor entities that originate from different precursor
Abstract,"""Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36853018,remain,remains,"chemotherapy, glioblastoma remains refractory to treatment and recurrence is inevitable."
Abstract,"""Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36853018,remain,remains,of recurrent glioblastoma remains unclear.
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,remain,remains,patients with glioblastoma prognosis remains bleak.
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,encompass,encompassing,"interplays between glioblastoma and the cellular architecture of the brain, encompassing"
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,reveal,revealing,"of a glioblastoma, and a patient's overall survival, revealing"
Abstract,"""Glioblastoma and brain connectivity: the need for a paradigm shift.""",https://pubmed.ncbi.nlm.nih.gov/38876751,unveil,unveil,"treatment of glioblastomas, which could unveil new prognostic factors and surgical"
Abstract,"""Understanding glioblastoma at the single-cell level: Recent advances and future challenges.""",https://pubmed.ncbi.nlm.nih.gov/38814900,provide,providing,"cells within glioblastomas, providing previously unattainable insights into the genetic and"
Abstract,"""Understanding glioblastoma at the single-cell level: Recent advances and future challenges.""",https://pubmed.ncbi.nlm.nih.gov/38814900,expect,expected,"heterogeneity of glioblastomas are expected, which will help guide the development"
Title,"""Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis.""",https://pubmed.ncbi.nlm.nih.gov/39297872,unveil,unveiling,macrophages in glioblastoma: unveiling therapeutic insights from tumour microenvironment analysis.
Abstract,"""Identification of hypoxic macrophages in glioblastoma: Unveiling therapeutic insights from tumour microenvironment analysis.""",https://pubmed.ncbi.nlm.nih.gov/39297872,propose,propose,"locations in glioblastomas, and propose future directions for studying the temporospatial"
Title,"""Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.""",https://pubmed.ncbi.nlm.nih.gov/34011400,reveal,reveals,macrophages in glioblastoma reveals marco as a mesenchymal pro-tumor marker
Abstract,"""Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.""",https://pubmed.ncbi.nlm.nih.gov/34011400,suggest,suggest,progression in glioblastomas and suggest potential therapeutic targets to prevent their recruitment
Abstract,"""Perioperative Management of Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33223018,require,requires,"presentation of glioblastomas is varied, and definitive diagnosis requires pathologic examination"
Abstract,"""Perioperative Management of Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33223018,include,includes,"management of glioblastomas includes surgery and adjuvant chemotherapy and radiotherapy, with"
Abstract,"""Perioperative Management of Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33223018,include,including,patients with glioblastoma including tools and surgical adjuncts to maximize extent of
Abstract,"""Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38806071,improve,improved,prognosis of glioblastoma can be improved.
Abstract,"""Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38806071,show,show,treatment of glioblastoma and show how they can be modified for this
Abstract,"""Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets.""",https://pubmed.ncbi.nlm.nih.gov/32268863,study,studied,progression in glioblastoma are being studied.
Abstract,"""Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets.""",https://pubmed.ncbi.nlm.nih.gov/32268863,discuss,discussed,therapy for glioblastoma has also been discussed.
Title,"""Risk factors for glioblastoma are shared by other brain tumor types.""",https://pubmed.ncbi.nlm.nih.gov/38520250,share,shared,factors for glioblastoma are shared by other brain tumor types.
Abstract,"""Risk factors for glioblastoma are shared by other brain tumor types.""",https://pubmed.ncbi.nlm.nih.gov/38520250,ionize,ionizing,"factors for glioblastoma (gbm), i.e., ionizing radiation,"
Abstract,"""Management of Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28324304,represent,represents,review: glioblastoma represents one of the major challenges in neurooncology and
Abstract,"""Management of Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28324304,remain,remains,patients with glioblastoma remains poor.
Abstract,"""Understanding the Role of Endothelial Cells in Glioblastoma: Mechanisms and Novel Treatments.""",https://pubmed.ncbi.nlm.nih.gov/38892305,facilitate,facilitating,"role in glioblastoma growth and progression, facilitating angiogenesis, cellular communication"
Abstract,"""Role of surgery in multifocal glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35320251,come,come,outcomes in glioblastoma management come from gross total resection (gtr)
Abstract,"""Optimizing glioblastoma resection: intraoperative mapping and beyond.""",https://pubmed.ncbi.nlm.nih.gov/25363008,start,starts,"management of glioblastomas starts with surgical resection if possible, along with"
Abstract,"""Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.""",https://pubmed.ncbi.nlm.nih.gov/36131011,facilitate,facilitated,"glioblastoma evolution is facilitated by intratumour heterogeneity, which poses"
Abstract,"""Palliative Radiotherapy of Primary Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33402500,achieve,achieved,resection of glioblastomas cannot be achieved.
Abstract,"""Palliative Radiotherapy of Primary Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33402500,analyze,analyzed,of primary glioblastoma were retrospectively analyzed.
Abstract,"""Glioblastoma metastases: a literature review and a description of six clinical observations.""",https://pubmed.ncbi.nlm.nih.gov/26146042,locate,located,cases of glioblastoma metastases with the development of foci located at a
Abstract,"""Glioblastoma metastases: a literature review and a description of six clinical observations.""",https://pubmed.ncbi.nlm.nih.gov/26146042,receive,received,with brain glioblastomas who received treatment at the burdenko neurosurgical institute (
Abstract,"""Glioblastoma metastases: a literature review and a description of six clinical observations.""",https://pubmed.ncbi.nlm.nih.gov/26146042,associate,associated,metastases of glioblastomas that are closely associated with the cerebrospinal fluid circulation
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,emerge,emerged,pivotal in glioblastoma treatment resistance and dna methylation emerged as an important
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,subject,subjected,"from 47 glioblastoma patients were subjected to dna methylation profiling, including"
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,show,showed,"general, glioblastomas with a subclass transition showed upregulated metabolic processes."
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,display,displayed,newly diagnosed glioblastomas with mesenchymal transition displayed increased stem cell-like
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,show,showed,of recurrent glioblastomas with mesenchymal transition showed increased immune components but decreased
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,impact,impacting,"% of glioblastomas, not impacting patient survival."
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,target,targeted,for recurrent glioblastoma targeted therapies.
Abstract,"""Differentiating brain metastasis from glioblastoma by time-dependent diffusion MRI.""",https://pubmed.ncbi.nlm.nih.gov/37553578,use,using,patients with glioblastomas and 27 patients with metastases using a diffusion-
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,constitute,constitutes,glioblastoma is the most common intracranial malignancy and constitutes about
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,explain,explain,profiles in glioblastoma may explain the difficulties encountered in the validation of
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,call,call,"heterogeneity of glioblastomas, and call attention to the importance of this"
Abstract,"""The potential of advanced MR techniques for precision radiotherapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35129718,visualize,visualized,processes in glioblastomas can be visualized with different advanced mr techniques.
Abstract,"""GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35456993,promote,promotes,% of glioblastomas and promotes tumor formation and progression.
Abstract,"""GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35456993,utilize,utilizing,subset of glioblastomas and our data warrants further preclinical studies utilizing xenograft
Abstract,"""Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.""",https://pubmed.ncbi.nlm.nih.gov/28816643,serve,serve,suggest that glioblastomas serve as a useful application paradigm.
Abstract,"""A peculiar case of pure intraventricular glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37382731,name,named,glioblastoma (formerly named glioblastoma multiforme) is the most
Abstract,"""A peculiar case of pure intraventricular glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37382731,define,defining,"of intraventricular glioblastomas, defining those as secondary ventricular tumors because of"
Abstract,"""A peculiar case of pure intraventricular glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37382731,lie,lying,"an intraventricular glioblastoma lying entirely within the ventricular walls, involving all"
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,have,have,diagnosed as glioblastoma lack contrast enhancement and have a 'low-
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,identify,identified,"-wildtype glioblastomas, we identified 98 patients (7.4%)"
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,have,had,"to ce glioblastoma, patients with non-ce glioblastoma had a"
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,have,had,-ce glioblastoma had a more favorable clinical profile and superior outcome
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,use,using,-ce glioblastoma to patients with ce glioblastoma using a large set
Abstract,"""Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/37665776,use,using,with ce glioblastoma using a large set of clinical variables.
Abstract,"""Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.""",https://pubmed.ncbi.nlm.nih.gov/25289896,advance,advances,"mechanisms of glioblastomas, advances in treatment that translate into substantial improvement"
Abstract,"""Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.""",https://pubmed.ncbi.nlm.nih.gov/25289896,propose,proposed,cytomegalovirus in glioblastoma pathogenesis was proposed more than a decade ago and
Abstract,"""Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.""",https://pubmed.ncbi.nlm.nih.gov/25289896,demonstrate,demonstrate,treatment of glioblastoma did not demonstrate a beneficial effect on tumor growth
Title,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,base,based,glioblastoma molecular classification tool based on mrna analysis: from
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,incorporate,incorporate,most glioblastoma studies incorporate the layer of tumor molecular subtype based
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,apply,applies,"tool for glioblastoma molecular subtyping, and each study applies a different"
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,use,using,"tool for glioblastoma classification, with high accuracy, while using a"
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,base,based,tool for glioblastoma molecular classification based on the mrna analysis of only
Abstract,"""Insular glioblastoma: surgical challenges, survival outcomes and prognostic factors.""",https://pubmed.ncbi.nlm.nih.gov/33356607,analyse,analysed,insular glioblastomas (igbm) have not been analysed separately before
Abstract,"""Insular glioblastoma: surgical challenges, survival outcomes and prognostic factors.""",https://pubmed.ncbi.nlm.nih.gov/33356607,have,had,"patients had glioblastoma, while four had gliosarcoma."
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,originate,originating,glioblastomas are highly malignant primary brain tumors presumably originating from
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,review,reviewed,"classification of glioblastoma were reviewed, and their impact on clinical decision"
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,classify,classified,"results: glioblastomas can be classified by morphology, clinical characteristics,"
Abstract,"""Individualized targeted therapy for glioblastoma: fact or fiction?""",https://pubmed.ncbi.nlm.nih.gov/22290256,base,based,decisions for glioblastoma patients are still based on age and performance status
Abstract,"""Glioblastoma of the cerebellum in children: report of five cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/23299302,compare,compared,"with cerebellar glioblastomas is dismal, even when compared to adult counterparts"
Abstract,"""Glioblastoma of the cerebellum in children: report of five cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/23299302,have,have,cerebellar glioblastomas have a tendency to recur and disseminate despite treatment
Abstract,"""Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.""",https://pubmed.ncbi.nlm.nih.gov/29081039,remain,remains,glioblastoma remains a clinical challenge in spite of years of
Abstract,"""Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.""",https://pubmed.ncbi.nlm.nih.gov/29081039,base,based,in vivo glioblastomas based on contemporary imaging techniques.
Abstract,"""Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.""",https://pubmed.ncbi.nlm.nih.gov/19770591,continue,continue,glioblastomas continue to rank among the most lethal primary human
Abstract,"""Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.""",https://pubmed.ncbi.nlm.nih.gov/19770591,demonstrate,demonstrated,"hallmarks of glioblastoma, necrosis has been demonstrated to be a powerful"
Abstract,"""Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.""",https://pubmed.ncbi.nlm.nih.gov/19770591,lead,lead,"mechanisms underlying glioblastoma formation, yet the mechanisms that lead to tumor"
Abstract,"""Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.""",https://pubmed.ncbi.nlm.nih.gov/19770591,involve,involves,"necrosis in glioblastoma involves the neurotransmitter, glutamate, which has been"
Abstract,"""Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.""",https://pubmed.ncbi.nlm.nih.gov/19770591,involve,involving,perspective on glioblastoma necrosis involving the process of glutamate excitotoxicity.
Abstract,"""Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.""",https://pubmed.ncbi.nlm.nih.gov/19770591,begin,begin,necrosis in glioblastoma and to begin to develop targeted therapies that may
Abstract,"""MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme.""",https://pubmed.ncbi.nlm.nih.gov/35806153,highlight,highlighting,"changes in glioblastomas, also highlighting benefits, including those of liquid"
Abstract,"""MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme.""",https://pubmed.ncbi.nlm.nih.gov/35806153,bear,bearing,especially in glioblastomas bearing mutations in the isocitrate dehydrogenase (idh)
Abstract,"""Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.""",https://pubmed.ncbi.nlm.nih.gov/39560695,associate,associated,) in glioblastoma is rare and associated with perceived poor prognosis.
Abstract,"""Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.""",https://pubmed.ncbi.nlm.nih.gov/39560695,grade,grade,newly diagnosed glioblastoma (cns who grade 4) were assessed.
Abstract,"""Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis.""",https://pubmed.ncbi.nlm.nih.gov/39560695,treat,treated,suggests that glioblastomas with multiple lesions treated with multimodal therapy equal survival
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,associate,associated,in glioblastoma it is associated with a poor prognosis and more
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,examine,examine,cxcr4 in glioblastoma tissue to further examine the potential of these pet
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,stain,stained,glioblastoma tissue cores were stained for cxcr4.
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,undergo,underwent,with recurrent glioblastoma underwent [68ga]ga-pentixafor pet; residual resected
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,analyze,analyzed,"the 191 glioblastomas, 426 cores were analyzed using immunohistochemistry."
Abstract,"""Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21656012,occur,occurs,glioblastoma occurs rarely in pediatric patients (0.6-7.9
Abstract,"""Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21656012,appear,appeared,histopathologically confirmed glioblastoma multiforme whose lesions appeared within just 1 week of
Abstract,"""Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21656012,emphasize,emphasizes,development of glioblastoma in childhood and emphasizes the importance of serial neuroimaging
Abstract,"""Biodistribution and pharmacokinetics of [(89)Zr]-anti-VEGF mAbs using PET in glioblastoma rat models.""",https://pubmed.ncbi.nlm.nih.gov/38224761,present,present,"introduction: glioblastomas present intensive angiogenesis, thus anti-vascular endothelial"
Abstract,"""Biodistribution and pharmacokinetics of [(89)Zr]-anti-VEGF mAbs using PET in glioblastoma rat models.""",https://pubmed.ncbi.nlm.nih.gov/38224761,use,using,model of glioblastoma in rats using positron emission tomography (pet)
Title,"""Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.""",https://pubmed.ncbi.nlm.nih.gov/22218709,base,based,glioblastoma angiogenesis: vegf resistance solutions and new strategies based
Abstract,"""Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.""",https://pubmed.ncbi.nlm.nih.gov/22218709,provide,provides,"only nourishes glioblastomas, but also provides a specialized microenvironment for tumor"
Abstract,"""Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.""",https://pubmed.ncbi.nlm.nih.gov/22218709,result,result,biology of glioblastomas which may ultimately result in new modes of treatment
Title,"""Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/35303420,match,matched,of primary glioblastomas and matched explants and cell lines show variable retention
Abstract,"""Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/35303420,characterize,characterized,glioblastomas (gbms) are aggressive brain tumors characterized by
Abstract,"""EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.""",https://pubmed.ncbi.nlm.nih.gov/24671641,represent,represents,"% of glioblastomas, it currently represents one of the most promising"
Abstract,"""Standard therapy for glioblastoma--a review of where we are.""",https://pubmed.ncbi.nlm.nih.gov/20885105,base,based,"and recurrent glioblastomas, based on the most authoritative guidelines, the"
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,cement,cemented,regards to glioblastoma etiology has been particularly satisfying because it cemented the
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,set,set,how the glioblastoma genomic data set serves as an illustrative platform for
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,evolve,evolve,that most glioblastomas evolve along a multitude of pathways rather than a
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,relate,relate,subtypes of glioblastoma as they relate to key principles of developmental neurobiology
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,drive,driven,glioblastomas are heterogeneous neoplasms that are driven by complex signalling
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,remain,remains,patients with glioblastomas remains poor.
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,stimulate,stimulated,"pathogenesis of glioblastomas has stimulated the development of novel therapies, including"
Abstract,"""Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?""",https://pubmed.ncbi.nlm.nih.gov/23183634,target,targeted,"biology of glioblastomas, targeted, antiangiogenic and immunotherapies that have impacted"
Abstract,"""Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25885672,represent,represents,"feature of glioblastomas (gbm), and its inhibition represents a"
Abstract,"""[Angiogenesis and anti-angiogenic strategies for glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/15888393,summarize,summarized,studies in glioblastoma models in vivo are summarized and clinical perspectives are
Title,"""Glioblastoma multiforme presenting with ischemic stroke: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21489628,present,presenting,glioblastoma multiforme presenting with ischemic stroke: case report and
Abstract,"""Glioblastoma multiforme presenting with ischemic stroke: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21489628,confirm,confirmed,diagnosis of glioblastoma multiforme was confirmed.
Abstract,"""Glioblastoma multiforme presenting with ischemic stroke: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21489628,present,presenting,"knowledge, glioblastomas presenting with ischemic stroke are rare, and such"
Abstract,"""Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization.""",https://pubmed.ncbi.nlm.nih.gov/26439689,drive,drive,acts on glioblastoma-stem like cells (gscs) to drive
Title,"""Congenital glioblastoma diagnosed by fetal sonography.""",https://pubmed.ncbi.nlm.nih.gov/10361971,diagnose,diagnosed,congenital glioblastoma diagnosed by fetal sonography.
Abstract,"""Congenital glioblastoma diagnosed by fetal sonography.""",https://pubmed.ncbi.nlm.nih.gov/10361971,detect,detected,of congenital glioblastoma detected at the 39th week of gestation by fetal
Abstract,"""Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities.""",https://pubmed.ncbi.nlm.nih.gov/18492463,discuss,discusses,"research on glioblastoma angiogenesis and discusses its underlying biology, clinical trial"
Title,"""Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23590435,radio-,radio-,mechanisms of glioblastoma resistance to radio- and chemotherapy.
Abstract,"""Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23590435,characterize,characterized,"and multiform glioblastoma are characterized by highly pronounced anaplasia, malignization,"
Abstract,"""Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17676389,develop,developed,"and curing glioblastoma, new and innovative therapeutic strategies must be developed"
Abstract,"""Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17676389,gap,gaps,"options for glioblastomas, gaps in our knowledge of immune recognition of"
Abstract,"""Approaching glioblastoma during COVID-19 pandemic: current recommendations and considerations in Brazil.""",https://pubmed.ncbi.nlm.nih.gov/33759984,have,have,"general and glioblastoma patients, in particular, have an increased risk"
Abstract,"""Approaching glioblastoma during COVID-19 pandemic: current recommendations and considerations in Brazil.""",https://pubmed.ncbi.nlm.nih.gov/33759984,guide,guide,management of glioblastomas during covid-19 pandemic to guide surgical and clinical decisions
Abstract,"""Approaching glioblastoma during COVID-19 pandemic: current recommendations and considerations in Brazil.""",https://pubmed.ncbi.nlm.nih.gov/33759984,help,help,"when approaching glioblastoma during the covid-19 pandemic, important parameters that help"
Abstract,"""Approaching glioblastoma during COVID-19 pandemic: current recommendations and considerations in Brazil.""",https://pubmed.ncbi.nlm.nih.gov/33759984,challenge,challenging,": approaching glioblastoma during the covid-19 pandemic will be challenging worldwide,"
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,remain,remains,treatment of glioblastomas remains ineffective and essentially palliative.
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,display,display,cells called glioblastoma stem cells (gscs) display relative resistance to
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,metastasize,metastasize,"while glioblastomas rarely metastasize beyond the central nervous system, glioblastomas"
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,invade,invade,"system, glioblastomas invade into brain structures to prevent surgical cure and"
Abstract,"""A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37427593,lack,lack,glioblastomas (gbm) are aggressive tumors that lack effective
Abstract,"""[Glioblastoma treatment in 2010].""",https://pubmed.ncbi.nlm.nih.gov/19998795,require,requires,treatment of glioblastomas requires a multidisciplinary approach because despite the progresses in
Abstract,"""[Glioblastoma treatment in 2010].""",https://pubmed.ncbi.nlm.nih.gov/19998795,undergo,undergo,patients with glioblastoma should undergo maximum surgical resection followed by concurrent radiation
Abstract,"""[Glioblastoma treatment in 2010].""",https://pubmed.ncbi.nlm.nih.gov/19998795,emphasize,emphasize,combination for glioblastoma therapy and we also emphasize the importance of vaccinotherapy
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,remain,remains,prognosis of glioblastoma patients remains dismal with a median overall survival below
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,throughput,throughput,characterization of glioblastoma mainly thanks to high throughput molecular biology techniques.
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,target,targeted,"knowledge of glioblastoma molecular biology, these molecular targeted therapies also appear"
Abstract,"""[Targeted therapy in glioblastoma: update and perspectives].""",https://pubmed.ncbi.nlm.nih.gov/29874421,improve,improve,directed against glioblastomas to improve survival and quality of ife of patients
Title,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,represent,represent,metastasis in glioblastoma may represent the emergence of neoplastic subclones.
Abstract,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,metastasize,metastasize,glioblastomas only rarely metastasize to sites outside the central nervous
Abstract,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,find,found,and metastatic glioblastomas for genetic alterations commonly found in glioblastomas: tp53
Abstract,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,tend,tend,that metastatic glioblastomas tend to occur in younger adults who do not
Abstract,"""Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.""",https://pubmed.ncbi.nlm.nih.gov/33215339,sponsor,sponsored,newly diagnosed glioblastomas sponsored by the american association of neurological surgeons (
Abstract,"""Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods.""",https://pubmed.ncbi.nlm.nih.gov/33215339,use,used,newly diagnosed glioblastomas over all commonly used diagnostic and treatment modalities in
Title,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,underline,underline,secreted by glioblastoma stem-like cells underline the need for combinatorial
Abstract,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,endow,endowed,populations of glioblastoma stem-like cells (gscs) endowed with
Abstract,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,vascularize,vascularized,glioblastomas are highly vascularized tumors resulting in a rich dialog
Abstract,"""Critical multiple angiogenic factors secreted by glioblastoma stem-like cells underline the need for combinatorial anti-angiogenic therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/23229792,overcome,overcome,attack of glioblastoma vasculature that could overcome the development of resistance to
Title,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,derive,derived,metabolism of glioblastoma derived from the depiction of (18)f-fluoromisonidazole
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,characterize,characterized,"purpose: glioblastoma is the most aggressive primary brain tumor, characterized"
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,undergo,underwent,patients with glioblastoma (n = 33) who underwent preoperative 18f
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,receive,received,"among the glioblastoma patients who received gross total resection, mrna expressions"
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,validate,validated,"survival in glioblastoma, as validated by tcga database."
Abstract,"""Glioblastoma multiforme in children.""",https://pubmed.ncbi.nlm.nih.gov/176331,occur,occurred,glioblastoma multiforme of the cerebral hemispheres occurred at a mean
Abstract,"""Glioblastoma multiforme in children.""",https://pubmed.ncbi.nlm.nih.gov/176331,occur,occurred,"brain stem glioblastomas occurred at a mean age of 6.7 years,"
Abstract,"""Glioblastoma multiforme in children.""",https://pubmed.ncbi.nlm.nih.gov/176331,increase,increased,children with glioblastoma multiforme was significantly increased with steroid therapy.
Abstract,"""Glioblastoma multiforme in children.""",https://pubmed.ncbi.nlm.nih.gov/176331,behave,behaves,glioblastoma multiforme behaves similarly in children and adults.
Abstract,"""Glioblastoma multiforme in children.""",https://pubmed.ncbi.nlm.nih.gov/176331,have,have,intracranial glioblastomas have a more rapidly fatal course than that of
Abstract,"""Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37840492,increase,increase,", and glioblastomas increase the risk of ad."
Abstract,"""Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37840492,relate,related,"surgery, glioblastoma was related to a significantly lower ad risk than"
Abstract,"""Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37840492,associate,associated,gliomas and glioblastomas were associated with a significantly lower risk of death
Title,"""Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.""",https://pubmed.ncbi.nlm.nih.gov/37129737,use,using,patients with glioblastoma using a multiparametric mri-based prediction model.
Abstract,"""Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.""",https://pubmed.ncbi.nlm.nih.gov/37129737,treat,treated,response in glioblastoma patients treated with dcvax-l. methods: seventeen
Abstract,"""Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction model.""",https://pubmed.ncbi.nlm.nih.gov/37129737,treat,treated,: seventeen glioblastoma patients treated with standard-of-care therapy
Abstract,"""The clinical characteristics and outcomes of incidentally discovered glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34985720,identify,identified,number of glioblastomas (gbms) are identified by incidental radiological images
Abstract,"""Glioblastoma multiforme of the pineal region.""",https://pubmed.ncbi.nlm.nih.gov/1965444,restrict,restricted,case of glioblastoma multiforme restricted to the pineal region is presented.
Title,"""Single brain metastasis versus glioblastoma multiforme: a VOI-based multiparametric analysis for differential diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/35316518,base,based,metastasis versus glioblastoma multiforme: a voi-based multiparametric analysis for
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,require,requires,treatment of glioblastomas requires a multidisciplinary approach that takes the presently incurable
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,undergo,undergo,"patients with glioblastomas should undergo maximum surgical resection, followed by concurrent"
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,describe,described,to treat glioblastoma patients are described.
Abstract,"""Present and potential future issues in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/16759163,recur,recur,"however, glioblastomas almost invariably recur near their initial sites."
Abstract,"""Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37713930,have,have,"patients with glioblastomas have a dismal prognosis, and there is no"
Abstract,"""Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37713930,treat,treated,study in glioblastoma patients treated with standard radio-chemotherapy was conducted
Abstract,"""Association between post-operative hPG(80) (circulating progastrin) detectable level and worse prognosis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37713930,treat,treated,patients with glioblastoma treated with radio-chemotherapy.
Abstract,"""OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/30622231,detect,detected,in human glioblastoma stem cells and glioblastoma cells and was mainly detected
Abstract,"""OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/30622231,detect,detected,cells and glioblastoma cells and was mainly detected in the cytoplasm rather
Abstract,"""OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/30622231,grow,grown,formation of glioblastoma cells when grown in soft agar culture conditions.
Abstract,"""Lipidized glioblastoma: a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/20667010,arise,arising,of lipidized glioblastoma arising in the tempo-parietal lobe of a
Abstract,"""Lipidized glioblastoma: a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/20667010,add,adds,occurring in glioblastoma and adds observational data to the existing literature on
Abstract,"""The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32729303,identify,identified,associated with glioblastoma development have been identified.
Abstract,"""The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32729303,evaluate,evaluated,patients with glioblastomas were retrospectively evaluated.
Abstract,"""The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32729303,have,had,"patients with glioblastoma; however, radiotherapy and chemotherapy had a positive"
Abstract,"""Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.""",https://pubmed.ncbi.nlm.nih.gov/9694343,define,defined,giant cell glioblastomas are defined as glioblastomas with a marked predominance of
Abstract,"""Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.""",https://pubmed.ncbi.nlm.nih.gov/9694343,occur,occur,of all glioblastomas and can occur at any site of the central
Abstract,"""Favorable outcome of giant cell glioblastoma in a child. Report of an 11-year survival period.""",https://pubmed.ncbi.nlm.nih.gov/9694343,show,show,giant cell glioblastomas show a prolonged survival period compared with common glioblastoma
Title,"""Thiophene Carboxamide Analogs with Long Alkyl Chains Comprising Ethylene Glycol Units Inhibit Glioblastoma Cell Proliferation by Activating AMPK.""",https://pubmed.ncbi.nlm.nih.gov/37116172,activate,activating,units inhibit glioblastoma cell proliferation by activating ampk.
Abstract,"""Thiophene Carboxamide Analogs with Long Alkyl Chains Comprising Ethylene Glycol Units Inhibit Glioblastoma Cell Proliferation by Activating AMPK.""",https://pubmed.ncbi.nlm.nih.gov/37116172,require,requires,glioblastoma is a refractory malignant tumor that requires novel therapeutic
Abstract,"""Thiophene Carboxamide Analogs with Long Alkyl Chains Comprising Ethylene Glycol Units Inhibit Glioblastoma Cell Proliferation by Activating AMPK.""",https://pubmed.ncbi.nlm.nih.gov/37116172,inhibit,inhibiting,growth of glioblastoma stem cells by inhibiting mitochondrial function and synergistically enhancing
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,undergo,undergo,patients with glioblastoma who undergo maximal safe surgical resection.
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,invade,invade,glioblastomas that invade the corpus callosum and cross midline to
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,bgbms)-are,bgbms)-are,-butterfly glioblastomas (bgbms)-are one subgroup of tumors traditionally deemed inoperable
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,increase,increased,of butterfly glioblastoma prolongs survival without increased risk of permanent neurologic deficit
Abstract,"""Glioblastoma multiforme in three baboons (Papio spp).""",https://pubmed.ncbi.nlm.nih.gov/15232146,rear,reared,describes three glioblastomas in adult captive-reared baboons.
Abstract,"""Glioblastoma multiforme in three baboons (Papio spp).""",https://pubmed.ncbi.nlm.nih.gov/15232146,share,share,these baboon glioblastomas share many features with those of humans.
Abstract,"""Performance of (18) F-FAPI PET/CT in assessing glioblastoma before radiotherapy: a pilot study.""",https://pubmed.ncbi.nlm.nih.gov/36566187,undergo,undergone,: twelve glioblastoma patients having undergone incomplete surgical resection or biopsy were
Abstract,"""Morphologic and Molecular Aspects of Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33781498,evolve,evolved,definition of glioblastomas has continually evolved from a reliance on strict morphologic
Abstract,"""Morphologic and Molecular Aspects of Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33781498,include,includes,"workup of glioblastomas includes intraoperative evaluations with tissue-sparing techniques,"
Title,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,measure,measured,glioblastoma blood flow measured with stable xenon ct indicates tumor
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,use,using,patients with glioblastoma using stable xenon ct.
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,have,have,type i glioblastomas have unimodal high blood flow histograms; histologically there
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,have,have,type ii glioblastomas have unimodal low blood flow histograms; histologically there
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,induce,induced,"type ii glioblastoma, the abnormal vessels induced by hypoxia are inefficient"
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,multimodal,multimodal,type iii glioblastomas have multimodal blood flow histograms.
Abstract,"""Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/22492958,develop,develop,type iii glioblastomas were more likely to develop a post-surgical
Abstract,"""Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres.""",https://pubmed.ncbi.nlm.nih.gov/35538218,remain,remain,glioblastomas remain the most lethal primary brain tumors.
Abstract,"""Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres.""",https://pubmed.ncbi.nlm.nih.gov/35538218,select,select,"treatment of glioblastomas, since these cells can select and lyse therapy"
Abstract,"""Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.""",https://pubmed.ncbi.nlm.nih.gov/35486306,investigate,investigated,newly diagnosed glioblastoma were investigated.
Abstract,"""Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.""",https://pubmed.ncbi.nlm.nih.gov/35486306,use,using,newly diagnosed glioblastoma using custom made or commercially available assays.
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,investigate,investigated,"the pediatric glioblastomas have been extensively investigated, young adult glioblastomas were"
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,examine,examine,"young adult glioblastomas by braf, h3f3a and idh1 mutations and examine"
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,age,aged,"in 107 glioblastomas aged from 17 to 35 years, mutually exclusive"
Abstract,"""Biomarker-based prognostic stratification of young adult glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26452024,associate,associated,m mutated glioblastomas were tightly associated with midline locations and showed dismal
Abstract,"""Spindle-cell glioblastoma or gliosarcoma?""",https://pubmed.ncbi.nlm.nih.gov/1653908,suggest,suggests,' from glioblastoma multiforme and suggests that 'gliosarcomas' should be
Abstract,"""Spindle-cell glioblastoma or gliosarcoma?""",https://pubmed.ncbi.nlm.nih.gov/1653908,contain,containing,with typical glioblastomas containing only small islands of spindle cells and reticulin
Abstract,"""Spindle-cell glioblastoma or gliosarcoma?""",https://pubmed.ncbi.nlm.nih.gov/1653908,express,expressed,' and glioblastomas expressed s100 protein and gfap; many expressed asma
Abstract,"""Spindle-cell glioblastoma or gliosarcoma?""",https://pubmed.ncbi.nlm.nih.gov/1653908,express,expressed,' and glioblastomas most frequently expressed asma but many cells also expressed
Abstract,"""Spindle-cell glioblastoma or gliosarcoma?""",https://pubmed.ncbi.nlm.nih.gov/1653908,consider,considered,spindle cell glioblastomas and not be considered as a mixture of glioma
Title,"""Congenital Glioblastoma: Lessons Learned from a Rare Case with Unusual Presentation.""",https://pubmed.ncbi.nlm.nih.gov/27438622,learn,learned,congenital glioblastoma: lessons learned from a rare case with unusual
Abstract,"""Congenital Glioblastoma: Lessons Learned from a Rare Case with Unusual Presentation.""",https://pubmed.ncbi.nlm.nih.gov/27438622,undiagnose,undiagnosed,a congenital glioblastoma undiagnosed at pregnancy presented to our emergencies with rapid
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,induce,induced,in human glioblastomas was induced.
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,select,selected,-r9 glioblastoma cells were selected and prepared from human drug-
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,augment,augmented,-tolerant glioblastoma cells were augmented following honokiol administration.
Abstract,"""Major Contribution of Caspase-9 to Honokiol-Induced Apoptotic Insults to Human Drug-Resistant Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/32210117,induce,induced,-resistant glioblastoma cells with honokiol induced cell apoptosis but did not
Abstract,"""CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway.""",https://pubmed.ncbi.nlm.nih.gov/29321087,underlie,underlying,"promotes human glioblastoma invasion and, if so, the underlying mechanisms"
Abstract,"""Prognostic value of 11C-methionine volume-based PET parameters in IDH wild type glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35213602,undergo,underwent,wild type glioblastoma patients underwent preoperative 11c-met pet.
Title,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,accord,according,"newly diagnosed glioblastoma, idh-wildtype according to who 2021 classification"
Abstract,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,assess,assess,"-diagnosed glioblastoma, idh-wildtype in order to assess the"
Abstract,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,enhance,enhanced,contrast enhanced glioblastomas (26.7 months) than in contrast enhanced glioblastomas
Abstract,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,associate,associated,"contrast enhanced glioblastomas, a ring-like pattern was associated with"
Abstract,"""Glioblastoma multiforme and the meningeal syndrome.""",https://pubmed.ncbi.nlm.nih.gov/185547,detect,detected,irritants of glioblastomas and craniopharyngiomas are similar chemically and can be detected
Title,"""Glioblastoma brain tumours: estimating the time from brain tumour initiation and resolution of a patient survival anomaly after similar treatment protocols.""",https://pubmed.ncbi.nlm.nih.gov/22882019,estimate,estimating,glioblastoma brain tumours: estimating the time from brain tumour
Abstract,"""Glioblastoma brain tumours: estimating the time from brain tumour initiation and resolution of a patient survival anomaly after similar treatment protocols.""",https://pubmed.ncbi.nlm.nih.gov/22882019,incorporate,incorporates,"model for glioblastomas (brain tumours), which incorporates the two"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,recognize,recognized,) in glioblastomas is recognized as an important treatment target.
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,use,using,"-mediated glioblastoma progression by using cell proliferation (3-(4,5-dimethylthiazol-2"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,bear,bearing,", a glioblastoma-bearing animal model was used to validate the"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,induce,induces,anti-glioblastoma drug which induces apoptosis and has the capacity to
Abstract,"""A deep convolutional neural network for the automatic segmentation of glioblastoma brain tumor: Joint spatial pyramid module and attention mechanism network.""",https://pubmed.ncbi.nlm.nih.gov/38325925,aim,aiming,"segmentation of glioblastoma brain tumors, aiming sat replacing the manual segmentation"
Title,"""Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth.""",https://pubmed.ncbi.nlm.nih.gov/37162706,exhibit,exhibit,-derived glioblastoma cell line while exhibit moderate effect on normal stem
Abstract,"""Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth.""",https://pubmed.ncbi.nlm.nih.gov/37162706,know,known,"glioblastomas (gbm), also known as glioblastoma multiforme"
Abstract,"""Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37056564,identify,identified,datasets of glioblastomas and identified 2 robust immune subtypes based on lncrna
Abstract,"""Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37056564,facilitate,facilitate,"regulation in glioblastomas, and will facilitate the development of epigenetic immunotherapy"
Title,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,transplant,transplanted,of human glioblastoma transplanted on chicken chorioallantoic membrane.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,take,taken,survival of glioblastoma tumors taken immediately from operating theatre and transplanted on
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,obtain,obtained,glioblastoma samples obtained from 10 patients were transplanted onto 200
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,reveal,revealed,were not glioblastomas as it was revealed later.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,exhibit,exhibited,transplanted glioblastomas exhibited the same features as original glioblastomas - necrosis
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,show,showed,while transplanted glioblastomas also showed glial fibrillary acidic protein (gfap)
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,show,show,transplanted glioblastomas did not show any immunoreactivity of p53.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,survive,survive,pieces of glioblastoma survive with all cytological features.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,remain,remains,"that transplanted glioblastoma remains as insulated unit, which survives from nourishment"
Abstract,"""Integrin alphavbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22914772,use,using,expression in glioblastomas using near-infrared fluorescent (nirf) imaging
Abstract,"""Integrin alphavbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22914772,drive,driven,a transgenic glioblastoma mouse model (rcas-pdgf-driven/
Abstract,"""Integrin alphavbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22914772,mimic,mimics,"-a glioblastoma, which mimics the infiltrative growth pattern of human"
Abstract,"""Integrin alphavbeta3-targeted IRDye 800CW near-infrared imaging of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22914772,overexpresse,overexpressed,localized to glioblastoma tissue with overexpressed integrin receptors and is retained over
Abstract,"""Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27777151,treat,treated,spinal cord glioblastoma treated in our department were included in this study
Abstract,"""Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27777151,identify,identified,"spinal cord glioblastoma were identified between 2006 and 2015, all of"
Abstract,"""Management of Patients with Primary Intramedullary Spinal Cord Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27777151,remain,remains,spinal cord glioblastoma still remains poor.
Abstract,"""Analysis Suggests Drug Combos for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27165727,develop,develop,shown that glioblastomas can develop resistance to a drug by rewiring their
Abstract,"""A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34320218,recommend,recommend,sptrs for glioblastomas in the past year were more likely to recommend
Abstract,"""A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34320218,consider,considered,right frontal glioblastomas were considered the best randomization candidates.
Abstract,"""A Crowdsourced Consensus on Supratotal Resection Versus Gross Total Resection for Anatomically Distinct Primary Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34320218,identify,identified,sptr of glioblastoma and identified anatomically distinct locations deemed most amenable to
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,let,let,structure of glioblastoma let us to investigate hmga2 expression in the border
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,analyze,analyzed,grade 4 glioblastomas were analyzed for hmga2 expression using quantitative real-
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,compare,compared,"expressed in glioblastoma compared to healthy brain tissue (qpcr, p=0.013"
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,seem,seems,"zone of glioblastomas; thus, the expression cluster of hmga2 seems"
Abstract,"""Unique molecular characteristics of radiation-induced glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17882018,represent,represent,-induced glioblastomas (rigs) represent a significant proportion of glioblastomas
Abstract,"""Unique molecular characteristics of radiation-induced glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17882018,see,seen,proportion of glioblastomas (gbms) seen in children and young adults
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,suggest,suggests,"expression in glioblastomas are unknown, but evidence suggests that transforming growth"
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,display,display,upregulated in glioblastomas and display a significant positive correlation.
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,include,including,"broadly in glioblastoma tissues, including tumor parenchyma regions in the immediate"
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,derive,derived,", and glioblastoma-derived endothelial and fap+ mesenchymal cells, but"
Abstract,"""[Cerebellar glioblastoma multiforme: a case report].""",https://pubmed.ncbi.nlm.nih.gov/15152353,account,accounts,: cerebellar glioblastoma multiforme (cgm) accounts for less than 1
Abstract,"""[Cerebellar glioblastoma multiforme: a case report].""",https://pubmed.ncbi.nlm.nih.gov/15152353,spread,spreads,"all intracranial glioblastomas; it spreads quickly locally, above all towards"
Abstract,"""[Cerebellar glioblastoma multiforme: a case report].""",https://pubmed.ncbi.nlm.nih.gov/15152353,make,made,diagnosis of glioblastoma multiforme to be made; radio and chemotherapy were
Abstract,"""GammaTile(): Surgically targeted radiation therapy for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32618209,recur,recur,% of glioblastomas recur in proximity to the resection cavity.
Title,"""Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/35650594,target,targeting,assessment of glioblastoma-targeting car-t based immunotherapies.
Abstract,"""Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies.""",https://pubmed.ncbi.nlm.nih.gov/35650594,overexpresse,overexpressing,mg human glioblastoma (gbm) cells overexpressing the tumor-specific
Abstract,"""Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.""",https://pubmed.ncbi.nlm.nih.gov/24412053,use,using,-embedded glioblastoma samples using a locked nucleic acid real-time
Abstract,"""Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.""",https://pubmed.ncbi.nlm.nih.gov/24412053,use,using,"the 60 glioblastomas, using three different non-neoplastic references as"
Abstract,"""Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III.""",https://pubmed.ncbi.nlm.nih.gov/24412053,suggest,suggests,profile for glioblastoma and suggests that different-grade neoplasia could be
Abstract,"""Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37154886,undergo,undergoing,-wildtype glioblastomas which are undergoing evaluation in clinical trials.
Abstract,"""Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37154886,offer,offer,-wildtype glioblastomas offer hope and the prospect of incremental improvements in
Abstract,"""Contrast Enhancement Patterns in Pediatric Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/36112052,comprise,comprise,", pediatric glioblastomas (gbms) comprise 2.9% of all central"
Abstract,"""Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.""",https://pubmed.ncbi.nlm.nih.gov/30346623,infiltrate,infiltrating,": although glioblastomas are heterogeneous brain-infiltrating tumors, their treatment"
Abstract,"""Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.""",https://pubmed.ncbi.nlm.nih.gov/30346623,evaluate,evaluate,-defined glioblastoma subregions and evaluate their potential prognostic value.
Abstract,"""Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival.""",https://pubmed.ncbi.nlm.nih.gov/30346623,show,show,conclusions: glioblastomas show heterogeneous amino acid uptake with high-uptake
Abstract,"""Glioblastoma multiforme of the cerebellum: description of three cases.""",https://pubmed.ncbi.nlm.nih.gov/6254346,report,reported,cases of glioblastoma multiforme of the cerebellum have been reported in the
Abstract,"""Glioblastoma multiforme of the cerebellum: description of three cases.""",https://pubmed.ncbi.nlm.nih.gov/6254346,confirm,confirmed,"3 cerebellar glioblastomas in a review of 1,206 consecutive confirmed cases of"
Abstract,"""Glioblastoma multiforme of the cerebellum: description of three cases.""",https://pubmed.ncbi.nlm.nih.gov/6254346,operate,operated,cases of glioblastoma operated on between 1947 and 1977 at the istituto
Abstract,"""Cerebellar glioblastoma in childhood. Case report.""",https://pubmed.ncbi.nlm.nih.gov/185342,report,reported,childhood cerebellar glioblastomas have been reported previously in the world literature.
Abstract,"""Glioblastoma multiforme of the cerebellum in an elderly man. A case report.""",https://pubmed.ncbi.nlm.nih.gov/2559527,comprise,comprises,glioblastoma multiforme of the cerebellum is rare and comprises a
Title,"""Papillary glioblastoma exhibiting a neuroradiological cyst with a mural nodule: A case report.""",https://pubmed.ncbi.nlm.nih.gov/30633222,exhibit,exhibiting,papillary glioblastoma exhibiting a neuroradiological cyst with a mural nodule:
Abstract,"""Papillary glioblastoma exhibiting a neuroradiological cyst with a mural nodule: A case report.""",https://pubmed.ncbi.nlm.nih.gov/30633222,infiltrate,infiltrating,"rationale: glioblastomas are malignant, infiltrating gliomas classified as grade iv"
Abstract,"""Papillary glioblastoma exhibiting a neuroradiological cyst with a mural nodule: A case report.""",https://pubmed.ncbi.nlm.nih.gov/30633222,exhibit,exhibit,", most glioblastomas do not exhibit the isocitrate dehydrogenase (idh)"
Abstract,"""Papillary glioblastoma exhibiting a neuroradiological cyst with a mural nodule: A case report.""",https://pubmed.ncbi.nlm.nih.gov/30633222,form,form,"neuroradiologically, glioblastomas rarely form a cyst with a mural nodule lesion"
Abstract,"""Papillary glioblastoma exhibiting a neuroradiological cyst with a mural nodule: A case report.""",https://pubmed.ncbi.nlm.nih.gov/30633222,exhibit,exhibited,", a glioblastoma, exhibited pseudopapillary features with non-hyalinized capillary"
Abstract,"""Papillary glioblastoma exhibiting a neuroradiological cyst with a mural nodule: A case report.""",https://pubmed.ncbi.nlm.nih.gov/30633222,exhibit,exhibited,"case of glioblastoma that exhibited novel neuroradiological, histopathological, and genetic"
Abstract,"""Alterations of the Glymphatic System in Glioblastomas: A Systematic Review.""",https://pubmed.ncbi.nlm.nih.gov/39060078,aim,aiming,"relationship between glioblastomas and the glymphatic system, aiming to elucidate their"
Abstract,"""Alterations of the Glymphatic System in Glioblastomas: A Systematic Review.""",https://pubmed.ncbi.nlm.nih.gov/39060078,include,including,"system in glioblastomas exhibits changes, including diminished lymphatic outflow, disruptions"
Abstract,"""Therapeutic strategies for inhibiting invasion in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19344303,invade,invade,patients with glioblastomas is the propensity of the tumor to invade into
Abstract,"""MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/31592732,accord,according,"location of glioblastomas according to subventricular zone, age, sex,"
Abstract,"""MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/31592732,accord,according,-type glioblastomas according to parameters of interest and provided an image
Abstract,"""MRI Atlas of IDH Wild-Type Supratentorial Glioblastoma: Probabilistic Maps of Phenotype, Management, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/31592732,integrate,integrating,role of glioblastoma location as a surrogate and multimodal parameter integrating several
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,affect,affecting,"glioblastoma, the most common and heterogeneous tumor affecting brain"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,explore,explored,"features of glioblastomas that are, indeed, currently explored in preclinical"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,discuss,discussing,"landscapes of glioblastomas, in each case discussing the corresponding targeted therapies"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,enforce,enforcing,"investigate many glioblastoma epigenetic biomarkers in clinical practice, further enforcing the"
Abstract,"""Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26007164,propose,proposed,) by glioblastomas has been proposed to reveal their origin and may
Abstract,"""Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26007164,include,including,predictors of glioblastoma patient prognosis; the expression profiles (including stemness
Abstract,"""Can lateral ventricle contact predict the ontogeny and prognosis of glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26007164,estimate,estimated,"origin of glioblastomas cannot be simply estimated by radiographic lvc,"
Title,"""Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.""",https://pubmed.ncbi.nlm.nih.gov/29788733,make,making,differentiation of glioblastoma stem cells making them more sensitive to oxidative stress
Abstract,"""Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.""",https://pubmed.ncbi.nlm.nih.gov/29788733,arise,arise,proposes that glioblastomas arise from mutations that transform normal neural stem cells
Abstract,"""Current and Future Drug Treatments for Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27758718,have,have,glioblastomas are the most aggressive of all gliomas and have
Title,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,confirm,confirmed,"metastases from glioblastoma, as confirmed with the oncoscan assay."
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,base,based,metastasis from glioblastoma is usually based on the histopathology and immunohistochemical staining
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,locate,located,with a glioblastoma located in the left temporal lobe underwent resection followed
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,confirm,confirmed,metastases from glioblastoma was confirmed with an oncoscan assay and pathologic analysis
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,spread,spread,"carcinomas, glioblastomas can spread via the lymphatic route."
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,alleviate,alleviate,"metastases from glioblastoma can alleviate discomfort and prolong survival, especially in"
Abstract,"""Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28223536,take,taking,") in glioblastomas (gbms), taking into consideration the role"
Abstract,"""LINGO1, C7orf31 and VEGFA are prognostic genes of primary glioblastoma: analysis of gene expression microarray.""",https://pubmed.ncbi.nlm.nih.gov/30064229,grade,grade,glioblastoma is the most prevalent malignant glioma in who grade
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,guide,guide,of cerebellar glioblastomas in order to guide patient management.
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,diagnose,diagnosed,with cerebellar glioblastoma diagnosed between 2003 and 2017.
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,analyze,analyzed,"118 cerebellar glioblastoma patients were analyzed (mean age 55.9 years,"
Abstract,"""Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33399987,associate,associated,"of cerebellar glioblastoma is associated with improved onco-functional outcomes,"
Title,"""[Glioblastomas exploit neuronal properties: a key to new forms of treatment?].""",https://pubmed.ncbi.nlm.nih.gov/38157044,exploit,exploit,[glioblastomas exploit neuronal properties: a key to new forms
Abstract,"""[Glioblastomas exploit neuronal properties: a key to new forms of treatment?].""",https://pubmed.ncbi.nlm.nih.gov/38157044,exhibit,exhibit,indicates that glioblastomas exhibit different neural properties that successfully promote tumor growth
Abstract,"""[Glioblastomas exploit neuronal properties: a key to new forms of treatment?].""",https://pubmed.ncbi.nlm.nih.gov/38157044,contribute,contribute,"of the glioblastoma networks contribute to malignancy and resistance, which is"
Abstract,"""An update on the epigenetics of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27585647,know,known,"glioblastomas, also known as glioblastoma multiforme (gbm)"
Abstract,"""An update on the epigenetics of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27585647,noncode,noncoding,"modification, glioblastoma stem cells, dna methylation, noncoding rnas expression"
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,show,showing,"with primary glioblastomas showing prominent adipocytic (lipomatous) differentiation, hence"
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,contain,contained,features of glioblastoma but additionally contained areas consisting of glial fibrillary acidic
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,indicate,indicate,a rare glioblastoma differentiation pattern and indicate that glioblastomas with adipocyte-
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,share,share,indicate that glioblastomas with adipocyte-like tumor cell differentiation share common
Abstract,"""Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy.""",https://pubmed.ncbi.nlm.nih.gov/23264191,analyze,analyzed,newly diagnosed glioblastoma were analyzed by early post-operative magnetic resonance
Abstract,"""Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy.""",https://pubmed.ncbi.nlm.nih.gov/23264191,observe,observed,of resected glioblastomas are frequently observed.
Abstract,"""An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.""",https://pubmed.ncbi.nlm.nih.gov/24484232,remain,remains,"patients with glioblastoma, tumor recurrence remains inevitable."
Abstract,"""An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.""",https://pubmed.ncbi.nlm.nih.gov/24484232,remove,removed,enhancing recurrent glioblastoma tissue must be removed to improve overall survival and
Abstract,"""An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.""",https://pubmed.ncbi.nlm.nih.gov/24484232,treat,treated,recurrent supratentorial glioblastomas treated at the barrow neurological institute from 2001 to
Abstract,"""An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.""",https://pubmed.ncbi.nlm.nih.gov/24484232,follow,following,de novo glioblastoma and following their initial resection received standard temozolomide and
Abstract,"""An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.""",https://pubmed.ncbi.nlm.nih.gov/24484232,attain,attained,"for recurrent glioblastomas, an improvement in overall survival can be attained"
Abstract,"""An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.""",https://pubmed.ncbi.nlm.nih.gov/24484232,suggest,suggesting,"newly diagnosed glioblastomas, suggesting that for a subset of patients,"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,constitute,constitute,these glioblastoma subtypes constitute distinct disease entities that affect patients of
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,develop,develop,"that primary glioblastomas develop in older patients (mean age, 62"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,develop,develop,"secondary glioblastomas develop in younger patients (mean, 45 years"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,locate,located,"in secondary glioblastomas, 57% were located in hotspot codons 248"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,distribute,distributed,"in primary glioblastomas, mutations were more widely distributed."
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,arise,arise,in these glioblastoma subtypes arise through different mechanisms.
Abstract,"""Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/23142818,shed,shed,"glioblastomas shed large quantities of small, membrane-bound"
Title,"""[Primary connus medullaris glioblastoma: case report].""",https://pubmed.ncbi.nlm.nih.gov/16059615,report,report,connus medullaris glioblastoma: case report].
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,suggest,suggesting,newly diagnosed glioblastoma patients with clinical characteristics suggesting poor prognosis.
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergoing,newly diagnosed glioblastoma undergoing surgery.
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergo,newly diagnosed glioblastoma undergo pretreatment radio-labeled amino acid tracer positron
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of radiation
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of chemotherapy
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of molecular
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of immunologically
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergone,newly diagnosed glioblastoma who have undergone surgical debulking and completed concurrent chemoradiation
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,increase,increasing,dissemination of glioblastomas is very rare but is increasing as patients live
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,operate,operated,histologically proven glioblastoma multiforme were operated on in the neurosurgical department of
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,include,including,spread of glioblastoma multiforme including spinal drop metastases.
Abstract,"""Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.""",https://pubmed.ncbi.nlm.nih.gov/9587932,express,express,that untreated glioblastomas primarily express p-glycoprotein even if they are
Abstract,"""Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo.""",https://pubmed.ncbi.nlm.nih.gov/20665905,include,included,histologically proven glioblastoma or metastasis were included in the study.
Abstract,"""Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo.""",https://pubmed.ncbi.nlm.nih.gov/20665905,discriminate,discriminated,"combination, glioblastoma can be reliably discriminated from cerebral metastases."
Abstract,"""Expression of Tax-interacting protein 1 (TIP-1) facilitates angiogenesis and tumor formation of human glioblastoma cells in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/23010083,characterize,characterized,"of human glioblastomas, this study has characterized tip-1 as one contributing"
Abstract,"""CD34 expression in glioblastoma and giant cell glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20175958,assess,assessed,giant cell glioblastomas and 16 non-giant cell glioblastomas were assessed
Abstract,"""CD34 expression in glioblastoma and giant cell glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20175958,assess,assessed,giant cell glioblastomas were assessed with immunocytochemical staining for cd34. method
Abstract,"""CD34 expression in glioblastoma and giant cell glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20175958,show,showed,"giant cell glioblastomas showed some degree of staining for cd34, and"
Abstract,"""CD34 expression in glioblastoma and giant cell glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20175958,show,showed,"giant cell glioblastomas showed some degree of cd34 staining, and 25"
Abstract,"""CD34 expression in glioblastoma and giant cell glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20175958,show,show,"giant cell glioblastomas frequently show cd34 expression by neoplastic cells, which"
Title,"""Glioblastomas: Hijacking Metabolism to Build a Flexible Shield for Therapy Resistance.""",https://pubmed.ncbi.nlm.nih.gov/37022791,build,build,glioblastomas: hijacking metabolism to build a flexible shield for
Title,"""Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.""",https://pubmed.ncbi.nlm.nih.gov/21989663,derive,derived,subventricular zone glioblastoma-derived stem-like cells display different molecular
Abstract,"""Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.""",https://pubmed.ncbi.nlm.nih.gov/21989663,use,used,"-dissociated glioblastomas and a2b5+ magnetic cell sorting, were used"
Abstract,"""Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.""",https://pubmed.ncbi.nlm.nih.gov/21989663,contain,contained,a cortical glioblastoma and contained a high number of cd133(+) cells
Title,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,associate,associated,lymphocytes in glioblastoma are associated with specific genomic alterations and related to
Abstract,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,define,defined,roles in glioblastoma have not been fully defined.
Abstract,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,associate,associated,"tils in glioblastoma are associated with molecular alterations, histologies, and"
Abstract,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,associate,associated,"enriched in glioblastomas of the mesenchymal class, strongly associated with mutations"
Abstract,"""STAT-1 expression in human glioblastoma and peritumoral tissue.""",https://pubmed.ncbi.nlm.nih.gov/18225539,analyse,analysed,-six glioblastoma samples have been analysed for the expression of stat-1
Abstract,"""STAT-1 expression in human glioblastoma and peritumoral tissue.""",https://pubmed.ncbi.nlm.nih.gov/18225539,stain,staining,of 46 glioblastomas (48%) were strongly positive for staining
Abstract,"""STAT-1 expression in human glioblastoma and peritumoral tissue.""",https://pubmed.ncbi.nlm.nih.gov/18225539,document,documented,"majority of glioblastomas, together with its documented role in apoptosis and"
Abstract,"""STAT-1 expression in human glioblastoma and peritumoral tissue.""",https://pubmed.ncbi.nlm.nih.gov/18225539,chemotherapy,chemotherapy,response of glioblastomas to chemotherapy.
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,associate,associated,"of 98 glioblastoma patients, idh1 ( r132 ) mutations were associated"
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,carry,carried,to 51 glioblastoma samples of which 16 carried an idh1 (r132
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,provide,provided,capacity in glioblastoma was provided for 65% by idh activity and
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,explain,explaining,"may sensitize glioblastoma to irradiation and chemotherapy, thus explaining the prolonged"
Abstract,"""Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.""",https://pubmed.ncbi.nlm.nih.gov/18575745,promote,promote,in a glioblastoma could promote its rapid growth and clinical progression.
Abstract,"""Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.""",https://pubmed.ncbi.nlm.nih.gov/18575745,seem,seems,necrosis of glioblastoma seems to be associated with thrombosis that result from
Abstract,"""Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.""",https://pubmed.ncbi.nlm.nih.gov/18575745,have,had,found that glioblastoma cells had a high level of constitutive nuclear factor
Abstract,"""Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.""",https://pubmed.ncbi.nlm.nih.gov/18575745,indicate,indicating,"activity of glioblastoma cells, indicating a tf-dependent mechanism."
Abstract,"""Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.""",https://pubmed.ncbi.nlm.nih.gov/18575745,play,plays,activity in glioblastomas cells plays a critical role in necrosis formation of
Abstract,"""Aberrant NF-kappaB activity is critical in focal necrosis formation of human glioblastoma by regulation of the expression of tissue factor.""",https://pubmed.ncbi.nlm.nih.gov/18575745,suppress,suppress,activity in glioblastoma can suppress necrosis formation and progressive growth.
Title,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,consider,considering,optimization for glioblastomas considering immune responses.
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,show,shown,", including glioblastomas, but little has been shown to be effective"
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,have,have,is that glioblastomas have a high ability to evade attacks from the
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,vary,varies,therapy for glioblastomas varies among guidelines and clinical trials.
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,conduct,conducted,"radiotherapy for glioblastomas was conducted, and it was reported that the"
Abstract,"""The need of radiotherapy optimization for glioblastomas considering immune responses.""",https://pubmed.ncbi.nlm.nih.gov/37071249,propose,propose,immunotherapy to glioblastomas and the novel role of radiotherapy and propose the
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,occur,occur,whereas some glioblastomas occur with no prior evidence of a lower-
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,identify,identified,groups of glioblastomas have been identified previously.
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,associate,associated,to identify glioblastoma-associated genes (gag) that are associated
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,confirm,confirmed,staining of glioblastoma tissue arrays confirmed expression differences.
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,include,included,"mutant primary glioblastomas only, as previous series included secondary glioblastomas."
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,retrieve,retrieved,-wildtype glioblastomas and idh-mutant secondary glioblastomas retrieved from datasets
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,retrieve,retrieved,mutant secondary glioblastomas retrieved from datasets.
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,combine,combined,"seen in glioblastomas, such as egfr amplification, combined +7/-10,"
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,mismatch,mismatch,"pathogenesis in glioblastomas, chromatin modifying and mismatch repair pathways were common"
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,have,have,mutant primary glioblastomas have better prognosis than secondary glioblastomas and have major
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,have,have,than secondary glioblastomas and have major molecular differences from other commoner glioblastomas
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,have,have,"aims: glioblastoma patients have a dismal prognosis, due to inevitable"
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,implicate,implicated,dominate the glioblastoma tumour microenvironment and have been implicated in tumour progression
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,contain,contain,"early recurrent glioblastomas contain focal reactive regions with occasional fibrosis, chronic"
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,compare,compared,and recurrent glioblastomas were compared between patients with early recurrences (n
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,show,showed,"early recurrent glioblastomas showed enrichment for tams, expressing both pro- and"
Abstract,"""Non-enhancing de novo glioblastoma: report of two cases.""",https://pubmed.ncbi.nlm.nih.gov/15449198,demonstrate,demonstrate,de novo glioblastomas may demonstrate a non-enhancing tumor suggestive of
Abstract,"""Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25455996,have,had,determined that glioblastomas with few mss and vcs had many gvps and
Abstract,"""Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25455996,categorize,categorized,mvps in glioblastoma can be categorized properly by certain histopathologic and statistical
Abstract,"""Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status.""",https://pubmed.ncbi.nlm.nih.gov/29209894,characterize,characterized,three human glioblastoma cell lines characterized by a different pten gene status
Abstract,"""Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28988652,enhance,enhancing,glioblastomas with a substantial proportion of noncontrast-enhancing tumour
Abstract,"""Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28988652,demonstrate,demonstrating,determine whether glioblastomas demonstrating a substantial proportion (>33%)
Abstract,"""Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28988652,review,reviewed,diagnosis of glioblastoma were reviewed.
Title,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,identify,identify,and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,classify,classified,glioblastoma is classified into two subtypes on the basis of
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,arise,arising,'primary glioblastoma' arising de novo without detectable antecedent disease and
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,evolve,evolve,and secondary glioblastomas evolve through similar or different molecular pathogenetic routes.
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,subject,subjected,and secondary glioblastoma samples were subjected to high-resolution copy number
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,remain,remaining,"defined primary glioblastomas, the remaining two stratified secondary glioblastoma into two"
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,show,shown,"and secondary glioblastomas that were previously unappreciated, and has shown for"
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,compose,composed,conclude that glioblastoma is composed of at least three distinct molecular subtypes
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,benefit,benefit,"of secondary glioblastoma, which may benefit from different therapeutic strategies."
Abstract,"""Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/8824552,suppress,suppress,"of human glioblastomas, and re-introduction of p53 can suppress"
Abstract,"""Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/8824552,analyze,analyzed,"therapy of glioblastoma, we have analyzed the response of human glioblastoma"
Title,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,depend,depends,cells towards glioblastoma cells depends on hepatocyte-growth factor and is
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,contribute,contributes,"expressed by glioblastomas and contributes to their growth, migration and invasion"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,exploit,exploited,"tropism for glioblastomas, which is exploited in gene therapy to deliver"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,mediate,mediated,msc by glioblastoma cells and whether aminolaevulinic acid-mediated photodynamic therapy
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,affect,affects,"apoptosis in glioblastoma cells, affects hgf release and this migratory response"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,express,express,"thus, glioblastoma cells express hgf, which contributes to the attraction"
Abstract,"""[Glioblastomas: gliomagenesis, genetics, angiogenesis, and microenvironment].""",https://pubmed.ncbi.nlm.nih.gov/20817192,derive,derive,"studies, glioblastomas derive from malignant transformation of stem cells and/or glial"
Abstract,"""Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies.""",https://pubmed.ncbi.nlm.nih.gov/2539242,define,defined,"of the glioblastoma multiforme, the distribution of eight defined cell types"
Abstract,"""Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies.""",https://pubmed.ncbi.nlm.nih.gov/2539242,study,studied,of 18 glioblastomas studied postmortem.
Abstract,"""Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies.""",https://pubmed.ncbi.nlm.nih.gov/2539242,appear,appeared,", multifocal glioblastomas appeared to be emerging in the background of a"
Abstract,"""Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies.""",https://pubmed.ncbi.nlm.nih.gov/2539242,appear,appear,although some glioblastomas appear largely undifferentiated and consistent with the de novo
Abstract,"""Cytologic composition of the untreated glioblastoma with implications for evaluation of needle biopsies.""",https://pubmed.ncbi.nlm.nih.gov/2539242,underscore,underscores,in a glioblastoma underscores the care that must be exercised in utilization
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,base,based,cases of glioblastoma within a population-based study (1)
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,have,had,small cell glioblastomas had frequent egfr amplification and p16 deletion but infrequent
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,contain,containing,glioblastomas containing >or=5% multinucleated giant cells showed more
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,pseudopalisade,pseudopalisading,"in all glioblastomas, whereas large ischemic and/or pseudopalisading necrosis was observed"
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,associate,associated,glioblastomas with necrosis were associated with older age (59.2
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,associate,associated,features in glioblastomas are associated with specific genetic alterations and with clinical
Abstract,"""Multifocal glioblastoma with liver metastases in the absence of surgery. Case report.""",https://pubmed.ncbi.nlm.nih.gov/2553882,differ,differing,two intracerebral glioblastomas of differing histology with metastases to the liver in
Abstract,"""Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29546530,recur,recur,glioblastomas are aggressive brain tumors that frequently recur in the
Abstract,"""Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29546530,treat,treated,"diagnosed with glioblastoma and treated with surgery, radiation, and concurrent"
Abstract,"""Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29546530,recur,recurred,"glioblastomas frequently recurred in the subventricular zone, and patient"
Abstract,"""Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19712474,characterize,characterized,subtype of glioblastoma is characterized by overexpression of extracellular matrix (ecm)/mesenchymal
Abstract,"""Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19712474,associate,associated,overexpressed in glioblastomas and associated with worse outcome.
Abstract,"""Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19712474,perform,performed,"mgp in glioblastomas, we performed expression, migration and proliferation studies"
Title,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,treat,treated,of hypermutated glioblastoma: a patient with germline pole deficiency treated with
Abstract,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,hypermutate,hypermutated,left frontal glioblastoma with primitive neuroectodermal tumor features and hypermutated genotype in
Abstract,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,treat,treated,principle that glioblastomas with dna-repair defects treated with checkpoint blockade
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,raise,raised,subsets among glioblastomas has raised the question whether distinct mutations in glioblastoma
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,associate,associated,mutations in glioblastoma-associated genes may serve as prognostic markers.
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,sample,sampled,study on glioblastomas (gbm) from 97 consecutively sampled adult patients
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,provide,provide,genotyping of glioblastoma may provide clinical information of prognostic importance.
Abstract,"""Neuro-oncology: unmasking the multiforme in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20531430,require,required,classification of glioblastomas into various molecular entities is required for the successful
Title,"""Successful Preoperative Endovascular Embolization of an Extreme Hypervascular Glioblastoma Mimicking an Arteriovenous Malformation.""",https://pubmed.ncbi.nlm.nih.gov/26463396,mimic,mimicking,extreme hypervascular glioblastoma mimicking an arteriovenous malformation.
Abstract,"""Successful Preoperative Endovascular Embolization of an Extreme Hypervascular Glioblastoma Mimicking an Arteriovenous Malformation.""",https://pubmed.ncbi.nlm.nih.gov/26463396,establish,established,for hypervascular glioblastomas has not been established.
Abstract,"""Successful Preoperative Endovascular Embolization of an Extreme Hypervascular Glioblastoma Mimicking an Arteriovenous Malformation.""",https://pubmed.ncbi.nlm.nih.gov/26463396,mimic,mimicking,extreme hypervascular glioblastoma mimicking an arteriovenous malformation that was successfully treated with
Title,"""Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting.""",https://pubmed.ncbi.nlm.nih.gov/27467557,use,using,cellularity in glioblastoma and correlation with adc using trajectory analysis and automatic
Abstract,"""Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting.""",https://pubmed.ncbi.nlm.nih.gov/27467557,use,using,biopsies of glioblastoma patients using a new postprocessing approach including trajectory analysis
Abstract,"""Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting.""",https://pubmed.ncbi.nlm.nih.gov/27467557,enrol,enrolled,newly diagnosed glioblastomas were enrolled in this study.
Abstract,"""Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting.""",https://pubmed.ncbi.nlm.nih.gov/27467557,vary,varied,cellularity in glioblastomas that varied depending on the approach towards statistical analysis
Abstract,"""Role of extent of resection on quality of life in patients with newly diagnosed GBM.""",https://pubmed.ncbi.nlm.nih.gov/29371739,know,known,glioblastomas known for their adverse outcomes are most reportedly managed
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,base,based,"glioblastoma, grade iv malignant glioma based on the world"
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,cause,caused,prognosis of glioblastoma patients is largely caused by the striking radioresistance of
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,provide,provide,phenotype of glioblastomas and plausible mechanisms of radiation resistance can provide new
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,result,result,patients with glioblastoma and result in a better prognosis for these patients
Title,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,use,using,of human glioblastoma using quantitative sodium mr imaging.
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,fractionate,fractionated,of human glioblastoma to fractionated chemoradiation are described by changes in the
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,use,using,patients with glioblastomas (n = 20) using tsc obtained from
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,undergo,undergoing,diagnosed human glioblastomas undergoing treatment were compared with time-to-
Abstract,"""Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.""",https://pubmed.ncbi.nlm.nih.gov/30487127,produce,produces,chemoradiotherapy of glioblastomas produces variable responses with low cell killing efficiency.
Title,"""Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.""",https://pubmed.ncbi.nlm.nih.gov/25821160,associate,associated,and secondary glioblastoma is associated with differential molecular subtype distribution.
Abstract,"""Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.""",https://pubmed.ncbi.nlm.nih.gov/25821160,classify,classified,glioblastoma multiforme (gbm) is classified into primary (
Abstract,"""Novel diagnostic and therapeutic approaches to malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/21607882,represent,represents,"patients with glioblastoma represents a particular challenge, with surgery followed by"
Abstract,"""Novel diagnostic and therapeutic approaches to malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/21607882,complete,completed,newly diagnosed glioblastoma have completed enrolment.
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,describe,described,-molecular glioblastoma subtypes have been described: 'primary' glioblastomas
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,arise,arise,primary' glioblastomas arise de novo in older patients and often overexpress
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,know,known,of molecular glioblastoma subtype are known.
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,classify,classified,"reviewed 75 glioblastomas, classified as tp53-mutated (n=11)"
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,mutate,mutated,"-amplified glioblastomas, greater than that of tp53-mutated glioblastomas"
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,amplify,amplified,all 15 glioblastomas with t2 bsc<30.8 were egfr-amplified.
Abstract,"""A molecular genetic model of astrocytoma histopathology.""",https://pubmed.ncbi.nlm.nih.gov/9161727,emerge,emerge,"finally, glioblastomas may emerge from the microenvironmental outgrowth of more malignant"
Abstract,"""A molecular genetic model of astrocytoma histopathology.""",https://pubmed.ncbi.nlm.nih.gov/9161727,arise,arise,well that glioblastoma multiforme can arise via a number of independent genetic
Abstract,"""Cathepsin S expression: An independent prognostic factor in glioblastoma tumours--A pilot study.""",https://pubmed.ncbi.nlm.nih.gov/16550604,associate,associated,scores in glioblastomas were associated with significantly shorter survival (10 vs.
Abstract,"""Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/23774672,characterize,characterized,"glioblastomas, the most common primary gliomas, are characterized"
Abstract,"""Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/23774672,need,needs,autophagy in glioblastoma development still needs to be further investigated.
Abstract,"""Immunohistochemical analysis of giant cell glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/7550996,express,expresses,"as ordinary glioblastomas and, as these, expresses high levels of"
Abstract,"""Immunohistochemical analysis of giant cell glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/7550996,have,has,"as ordinary glioblastoma, has distinct biological and clinical characteristics, with"
Abstract,"""Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.""",https://pubmed.ncbi.nlm.nih.gov/23041832,include,including,"-conventional glioblastomas, including 45 small cell glioblastomas, 45 gliosarcomas"
Abstract,"""Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.""",https://pubmed.ncbi.nlm.nih.gov/23041832,rule,ruling,"granular cell glioblastomas, the latter being particularly helpful in ruling out"
Abstract,"""Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.""",https://pubmed.ncbi.nlm.nih.gov/23041832,exclude,excluding,"support for glioblastoma with oligodendroglial component, while essentially excluding small cell"
Abstract,"""Histopathologic and immunohistochemical profile of spinal glioblastoma: a study of six cases.""",https://pubmed.ncbi.nlm.nih.gov/21643805,know,known,spinal intramedullary glioblastomas are uncommon tumors and are known to have a
Abstract,"""Histopathologic and immunohistochemical profile of spinal glioblastoma: a study of six cases.""",https://pubmed.ncbi.nlm.nih.gov/21643805,underline,underlined,that spinal glioblastomas are heterogeneous tumors underlined by complex molecular pathways.
Title,"""A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.""",https://pubmed.ncbi.nlm.nih.gov/37619245,diagnose,diagnosed,young adult glioblastomas diagnosed using 2016 who guidelines for central nervous system
Abstract,"""A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.""",https://pubmed.ncbi.nlm.nih.gov/37619245,diagnose,diagnosed,young adult glioblastomas diagnosed using 2016 who world health organization classification of
Title,"""Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.""",https://pubmed.ncbi.nlm.nih.gov/38676720,base,based,-wildtype glioblastomas based on the new rano-resect classification.
Abstract,"""Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.""",https://pubmed.ncbi.nlm.nih.gov/38676720,debate,debated,"management of glioblastoma is a long-debated topic, recently widened"
Abstract,"""Prognostic implications of epilepsy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26489387,improve,improved,and secondary glioblastomas were factors that improved survival (p<0.001).
Abstract,"""Prognostic implications of epilepsy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26489387,predict,predict,symptom in glioblastomas predict longer survival.
Abstract,"""Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis.""",https://pubmed.ncbi.nlm.nih.gov/12626129,metastasize,metastasize,glioblastomas rarely metastasize outside the cns.
Abstract,"""Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis.""",https://pubmed.ncbi.nlm.nih.gov/12626129,associate,associated,of secondary glioblastoma associated with extracranial progression and distant metastasis.
Abstract,"""Amino Acid PET Imaging of the Early Metabolic Response During Tumor-Treating Fields (TTFields) Therapy in Recurrent Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29261637,detect,detected,"in recurrent glioblastoma, and this treatment response can be detected by"
Abstract,"""MicroRNAs in brain tumors : a new diagnostic and therapeutic perspective?""",https://pubmed.ncbi.nlm.nih.gov/21739238,summarize,summarized,adults (glioblastomas) and children (medulloblastomas) will be summarized
Abstract,"""Dendritic cell immunotherapy for brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/26037466,characterize,characterized,"glioblastomas are characterized by immunosuppression, rapid proliferation, angiogenesis"
Abstract,"""Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro.""",https://pubmed.ncbi.nlm.nih.gov/9219734,invade,invade,"glioblastomas extensively invade the surrounding normal brain tissue, with"
Abstract,"""Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro.""",https://pubmed.ncbi.nlm.nih.gov/9219734,study,study,"treatment of glioblastomas, to study the expression of upa in three"
Abstract,"""Cisplatin but not BCNU inhibits urokinase-type plasminogen activator levels in human glioblastoma cell lines in vitro.""",https://pubmed.ncbi.nlm.nih.gov/9219734,result,resulted,treatment of glioblastoma cells with cisplatin resulted in significantly decreased levels of
Abstract,"""The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/19161638,expose,exposed,in malignant glioblastomas exposed to hypoxia than in low grade astrocytic glial
Abstract,"""The treatment of glioblastomas: a systematic update on clinical Phase III trials.""",https://pubmed.ncbi.nlm.nih.gov/23453191,associate,associated,glioblastomas (gbms) are invariably associated with unavoidable tumor
Abstract,"""[Genetic diseases and glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20869734,relate,related,review discusses glioblastomas related to these diseases and the current knowledge on
Abstract,"""Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/16820883,pretreate,pretreated,glioblastoma cells pretreated with imatinib demonstrated an enhanced sensitivity to
Abstract,"""Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/16820883,expose,exposed,in irradiated glioblastoma cells exposed to imatinib may be a consequence of
Abstract,"""Enhancement of radiation sensitivity, delay of proliferative recovery after radiation and abrogation of MAPK (p44/42) signaling by imatinib in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/16820883,receive,receive,treatment of glioblastomas that receive radiation therapy.
Abstract,"""NFKBIA deletion in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21175304,have,have,tumorigenesis in glioblastomas that do not have alterations of egfr.
Abstract,"""NFKBIA deletion in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21175304,occur,occur,mutated in glioblastomas; most deletions occur in nonclassical subtypes of the
Abstract,"""NFKBIA deletion in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21175304,associate,associated,pathogenesis of glioblastoma and is associated with comparatively short survival.
Title,"""High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.""",https://pubmed.ncbi.nlm.nih.gov/26438560,associate,associated,angiography in glioblastoma: tumor-associated neovascularization as a biomarker for
Abstract,"""High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.""",https://pubmed.ncbi.nlm.nih.gov/26438560,include,including,) with glioblastoma underwent mri including first-pass dynamic susceptibility contrast
Abstract,"""High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.""",https://pubmed.ncbi.nlm.nih.gov/26438560,associate,associated,hypervascular glioblastomas were associated with higher cel volume and lower karnofsky
Abstract,"""High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.""",https://pubmed.ncbi.nlm.nih.gov/26438560,treat,treated,"and hypervascular glioblastomas treated with surgery, radiotherapy, and chemotherapy were"
Abstract,"""High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.""",https://pubmed.ncbi.nlm.nih.gov/26438560,seem,seems,newly diagnosed glioblastoma seems to be a useful biomarker that correlates with
Title,"""Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.""",https://pubmed.ncbi.nlm.nih.gov/16356835,convert,convert,rays in glioblastoma cells: a strategy to convert a radio-
Abstract,"""Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.""",https://pubmed.ncbi.nlm.nih.gov/16356835,show,show,"activity, glioblastomas show a high degree of radioresistance."
Title,"""In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats.""",https://pubmed.ncbi.nlm.nih.gov/17143538,etoposide,etoposide,of human glioblastoma cells by fas ligand plus etoposide and in vivo
Abstract,"""In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats.""",https://pubmed.ncbi.nlm.nih.gov/17143538,express,express,human glioblastomas that express fas/cd95 receptor are highly resistant
Abstract,"""In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats.""",https://pubmed.ncbi.nlm.nih.gov/17143538,study,studied,"-expressing glioblastoma cell line, u-87 mg, was firstly studied"
Abstract,"""In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats.""",https://pubmed.ncbi.nlm.nih.gov/17143538,fas,fas,sensitivity of glioblastoma cells to fas or etoposide-mediated apoptosis.
Title,"""[Familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and prognostic features].""",https://pubmed.ncbi.nlm.nih.gov/16960645,present,presenting,[familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and
Abstract,"""[Familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and prognostic features].""",https://pubmed.ncbi.nlm.nih.gov/16960645,associate,associated,metachronous glioblastomas have been associated to better prognosis in some studies
Abstract,"""The transcription factor ATF5: role in neurodevelopment and neural tumors.""",https://pubmed.ncbi.nlm.nih.gov/19046351,indicate,indicates,atf5 in glioblastoma cells indicates that interference with its expression or activity
Abstract,"""In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotion.""",https://pubmed.ncbi.nlm.nih.gov/7795275,slow,slow,"taxol for glioblastoma may slow the growth of bulk disease, but"
Title,"""Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.""",https://pubmed.ncbi.nlm.nih.gov/37495706,attenuate,attenuated,glioblastomas with and without peritumoral fluid-attenuated inversion recovery
Abstract,"""Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.""",https://pubmed.ncbi.nlm.nih.gov/37495706,attenuate,attenuated,objectives: glioblastoma (gb) without peritumoral fluid-attenuated inversion
Abstract,"""Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.""",https://pubmed.ncbi.nlm.nih.gov/37495706,show,show,statement: glioblastomas without peritumoral flair hyperintensity show less immature neovascularization and
Abstract,"""Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.""",https://pubmed.ncbi.nlm.nih.gov/37495706,show,showed,• glioblastomas without peritumoral flair hyperintensity showed less necrosis and contrast
Abstract,"""Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.""",https://pubmed.ncbi.nlm.nih.gov/37495706,have,had,• glioblastomas without peritumoral flair hyperintensity had less immature neovascularization and
Abstract,"""[Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].""",https://pubmed.ncbi.nlm.nih.gov/25536822,distinguish,distinguished,"two glioblastoma groups, which are distinguished from each other by"
Abstract,"""[Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].""",https://pubmed.ncbi.nlm.nih.gov/25536822,reflect,reflect,of the glioblastomas into two groups may reflect two pathways of astrocytic
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,divide,divided,glioblastoma can be divided into genetic subsets.
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,have,have,"third of glioblastomas have tp53 mutations, one third"
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,have,have,", secondary glioblastomas have a much higher incidence of tp53 mutations than"
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,have,have,"onset, glioblastomas in young adults are likely to have tp53 mutations"
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,define,defined,between the glioblastoma sites and the genetic subsets defined by the presence
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,seat,seated,suggest that glioblastomas deep-seated in the thalamus and basal ganglia
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,originate,originate,where the glioblastomas originate may be associated with the genetic features.
Abstract,"""[Fluorescence guided resection of malignant brain tumors - breakthrough in the surgery of brain tumors].""",https://pubmed.ncbi.nlm.nih.gov/19513974,represent,represents,the glioblastoma itself represents the most unfavorable tumor.
Abstract,"""[Fluorescence guided resection of malignant brain tumors - breakthrough in the surgery of brain tumors].""",https://pubmed.ncbi.nlm.nih.gov/19513974,challenge,challenging,removal of glioblastomas is challenging due to their infiltrative growth pattern.
Abstract,"""Radiological assessment of necrosis in glioblastoma: variability and prognostic value.""",https://pubmed.ncbi.nlm.nih.gov/9561517,have,had,of supratentorial glioblastomas and had ct and/or mri with contrast medium before
Abstract,"""Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach.""",https://pubmed.ncbi.nlm.nih.gov/31554364,analyse,analysed,vegf in glioblastoma and positively can be further analysed through in vitro
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,determine,determined,our human glioblastoma cases and determined the molecules that possibly influenced the
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,determine,determined,of 38 glioblastomas were determined.
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,show,showed,patients with glioblastomas showed that a high mib-1 li correlated with poor
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,result,resulting,"malignancy of glioblastomas, resulting in a poor survival."
Title,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,report,reported,primary spinal glioblastomas or gliosarcomas reported in literature until march 2015.
Abstract,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,report,reported,primary spinal glioblastomas (gb) or gliosarcomas (gs) reported
Abstract,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,use,using,"cases of glioblastomas / gliosarcomas with primary spinal origin, using predefined"
Abstract,"""A Systematic Review on the Characteristics, Treatments and Outcomes of the Patients with Primary Spinal Glioblastomas or Gliosarcomas Reported in Literature until March 2015.""",https://pubmed.ncbi.nlm.nih.gov/26859136,enter,entered,primary spinal glioblastomas should be entered into a central registry in order
Title,"""Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.""",https://pubmed.ncbi.nlm.nih.gov/24620969,reveal,revealed,) in glioblastoma multiforme who iv cells and blood vessels revealed by
Abstract,"""Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.""",https://pubmed.ncbi.nlm.nih.gov/24620969,lose,lost,glioblastomas are neuroepithelial tumors with lost cellular differentiation and tenfold
Abstract,"""Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.""",https://pubmed.ncbi.nlm.nih.gov/24620969,hinder,hindered,research on glioblastoma border zone was hindered by the tumor's intense
Abstract,"""Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.""",https://pubmed.ncbi.nlm.nih.gov/24620969,characterize,characterized,human multiform glioblastomas were characterized as a ncam-140 negative entity displaying three
Abstract,"""Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.""",https://pubmed.ncbi.nlm.nih.gov/24620969,compare,compared,mass of glioblastomas compared to their invasion zone and tumor-free
Abstract,"""Cytologic features of pleomorphic xanthoastrocytoma, WHO grade II. A comparative study with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28084690,relate,related,pxa and glioblastoma were related to cell turnover rather than cytomorphologic features
Abstract,"""Cytologic features of pleomorphic xanthoastrocytoma, WHO grade II. A comparative study with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28084690,show,shows,glioblastoma shows features of high cellular replication showing a dirty
Abstract,"""Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.""",https://pubmed.ncbi.nlm.nih.gov/36242633,predict,predicting,"with recurrent glioblastomas, and imaging biomarker predicting treatment response to anti"
Abstract,"""Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.""",https://pubmed.ncbi.nlm.nih.gov/36242633,treat,treated,with recurrent glioblastomas treated with bevacizumab.
Abstract,"""Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.""",https://pubmed.ncbi.nlm.nih.gov/36242633,treat,treated,with recurrent glioblastomas treated with bevacizumab who underwent pretreatment mri with dynamic
Abstract,"""Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.""",https://pubmed.ncbi.nlm.nih.gov/36242633,treat,treated,in recurrent glioblastomas treated with anti-angiogenic therapy and aided patient
Abstract,"""Vessel size and perfusion-derived vascular habitat refines prediction of treatment failure to bevacizumab in recurrent glioblastomas: validation in a prospective cohort.""",https://pubmed.ncbi.nlm.nih.gov/36242633,treat,treated,in recurrent glioblastomas treated with anti-angiogenic therapy.
Abstract,"""Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.""",https://pubmed.ncbi.nlm.nih.gov/33887763,base,based,identify midh glioblastoma based on radiomic features derived from magnetic resonance imaging
Abstract,"""Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.""",https://pubmed.ncbi.nlm.nih.gov/33887763,use,using,mutation in glioblastoma using preoperative t1 postcontrast imaging.
Abstract,"""Overexpression of LncRNA PSMG3-AS1 Distinguishes Glioblastomas from Sarcoidosis.""",https://pubmed.ncbi.nlm.nih.gov/32529538,misdiagnose,misdiagnosed,"practices, glioblastomas (gbm) in some cases can be misdiagnosed"
Abstract,"""Establishment and characterization of human glioblastoma cell line (HUBT-n).""",https://pubmed.ncbi.nlm.nih.gov/16130901,establish,established,", but glioblastoma cell line (hubt-n) was established"
Abstract,"""Spatial optimization for radiation therapy of brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/31251755,involve,involve,"treatments for glioblastomas commonly involve a combination of surgical intervention, chemotherapy"
Abstract,"""Spatial optimization for radiation therapy of brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/31251755,show,show,"growth of glioblastomas in vivo, but also show potential for the"
Abstract,"""Is there a role for bevacizumab in the treatment of glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/24056893,base,based,"in progressive glioblastoma, based on improved radiologic response rates observed with"
Abstract,"""Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23960453,undergo,underwent,patients with glioblastoma who underwent gtr and postoperative rt were analyzed.
Abstract,"""Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23960453,undergo,underwent,patients with glioblastoma who underwent gtr.
Title,"""Deciphering Nanoparticle Trafficking into Glioblastomas Uncovers an Augmented Antitumor Effect of Metronomic Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/34726310,uncover,uncovers,trafficking into glioblastomas uncovers an augmented antitumor effect of metronomic chemotherapy.
Abstract,"""Deciphering Nanoparticle Trafficking into Glioblastomas Uncovers an Augmented Antitumor Effect of Metronomic Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/34726310,traverse,traverse,explored in glioblastomas as they can traverse the blood-brain barrier
Abstract,"""Deciphering Nanoparticle Trafficking into Glioblastomas Uncovers an Augmented Antitumor Effect of Metronomic Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/34726310,underlie,underlying,trafficking into glioblastoma cells and their underlying intracellular fate after systemic administration
Abstract,"""Deciphering Nanoparticle Trafficking into Glioblastomas Uncovers an Augmented Antitumor Effect of Metronomic Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/34726310,show,shown,"an intracranial glioblastoma model, it is shown that ligand-modified"
Abstract,"""Deciphering Nanoparticle Trafficking into Glioblastomas Uncovers an Augmented Antitumor Effect of Metronomic Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/34726310,undergo,undergo,"lysosomes of glioblastoma cells, and undergo endolysosomal escape upon photochemical ionization"
Abstract,"""Topographic anatomy and CT correlations in the untreated glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/2833587,localize,localized,concept that glioblastomas are localized within 2 cm of the contrast-
Abstract,"""Topographic anatomy and CT correlations in the untreated glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/2833587,treat,treat,suggests that glioblastomas will be difficult to treat successfully by intra-
Abstract,"""Spontaneous radiographic resolution and subsequent redemonstration of an untreated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21476808,represent,represent,biology of glioblastomas but could also represent pseudoregression following successful control of
Title,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,matter,matter,heterogeneity of glioblastomas: does location matter?
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,develop,develop,glioblastomas in adults are highly heterogeneous tumors that can develop
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,demonstrate,demonstrated,derived two glioblastoma cell lines from cortical and periventricular locations and demonstrated
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,select,selected,to correlate glioblastoma locations with the expression of ten selected genes (
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,include,included,newly diagnosed glioblastomas were retrospectively included.
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,characterize,characterized,"to cortical glioblastomas, periventricular glioblastomas were characterized by a higher expression"
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,characterize,characterized,", periventricular glioblastomas were characterized by a higher expression of two mesenchymal"
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,associate,associated,-o glioblastomas were associated with lower expression of vegfc (p
Abstract,"""Altered cellular distribution and subcellular sorting of gamma-tubulin in diffuse astrocytic gliomas and human glioblastoma cell lines.""",https://pubmed.ncbi.nlm.nih.gov/16772870,compare,compared,astrocytomas and glioblastomas multiforme as compared to low-grade diffuse astrocytomas
Abstract,"""Prognostic significance of endothelial surface score and MIB-1 labeling index in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/10896201,treat,treated,"patients with glioblastoma, previously treated by surgical resection and radiotherapy."
Abstract,"""Microarray Analysis in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26113463,do,done,analysis in glioblastomas is done using either cell lines or patient samples
Abstract,"""Microarray Analysis in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26113463,plo,plos,"of the glioblastoma cells (jiang et al., plos one"
Abstract,"""Spontaneous penetration of dura mater and bone by glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/3041114,include,including,"only 15 glioblastomas, including the three cases, spontaneously penetrating the"
Abstract,"""Spontaneous penetration of dura mater and bone by glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/3041114,have,had,six glioblastomas also had spontaneous distant metastases.
Abstract,"""Spontaneous penetration of dura mater and bone by glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/3041114,promote,promote,of the glioblastomas may promote such spontaneous penetration into the cranial dura
Title,"""Travelling wave solutions of the reaction-diffusion mathematical model of glioblastoma growth: an Abel equation based approach.""",https://pubmed.ncbi.nlm.nih.gov/25811333,base,based,model of glioblastoma growth: an abel equation based approach.
Abstract,"""Travelling wave solutions of the reaction-diffusion mathematical model of glioblastoma growth: an Abel equation based approach.""",https://pubmed.ncbi.nlm.nih.gov/25811333,characterize,characterized,"evolution of glioblastomas, aggressive primary brain tumors that are characterized by"
Abstract,"""Travelling wave solutions of the reaction-diffusion mathematical model of glioblastoma growth: an Abel equation based approach.""",https://pubmed.ncbi.nlm.nih.gov/25811333,travel,travelling,describing the glioblastoma growth through travelling waves can be reduced to a
Abstract,"""Travelling wave solutions of the reaction-diffusion mathematical model of glioblastoma growth: an Abel equation based approach.""",https://pubmed.ncbi.nlm.nih.gov/25811333,obtain,obtained,"that describes glioblastoma growth are obtained, corresponding to different forms of"
Abstract,"""Stable radiobiological features in a genetically unstable glioblastoma cell line.""",https://pubmed.ncbi.nlm.nih.gov/9298111,inherit,inherited,radioresistance of glioblastomas might be inherited from the normal tissue from which
Abstract,"""Localization of congenital glioblastomas in the Japanese: a case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/11981623,arise,arise,most congenital glioblastomas arise in the cerebral hemispheres.
Abstract,"""Localization of congenital glioblastomas in the Japanese: a case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/11981623,report,reported,of congenital glioblastoma have been reported in the literature from asian countries
Abstract,"""Localization of congenital glioblastomas in the Japanese: a case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/11981623,recognize,recognized,"on congenital glioblastomas, we recognized that in japanese patients this tumor"
Abstract,"""Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/18343632,correlate,correlate,subclasses of glioblastomas that correlate with survival phenotypes.
Abstract,"""Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/18343632,perform,performed,stratify unknown glioblastomas between survival groups and performed this task with 100
Abstract,"""Dephosphorylation of beta-arrestin 1 in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19404096,show,showed,of the glioblastoma samples (58/81) showed nearly complete beta-
Title,"""Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.""",https://pubmed.ncbi.nlm.nih.gov/11131986,specimen,specimens,factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and
Abstract,"""Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.""",https://pubmed.ncbi.nlm.nih.gov/11131986,exist,exist,that in glioblastomas there exist a clear correlation between the tumor-
Abstract,"""Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.""",https://pubmed.ncbi.nlm.nih.gov/11131986,relate,related,"that in glioblastomas, tumor angiogenesis is clearly related to the expression"
Abstract,"""Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.""",https://pubmed.ncbi.nlm.nih.gov/18021194,include,including,"in 109 glioblastomas, including 98 primary glioblastomas and 11 secondary glioblastomas"
Abstract,"""Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.""",https://pubmed.ncbi.nlm.nih.gov/18021194,exhibit,exhibited,although glioblastomas with egfr gene amplification invariably exhibited egfr overexpression at
Abstract,"""Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.""",https://pubmed.ncbi.nlm.nih.gov/18021194,compose,composed,% of glioblastomas with egfr gene amplification were composed of areas with
Abstract,"""IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.""",https://pubmed.ncbi.nlm.nih.gov/31388723,transfecte,transfected,"used the glioblastoma cell line u87mg, fap-transfected fibrosarcoma"
Abstract,"""IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.""",https://pubmed.ncbi.nlm.nih.gov/31388723,observe,observed,"in glioblastomas, we observed spots with increased uptake in projection"
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,grade,grade,glioblastomas (who grade iv) may develop de novo
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,show,show,(secondary glioblastomas) both glioblastomas show similar histological features.
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,show,show,) both glioblastomas show similar histological features.
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,involve,involve,subtypes of glioblastoma involve distinct disease entities that evolve through different genetic
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,develop,develop,"majority of glioblastomas develop de novo (primary glioblastomas), without"
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,evolve,evolve,"subtypes of glioblastoma evolve through different genetic pathways, affect patients at"
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,occur,occur,primary glioblastomas occur in older patients and typically show epidermal growth
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,develop,develop,secondary glioblastomas develop in younger patients and often contain tp53 mutations
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,show,shown,variants of glioblastoma were shown to have intermediate clinical and genetic profiles
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,occupy,occupies,giant cell glioblastoma clinically and genetically occupies a hybrid position between primary
Abstract,"""Functional diversity of PFKFB3 splice variants in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/34234350,understand,understood,prognosis of glioblastomas is only partially understood.
Abstract,"""Gliobastoma multiforme of the cerebellum.""",https://pubmed.ncbi.nlm.nih.gov/167463,report,reported,of cerebellar glioblastoma have been reported.
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,examine,examined,glioblastomas were examined for abnormalities in fibroblast growth factor receptor
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,exhibit,exhibited,protein in glioblastomas: glioblastoma cells exhibited intense fgfr1 immunoreactivity in frozen
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,exhibit,exhibited,glioblastomas: glioblastoma cells exhibited intense fgfr1 immunoreactivity in frozen sections of
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,evaluate,evaluated,all glioblastomas evaluated in the present study expressed fgfr1 mrna and
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,result,result,mrna in glioblastomas did not result from gene amplification.
Abstract,"""Primary glioblastoma multiforme of the cerebellum. A case report.""",https://pubmed.ncbi.nlm.nih.gov/6246732,arise,arising,case of glioblastoma multiforme arising in the right cerebellar hemisphere is reported
Abstract,"""Primary glioblastoma multiforme of the cerebellum. A case report.""",https://pubmed.ncbi.nlm.nih.gov/6246732,emphasize,emphasized,the supratentorial glioblastomas is emphasized.
Abstract,"""MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12760291,survive,survive,patients with glioblastoma survive more than 2 years after diagnosis.
Abstract,"""MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12760291,live,lived,li of glioblastomas from 34 patients who lived for more than 2
Abstract,"""MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12760291,match,matched,and of glioblastomas from 34 age- and sex-matched control patients
Abstract,"""CHARACTERISTICS OF A172 AND T98G CELL LINES.""",https://pubmed.ncbi.nlm.nih.gov/30188626,serve,serve,features of glioblastomas and therefore can serve as research objects in investigation
Title,"""ell clusters isolation in glioblastomas and their functional and molecular characterization using new morphometric approaches.""",https://pubmed.ncbi.nlm.nih.gov/37582322,use,using,isolation in glioblastomas and their functional and molecular characterization using new morphometric
Abstract,"""Growth dynamics of untreated glioblastomas in vivo.""",https://pubmed.ncbi.nlm.nih.gov/25758748,reach,reach,assumption that glioblastomas reach a plateau phase and thus exhibit gompertzian growth
Abstract,"""Growth dynamics of untreated glioblastomas in vivo.""",https://pubmed.ncbi.nlm.nih.gov/25758748,show,shown,"rate of glioblastoma shown in this study, it is evident that"
Title,"""Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells.""",https://pubmed.ncbi.nlm.nih.gov/34504133,exclude,excluding,ki-67 in glioblastomas excluding contribution from non-neoplastic cells.
Abstract,"""Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells.""",https://pubmed.ncbi.nlm.nih.gov/34504133,vary,varies,survival of glioblastoma patients varies and prognostic markers are important in the
Abstract,"""Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells.""",https://pubmed.ncbi.nlm.nih.gov/34504133,exclude,excluding,) in glioblastomas more precisely than previously by excluding proliferation in non
Abstract,"""[A case of primary cerebellar glioblastoma in childhood].""",https://pubmed.ncbi.nlm.nih.gov/12491584,deteriorate,deteriorated,"primary cerebellar glioblastoma, who rapidly deteriorated due to cerebrospinal fluid dissemination"
Abstract,"""[A case of primary cerebellar glioblastoma in childhood].""",https://pubmed.ncbi.nlm.nih.gov/12491584,carry,carry,primary cerebellar glioblastomas in children carry a very poor prognosis and tend
Abstract,"""[Prenatal manifestation of a congenital glioblastoma - Case report].""",https://pubmed.ncbi.nlm.nih.gov/11887251,acute,acute,a congenital glioblastoma due to acute fetal internal hydrocephalus in the 37th
Abstract,"""[Prenatal manifestation of a congenital glioblastoma - Case report].""",https://pubmed.ncbi.nlm.nih.gov/11887251,stage,stage,a congenital glioblastoma (who stage iv) was confirmed by subtotal
Abstract,"""[Prenatal manifestation of a congenital glioblastoma - Case report].""",https://pubmed.ncbi.nlm.nih.gov/11887251,report,reported,"prenatally diagnosed glioblastomas have so far been reported, all of which"
Title,"""Optimal timing of chemoradiation after resection or biopsy of glioblastomas: a nationwide population-based study.""",https://pubmed.ncbi.nlm.nih.gov/39587516,base,based,biopsy of glioblastomas: a nationwide population-based study.
Abstract,"""PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/14642363,observe,observed,"dissemination of glioblastomas is often observed, but the underlying mechanism is"
Abstract,"""Prognostic significance of neuronal marker expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22922887,demonstrate,demonstrate,"differentiation in glioblastomas, they often demonstrate immunopositivity for neuronal markers."
Abstract,"""Prognostic significance of neuronal marker expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22922887,investigate,investigated,"expression in glioblastoma, this study investigated the expression of neuronal markers"
Abstract,"""Prognostic significance of neuronal marker expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22922887,present,presented,"outcome in glioblastoma is of considerable interest, the presented data support"
Abstract,"""Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/31822636,include,including,patients with glioblastoma (including one patient with samples available from the
Abstract,"""Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group.""",https://pubmed.ncbi.nlm.nih.gov/17122945,collect,collected,histologically proven glioblastomas from 9 lombardy hospitals collected in the same database
Title,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,predict,predicts,untreated human glioblastomas predicts the survival time for patients.
Abstract,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,collect,collected,"untreated human glioblastoma data collected in trondheim, norway, we first"
Abstract,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,re,re,"untreated human glioblastoma data in seattle, us, re-verify"
Abstract,"""Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients.""",https://pubmed.ncbi.nlm.nih.gov/32313150,predict,predict,"given the glioblastoma size in a patient, our model can predict"
Title,"""Reproducibility of rCBV in glioblastomas using T2*-weighted perfusion MRI: an evaluation of sampling, normalization, and experience.""",https://pubmed.ncbi.nlm.nih.gov/37789677,use,using,rcbv in glioblastomas using t2*-weighted perfusion mri: an evaluation
Abstract,"""Reproducibility of rCBV in glioblastomas using T2*-weighted perfusion MRI: an evaluation of sampling, normalization, and experience.""",https://pubmed.ncbi.nlm.nih.gov/37789677,use,using,measurement of glioblastomas using the hotspot method in dynamic susceptibility contrast perfusion
Abstract,"""Reproducibility of rCBV in glioblastomas using T2*-weighted perfusion MRI: an evaluation of sampling, normalization, and experience.""",https://pubmed.ncbi.nlm.nih.gov/37789677,evaluate,evaluated,patients with glioblastoma were retrospectively evaluated with dsc-mri at a
Abstract,"""[Morphological classification of glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20864138,classify,classified,"classification, glioblastomas are classified among the group of astrocytic tumors."
Abstract,"""[Morphological classification of glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20864138,exist,exist,"form of glioblastoma, two variants exist: the giant cell gbm"
Abstract,"""The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21229290,know,know,diagnose as glioblastomas some tumours we already know for which survival is
Abstract,"""The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21229290,expect,expected,"diagnosed as glioblastomas with oligodendroglioma component, obviously it must be expected"
Abstract,"""The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21229290,increase,increase,"incidence of glioblastoma will increase in these years; second, because"
Abstract,"""The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21229290,ascribe,ascribed,patients with glioblastoma in the next few years should be ascribed not
Title,"""Mesoscopic Assessment of Microstructure in Glioblastomas and Metastases by Merging Advanced Diffusion Imaging with Immunohistopathology.""",https://pubmed.ncbi.nlm.nih.gov/37884304,merge,merging,microstructure in glioblastomas and metastases by merging advanced diffusion imaging with immunohistopathology
Abstract,"""Mesoscopic Assessment of Microstructure in Glioblastomas and Metastases by Merging Advanced Diffusion Imaging with Immunohistopathology.""",https://pubmed.ncbi.nlm.nih.gov/37884304,assess,assessed,(10 glioblastomas and 9 metastases) were assessed for the presence
Abstract,"""Mesoscopic Assessment of Microstructure in Glioblastomas and Metastases by Merging Advanced Diffusion Imaging with Immunohistopathology.""",https://pubmed.ncbi.nlm.nih.gov/37884304,increase,increased,"we compared glioblastomas and metastases, fractional anisotropy was significantly increased and"
Abstract,"""[Secondary intraspinal localizations of glioblastoma. Apropos of a case].""",https://pubmed.ncbi.nlm.nih.gov/8577358,describe,described,of intracranial glioblastomas have been described for the first time more than
Abstract,"""[Secondary intraspinal localizations of glioblastoma. Apropos of a case].""",https://pubmed.ncbi.nlm.nih.gov/8577358,suggest,suggested,diagnosis of glioblastoma metastasis was suggested by intra-operative pathological findings
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,carry,carry,"subtypes of glioblastoma which carry very different prognoses, both defined by"
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,use,using,mutated secondary glioblastoma using evolutionary game theory to investigate the interactions between
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,reproduce,reproduce,model recapitulates glioblastoma behavior well and is able to reproduce two recent
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,experience,experience,that a glioblastoma will experience under different microenvironmental constraints.
Title,"""Histopathological investigation of glioblastomas resected under bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/27244880,resect,resected,investigation of glioblastomas resected under bevacizumab treatment.
Abstract,"""Histopathological investigation of glioblastomas resected under bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/27244880,resect,resected,collected six glioblastomas resected under bevacizumab treatment.
Abstract,"""Histopathological investigation of glioblastomas resected under bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/27244880,assess,assess,"eleven control glioblastomas to assess the differences in histological features, microvessel"
Abstract,"""The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33727611,observe,observed,"with intracranial glioblastoma xenografts, while no adverse effects were observed in"
Abstract,"""The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial.""",https://pubmed.ncbi.nlm.nih.gov/7671460,evaluate,evaluated,human glioblastomas were evaluated for overexpression of the epidermal growth factor
Abstract,"""Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30176837,suggest,suggested,"bearing orthotopic glioblastomas, it also suggested the administration did not completely"
Abstract,"""Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30176837,inoculate,inoculated,rat rg2 glioblastoma cells were inoculated into the brains of 36 rats
Abstract,"""Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.""",https://pubmed.ncbi.nlm.nih.gov/25514975,conduct,conducting,") in glioblastoma, by conducting a bioinformatics analysis."
Abstract,"""Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.""",https://pubmed.ncbi.nlm.nih.gov/25514975,use,used,with the glioblastoma gene expression profile were used to construct a regulatory
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,expect,expected,"in primary glioblastoma, thus the expected mgmt promoter methylation was low"
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,show,showed,glioblastoma patients with mgmt promoter methylation showed better response to
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,treat,treated,"32 primary glioblastomas, treated with radiotherapy and surgery, for tp53"
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,lead,lead,"in primary glioblastoma, but does not lead to g:c"
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,treat,treated,marker unless glioblastoma patients are treated with chemotherapy.
Abstract,"""[Giant cell glioblastoma. Case report].""",https://pubmed.ncbi.nlm.nih.gov/15259347,account,account,"giant cells glioblastomas, a subtype of these, account for less"
Abstract,"""[Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target].""",https://pubmed.ncbi.nlm.nih.gov/26156444,outline,outline,egfr in glioblastomas and outline the therapeutic approaches aimed against this receptor
Abstract,"""[Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target].""",https://pubmed.ncbi.nlm.nih.gov/26156444,base,based,"therapies for glioblastomas, based on inhibiting the egfr function."
Abstract,"""[Surgical treatment of glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20869732,confirm,confirm,need for glioblastoma surgery to confirm the histology and decrease the mass
Abstract,"""[Surgical treatment of glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20869732,treat,treated,"of 952 glioblastomas treated in france in 2004, 56% were"
Abstract,"""Multiscale modelling of palisade formation in gliobastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/26235287,show,show,as of glioblastomas growth dynamics; (2) we show that
Abstract,"""IL-6 gene amplification and expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11506489,contribute,contribute,feature in glioblastomas and may contribute to the il-6 over-expression
Abstract,"""Clinical significance of prognostic nutritional index in patients with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30508902,lack,lacking,in human glioblastomas (gbms) is lacking.
Abstract,"""Overexpression of mTOR and p(240-244)S6 in IDH1 Wild-Type Human Glioblastomas Is Predictive of Low Survival.""",https://pubmed.ncbi.nlm.nih.gov/29328863,increase,increased,-type glioblastomas might have increased benefit from targeted therapy against mtor
Abstract,"""Hans-Joachim Scherer (1906-1945), pioneer in glioma research.""",https://pubmed.ncbi.nlm.nih.gov/10219741,reflect,reflecting,"and secondary glioblastomas, and growth patterns reflecting the invasion of preexisting"
Abstract,"""A mathematical approach to virus therapy of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26738889,benefit,benefit,treatment of glioblastomas (gbm) could benefit from oncolytic virus therapy
Abstract,"""A mathematical approach to virus therapy of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26738889,observe,observed,vsv on glioblastoma observed in vitro.
Abstract,"""Proliferation index is related to patient age in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11342691,have,have,patients with glioblastomas have a significantly better prognosis than do older patients
Abstract,"""Proliferation index is related to patient age in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11342691,stain,stained,"cells, glioblastomas from patients of different ages were stained with the"
Abstract,"""Proliferation index is related to patient age in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11342691,afflict,afflict,type of glioblastomas that afflict younger patients.
Abstract,"""Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/34262079,get,got,"of 20 glioblastomas and 10 metastases, we got 93% accuracy"
Abstract,"""Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/34262079,use,using,metastases from glioblastomas using majority voting on patches.
Abstract,"""Algorithm for the standardized assessment of vascular patterns in glioblastoma specimens.""",https://pubmed.ncbi.nlm.nih.gov/15581027,use,used,"-immunostained glioblastoma specimens, which can be used for research and"
Abstract,"""Acidic and basic fibroblast growth factors are present in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/1717153,study,studied,from all glioblastomas studied.
Abstract,"""Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups.""",https://pubmed.ncbi.nlm.nih.gov/30923085,provide,provided,patients with glioblastomas from 10 local institutions during 2006-2017 provided
Abstract,"""Relationship between the overall survival in glioblastomas and the radiomic features of intraoperative ultrasound: a feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/33594589,guide,guide,diagnosed with glioblastoma (gbm) is essential to guide surgical strategy
Abstract,"""Relationship between the overall survival in glioblastomas and the radiomic features of intraoperative ultrasound: a feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/33594589,perform,performed,surgically treated glioblastomas between march 2018 and november 2019 was performed.
Abstract,"""Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/31880005,appear,appear,"of untreated glioblastomas appear to be able to visualize ca leakage,"
Abstract,"""Chromosome 7 in glioblastoma tissue. Parenchymal vs. endothelial cells.""",https://pubmed.ncbi.nlm.nih.gov/7497447,proliferate,proliferated,feature of glioblastomas and sometimes these proliferated areas transform into a malignant
Abstract,"""Chromosome 7 in glioblastoma tissue. Parenchymal vs. endothelial cells.""",https://pubmed.ncbi.nlm.nih.gov/7497447,result,resulting,"component of glioblastoma, resulting in gliosarcomas."
Title,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,glioblastomas located in proximity to the subventricular zone (svz
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,results: glioblastoma located in proximity to the svz showed increased mrna
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,exhibit,exhibit,"suggesting that glioblastoma stem cells exhibit increased dna repair capacity, glioblastomas"
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,show,showed,"capacity, glioblastomas in proximity to the svz also showed increased expression"
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,harbor,harbored,genomes of glioblastomas in svz proximity harbored fewer single nucleotide polymorphisms relative
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,exhibit,exhibited,patients with glioblastoma in proximity to svz exhibited poorer progression free and
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,suggests that glioblastomas located in proximity to the svz exhibited mrna expression
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,account,accounts,glioblastoma accounts for more than half of diffuse gliomas.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,remain,remains,patients with glioblastoma remains poor despite comprehensive and intensive treatments.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,remain,remains,prediction of glioblastomas remains limited.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,aid,aid,model for glioblastomas may aid in clinical prognosis evaluation.
Abstract,"""The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.""",https://pubmed.ncbi.nlm.nih.gov/35699848,classify,classified,features of glioblastoma (that would have otherwise been classified as grade
Abstract,"""[Growth rate of glioblastoma multiforme].""",https://pubmed.ncbi.nlm.nih.gov/1965467,know,known,cases of glioblastomas is well known.
Title,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,use,using,astrocytomas and glioblastoma using adult f344 rats and n-methyl-
Abstract,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,report,reported,astrocytomas and glioblastomas is reported.
Abstract,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,form,formed,"astrocytomas and glioblastomas of an astrocytic type formed the majority, whereas"
Abstract,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,predominate,predominated,", whereas glioblastomas of mixed oligo-astrocytic type predominated in aci"
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,remain,remain,enhancement in glioblastoma patients remain poorly understood.
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,segment,segmented,of 148 glioblastoma subjects from the cancer imaging archive were segmented using
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,enhance,enhancing,cimp) glioblastomas were poorly enhancing.
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,associate,associated,ce in glioblastoma is associated with distinct biological processes involved in inflammatory
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,guide,guide,state of glioblastomas and guide future therapeutic paradigms.
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,analyse,analysed,55 % glioblastomas analysed.
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,have,had,only one glioblastoma had both c228t and c250t mutations.
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,show,showed,glioblastoma patients with tert mutations showed a shorter survival than
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,analyse,analysed,and secondary glioblastomas were separately analysed.
Abstract,"""The Value of Immunohistochemical Methods and Preoperative Magnetic Resonance Imaging Findings in Diagnosis of IDH1 Mutant Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/34859824,use,using,mutation in glioblastomas using real-time polymerase chain reaction (rt
Abstract,"""The Value of Immunohistochemical Methods and Preoperative Magnetic Resonance Imaging Findings in Diagnosis of IDH1 Mutant Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/34859824,apply,applied,"diagnosed with glioblastoma, and idh1 stain was applied to the same"
Title,"""Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23418780,have,have,glioblastomas with oligodendroglial component have the same clinical phenotype as
Abstract,"""Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23418780,consider,considered,introduction: glioblastomas are the commonest primary brain tumour and are considered
Abstract,"""Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23418780,identify,identified,newly diagnosed glioblastomas were identified: 294 (74.2%) had
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,accompany,accompanied,astrocytoma to glioblastoma is often accompanied by increased angiogenesis and the upregulation
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,transduce,transduced,glioblastoma cells were transduced with an adenoviral vector encoding bai1
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,transplant,transplanted,-transduced glioblastoma cells transplanted into transparent skinfold chambers of scid mice
Abstract,"""Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29187298,use,using,expression in glioblastomas by using voxel-based neuroimaging analysis.
Abstract,"""Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29187298,review,reviewed,patients with glioblastomas were reviewed.
Abstract,"""Regional specificity of matrix metalloproteinase-9 expression in the brain: voxel-level mapping in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29187298,provide,provide,characteristics of glioblastoma and provide new insight into the molecular subtypes of
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,involve,involved,64 primary glioblastomas and 4 secondary glioblastomas were involved in this study
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,involve,involved,4 secondary glioblastomas were involved in this study.
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,target,targeting,treatment of glioblastomas targeting hcmv was needed to be revalued by studied
Title,"""Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.""",https://pubmed.ncbi.nlm.nih.gov/27856439,base,based,-stage glioblastomas: mr imaging-based classification and imaging evidence
Abstract,"""Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.""",https://pubmed.ncbi.nlm.nih.gov/27856439,report,reported,growth of glioblastomas from small to large tumors are seldom reported.
Abstract,"""Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.""",https://pubmed.ncbi.nlm.nih.gov/27856439,define,define,-stage glioblastomas and to define the order of appearance of different
Abstract,"""Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.""",https://pubmed.ncbi.nlm.nih.gov/27856439,review,reviewed,diagnosed with glioblastoma between 2006 and 2013 were reviewed.
Abstract,"""Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.""",https://pubmed.ncbi.nlm.nih.gov/27856439,define,defined,"-stage glioblastomas, defined as small mr imaging lesions detected early"
Abstract,"""Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.""",https://pubmed.ncbi.nlm.nih.gov/27856439,classify,classified,-stage glioblastomas were classified into 3 types and were all hyperintense
Abstract,"""Early-Stage Glioblastomas: MR Imaging-Based Classification and Imaging Evidence of Progressive Growth.""",https://pubmed.ncbi.nlm.nih.gov/27856439,confirm,confirmed,-stage glioblastomas of 16 patients were pathologically confirmed after imaging progression
Abstract,"""Visualization of angiographical arteriovenous shunting in perisylvian glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23435867,tend,tend,conclusions: glioblastomas in the perisylvian region tend to be associated with
Abstract,"""A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease.""",https://pubmed.ncbi.nlm.nih.gov/23216891,have,has,"glioblastoma multiformae, the most aggressive glioma subtype, has"
Abstract,"""A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease.""",https://pubmed.ncbi.nlm.nih.gov/23216891,correlate,correlates,rest in glioblastoma but how rest function correlates with disease outcome has
Abstract,"""Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.""",https://pubmed.ncbi.nlm.nih.gov/23063752,develop,developed,operational in glioblastomas that developed from lower-grade lesions.
Abstract,"""Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.""",https://pubmed.ncbi.nlm.nih.gov/23063752,lack,lacked,operational in glioblastomas that lacked idh mutation or history of antecedent lower
Abstract,"""Different angiogenic phenotypes in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16331629,suppose,supposed,"and secondary glioblastomas (pgbm, sgbm) are supposed to evolve"
Abstract,"""Different angiogenic phenotypes in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16331629,know,known,"in these glioblastoma subtypes is not known so far, but this"
Abstract,"""Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26945349,provide,provided,patients with glioblastomas that provided idh mutation and survival data were included
Abstract,"""A Bayesian diagnostic system to differentiate glioblastomas from solitary brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/23859240,base,based,"to differentiate glioblastomas from solitary metastases, based on multimodality mr examination"
Abstract,"""A Bayesian diagnostic system to differentiate glioblastomas from solitary brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/23859240,base,based,"accurately differentiates glioblastomas from solitary metastases, based on mr-derived"
Abstract,"""Association of stem cell marker CD133 expression with dissemination of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20135187,consider,considered,dissemination of glioblastoma was once considered rare but is now increasingly encountered
Abstract,"""Association of stem cell marker CD133 expression with dissemination of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20135187,mean,mean,"higher in glioblastomas with dissemination (mean 10.3, range 0.20-"
Abstract,"""Association of stem cell marker CD133 expression with dissemination of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20135187,give,give,"predictor of glioblastoma dissemination, and also give rise to an intriguing"
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,increase,increased,"of nine glioblastoma with five normal brain sage libraries, 44 increased"
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,both in glioblastomas and in glioblastoma cell lines suggesting their expression in
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,and in glioblastoma cell lines suggesting their expression in transformed cells.
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,"only in glioblastomas, not in glioblastoma cell lines suggesting an expression"
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,not in glioblastoma cell lines suggesting an expression possibly originated from host
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,produce,produce,"overexpressed in glioblastomas produce extracellular proteins, thereby providing possible therapeutic targets"
Title,"""Reply to: age as a predictive factor in glioblastomas: population-based study.""",https://pubmed.ncbi.nlm.nih.gov/20068359,base,based,factor in glioblastomas: population-based study.
Abstract,"""Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32890893,analyze,analyzed,operated for glioblastoma were analyzed.
Abstract,"""A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32748499,show,showed,"-wildtype glioblastomas, 33 samples (58.9%) showed a"
Abstract,"""A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32748499,reveal,revealed,-wildtype glioblastomas revealed 3 distinct groups of idh-wildtype glioblastomas
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,display,display,glioblastomas display variable phenotypes that include increased drug-resistance
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,chemotherapy,chemotherapy,to sensitize glioblastoma cells to chemotherapy.
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,inhibit,inhibit,"motility in glioblastomas, irrespective of their ability to inhibit tg2."
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,associate,associated,treatment of glioblastoma cells with erw1227b was associated with both down-
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,treat,treated,photography of glioblastoma cells treated with erw1227b showed cell death and rapid
Abstract,"""Novel chemo-sensitizing agent, ERW1227B, impairs cellular motility and enhances cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/20824305,demonstrate,demonstrated,in vivo glioblastoma models demonstrated the ability of erw1227b to sensitize tumor
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,assess,assess,"mutations in glioblastomas at a population level, and to assess whether"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,progress,progressed,novo) glioblastomas and secondary glioblastomas that progressed from low-grade
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,progress,progressed,and secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,base,based,we screened glioblastomas from a population-based study for idh1 mutations
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,mean,mean,"glioblastoma patients with idh1 mutations were younger (mean,"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,diagnose,diagnosed,frequent in glioblastomas diagnosed as secondary (22 of 30; 73
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,correspond,corresponded,of secondary glioblastoma corresponded to the respective clinical diagnosis in 95%
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,diagnose,diagnosed,glioblastomas with idh1 mutation diagnosed as primary had clinical and
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,suggest,suggesting,"of secondary glioblastomas, suggesting that they may have rapidly progressed from"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,diagnose,diagnosed,"conversely, glioblastomas without idh1 mutations clinically diagnosed as secondary typically developed"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,misclassifie,misclassified,"actually primary glioblastomas, that may have been misclassified, possibly due"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,complement,complements,of secondary glioblastomas that complements clinical criteria for distinguishing them from primary
Abstract,"""MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.""",https://pubmed.ncbi.nlm.nih.gov/25415048,have,have,and secondary glioblastomas have similar expression pattern in mirna level.
Title,"""Refined efficacy and outcome estimates of surgical treatment in oldest-old patients with glioblastomas based on competing risk model and conditional survival analysis: A surveillance, epidemiology, and end results population-based study.""",https://pubmed.ncbi.nlm.nih.gov/35930955,base,based,patients with glioblastomas based on competing risk model and conditional survival analysis
Title,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,use,using,-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,review,reviewed,-type glioblastomas were reviewed retrospectively and their efficacy was analysed using
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,use,using,compared between glioblastomas with different molecular statuses using the mann-whitney
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,demonstrate,demonstrated,glioblastomas in the high-ki-67-li group demonstrated
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,indicate,indicate,of the glioblastoma and indicate that dwi and dsc-pwi may
Title,"""IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.""",https://pubmed.ncbi.nlm.nih.gov/31084193,use,using,differentiation in glioblastomas using dwi and dsc-pwi in the enhancing
Abstract,"""IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.""",https://pubmed.ncbi.nlm.nih.gov/31084193,combine,combining,"for discriminating glioblastomas idh genotypes, and the diagnostic values of combining"
Abstract,"""IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.""",https://pubmed.ncbi.nlm.nih.gov/31084193,tend,tended,-m glioblastomas tended to present in frontal lobes and younger patients
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,screen,screened,"against human glioblastomas, we screened 12 parvoviruses at a high multiplicity"
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,test,tested,five human glioblastomas tested. h-1
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,infect,infected,", human glioblastoma xenografts were selectively infected by luiii when administered intratumorally"
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,characterize,characterized,novo) glioblastomas are characterized by amplification/overexpression of the egf
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,characterize,characterized,"to secondary glioblastomas, is characterized by the frequent occurrence of p53"
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,contain,contained,giant cell glioblastomas contained a p53 mutation.
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,develop,develop,giant cell glioblastomas develop de novo with a short preoperative history (
Title,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,mediate,mediate,arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,grow,growing,"-temozolomide glioblastomas, particularly those growing more rapidly during temozolomide treatment"
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,identify,identified,and postchemotherapy glioblastomas identified by the cancer genome atlas (tcga)
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,match,matched,posttreatment tcga glioblastomas but absent in matched pretreatment tumors.
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,result,resulted,-type glioblastoma line to temozolomide resulted in resistant clones; one
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,increase,increased,in the glioblastoma line u251 increased resistance to temozolomide cytotoxicity and reconstitution
Abstract,"""High Interobserver Agreement in the Subjective Classification of 5-Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32147864,use,using,resection of glioblastomas (gbm) using 5-aminolevulinic acid (
Abstract,"""Diffusion tensor invasive phenotypes can predict progression-free survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23445331,remain,remain,introduction: glioblastomas multiformes (gbm) remain incurable in most cases
Abstract,"""Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.""",https://pubmed.ncbi.nlm.nih.gov/22865003,develop,develop,and secondary glioblastomas develop through different genetic pathways.
Abstract,"""Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.""",https://pubmed.ncbi.nlm.nih.gov/22865003,confirm,confirming,"in primary glioblastoma, confirming that this mutation is a hallmark of"
Abstract,"""Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15269942,carcinoma,carcinomas,from 23 glioblastoma patients and 24 metastases patients (3 breast carcinomas
Abstract,"""An extent of resection threshold for newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21417701,remain,remains,patients with glioblastoma multiforme (gbm) remains controversial.
Abstract,"""Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.""",https://pubmed.ncbi.nlm.nih.gov/29355809,associate,associated,factor in glioblastomas and may be associated with clinical properties.
Abstract,"""Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.""",https://pubmed.ncbi.nlm.nih.gov/29355809,compare,compared,"and tl glioblastomas were compared to define their clinical properties, including"
Abstract,"""Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/20966543,contain,contains,subgroup of glioblastomas contains areas with histological features of oligodendroglial differentiation (
Abstract,"""Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/20966543,analyze,analyzed,classic' glioblastoma parts of 13 gbmo were analyzed separately by interphase
Abstract,"""Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19091885,know,known,glioblastoma multiforme is a primary brain tumor known for its
Abstract,"""Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/24503556,identify,identified,patients with glioblastomas and 93 with brain metastases were retrospectively identified.
Title,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,give,given,outcome in glioblastomas given temozolomide and radiotherapy.
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,treat,treated,survival in glioblastomas treated with alkylating agents.
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,treat,treated,methylation in glioblastomas treated with temozolomide and radiotherapy in a single uk
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,show,showed,of 109 glioblastomas showed average methylation >non-neoplastic brain in
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,give,given,"significant in glioblastomas given chemoradiotherapy in the routine clinic; furthermore,"
Abstract,"""Dual-modality optical biopsy of glioblastomas multiforme with diffuse reflectance and fluorescence: ex vivo retrieval of optical properties.""",https://pubmed.ncbi.nlm.nih.gov/28157245,account,accounts,", and glioblastoma multiforme (gbm) accounts for 55% of"
Title,"""AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.""",https://pubmed.ncbi.nlm.nih.gov/16740698,enhance,enhances,in human glioblastomas enhances proliferation via tsc2 and s6 kinase signaling.
Abstract,"""AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.""",https://pubmed.ncbi.nlm.nih.gov/16740698,emphasize,emphasizing,"of 29 glioblastomas, emphasizing the histologic distribution of molecular changes."
Abstract,"""Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings.""",https://pubmed.ncbi.nlm.nih.gov/2535765,distinguish,distinguished,appearance of glioblastomas multiforme distinguished them from less malignant gliomas.
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,mount,mounting,"prognosis of glioblastomas is still poor, mounting evidence suggests that more"
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,operate,operated,results of glioblastoma resection in 104 patients operated on between march 2005
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,find,found,removal of glioblastoma with many complexities (group 1) was found
Title,"""Differentiating Glioblastomas from Solitary Brain Metastases Using Arterial Spin Labeling Perfusion- and Diffusion Tensor Imaging-Derived Metrics.""",https://pubmed.ncbi.nlm.nih.gov/30928596,use,using,differentiating glioblastomas from solitary brain metastases using arterial spin labeling perfusion-
Abstract,"""Differentiating Glioblastomas from Solitary Brain Metastases Using Arterial Spin Labeling Perfusion- and Diffusion Tensor Imaging-Derived Metrics.""",https://pubmed.ncbi.nlm.nih.gov/30928596,use,using,to differentiate glioblastomas from solitary brain metastasis using arterial spin labeling perfusion
Abstract,"""Differentiating Glioblastomas from Solitary Brain Metastases Using Arterial Spin Labeling Perfusion- and Diffusion Tensor Imaging-Derived Metrics.""",https://pubmed.ncbi.nlm.nih.gov/30928596,undergo,underwent,diagnosis of glioblastomas versus brain metastasis who underwent asl and dti of
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,progress,progressed,glioblastomas and 16 secondary glioblastomas that had progressed from low
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,progress,progressed,16 secondary glioblastomas that had progressed from low-grade diffuse astrocytomas
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,have,had,of 29 glioblastomas (58%) had a p14arf homozygous deletion
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,show,showed,"thirteen glioblastomas showed both p14arf and p16ink4a homozygous deletion, while"
Abstract,"""A hypothesis and theoretical model speculating the possible role of therapy mediated neoplastic cell loss in promoting the process of glioblastoma relapse.""",https://pubmed.ncbi.nlm.nih.gov/20655317,comprise,comprising,"which envisages glioblastomas as neoplasms comprising of multiple, differentially regulated and"
Abstract,"""Correlation of proliferating cell nuclear antigen assessment, histologic parameters and age with survival in patients with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/7763035,study,studied,of 27 glioblastomas multiforme were studied to compare the prognostic value of
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,develop,develop,glioblastomas develop de novo (primary glioblastomas) or through
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,develop,develop,that these glioblastoma subtypes develop through different genetic pathways.
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,characterize,characterized,primary glioblastomas are characterized by egfr and mdm2 amplification/overexpression
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,contain,contain,whereas secondary glioblastomas frequently contain p53 mutations.
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,show,showed,"of primary glioblastomas with loh#10 showed loh at all informative markers,"
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,show,showed,", secondary glioblastomas with loh#10 showed partial or complete loss of chromosome"
Title,"""Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH.""",https://pubmed.ncbi.nlm.nih.gov/20621092,define,defined,pediatric infratentorial glioblastomas defined by acgh.
Abstract,"""Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH.""",https://pubmed.ncbi.nlm.nih.gov/20621092,show,show,pediatric infratentorial glioblastomas show a molecular karyotype that was more characteristic of
Abstract,"""[Oligodendroglial and neuronal component in glioblastomas: possible relation with prognosis].""",https://pubmed.ncbi.nlm.nih.gov/15608972,base,based,"classified as glioblastomas based on the who criteria, in order to"
Title,"""Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data.""",https://pubmed.ncbi.nlm.nih.gov/23334798,use,using,differentiation of glioblastomas from intracranial metastases using 3t mr spectroscopic and
Abstract,"""Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data.""",https://pubmed.ncbi.nlm.nih.gov/23334798,develop,developed,"differentiation of glioblastomas multiforme (gb) from metastases, we developed"
Abstract,"""Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.""",https://pubmed.ncbi.nlm.nih.gov/26585720,improve,improves,grade iv glioblastomas improves survival while preserving outcome in selected patients.
Abstract,"""Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.""",https://pubmed.ncbi.nlm.nih.gov/26585720,undergo,underwent,grade iv glioblastomas who underwent craniotomy and excision.
Abstract,"""Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.""",https://pubmed.ncbi.nlm.nih.gov/26585720,repeat,repeated,"grade iv glioblastomas, repeated excision, aiming for gross total resection"
Abstract,"""[Expression of p53 protein and proliferative activity in multiform glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/9864716,consider,considered,"in multiform glioblastoma cells, generally considered as the indirect index of"
Abstract,"""Multifarious proteomic signatures and regional heterogeneity in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19219580,introduce,introduced,"profiles in glioblastomas, a proteomic approach was introduced to compare samples"
Abstract,"""Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9274449,use,using,"radiation on glioblastoma, using an organotypic multicellular spheroid (oms)"
Abstract,"""Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9274449,treat,treated,from four glioblastomas were treated with hypofractionated radiation with a radiobiologically equivalent
Abstract,"""Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18462472,show,show,glioblastomas frequently show genetic alterations in the tp53 pathway.
Abstract,"""Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18462472,correlate,correlated,"in 360 glioblastomas, and correlated these with patient age and survival"
Abstract,"""Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18462472,carry,carrying,"patients with glioblastomas carrying a tp53 mutation, and among those treated"
Abstract,"""The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.""",https://pubmed.ncbi.nlm.nih.gov/27655705,use,using,differentiation of glioblastomas from solitary brain metastases using conventional mri remains an
Abstract,"""The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.""",https://pubmed.ncbi.nlm.nih.gov/27655705,undergo,underwent,patients with glioblastoma or a solitary metastatic lesion underwent three-dimensional
Abstract,"""[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].""",https://pubmed.ncbi.nlm.nih.gov/17642197,regulate,regulated,glioblastoma growth is a genetically regulated process.
Abstract,"""[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].""",https://pubmed.ncbi.nlm.nih.gov/17642197,follow,followed,glioblastoma multiforme is followed by a number of genetic breakages
Abstract,"""[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].""",https://pubmed.ncbi.nlm.nih.gov/17642197,show,showed,studies of glioblastomas showed that there were at least two immunologic phenotypes
Title,"""Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.""",https://pubmed.ncbi.nlm.nih.gov/8570130,compare,compared,in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared
Abstract,"""Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.""",https://pubmed.ncbi.nlm.nih.gov/8570130,treat,treated,patients with glioblastoma treated with radical or adjuvant radiotherapy (rt)
Abstract,"""Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone.""",https://pubmed.ncbi.nlm.nih.gov/8570130,randomize,randomized,"patients with glioblastoma, who were randomized to receive rt alone ("
Title,"""Comparisons Between PET With 11C-Methyl-L-Methionine and Arterial Spin Labeling Perfusion Imaging in Recurrent Glioblastomas Treated With Bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/30562194,treat,treated,in recurrent glioblastomas treated with bevacizumab.
Abstract,"""Comparisons Between PET With 11C-Methyl-L-Methionine and Arterial Spin Labeling Perfusion Imaging in Recurrent Glioblastomas Treated With Bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/30562194,examine,examined,with recurrent glioblastoma were examined using both asl and c-met
Title,"""True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.""",https://pubmed.ncbi.nlm.nih.gov/23901325,normalize,normalized,treatment of glioblastomas: a comparison study of normalized cerebral blood volume
Abstract,"""True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.""",https://pubmed.ncbi.nlm.nih.gov/23901325,treat,treated,pseudoprogression of glioblastomas treated with concurrent chemoradiotherapy (ccrt) with temozolomide
Abstract,"""True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.""",https://pubmed.ncbi.nlm.nih.gov/23901325,receive,received,histopathologically proven glioblastoma who had received ccrt with tmz underwent perfusion-
Abstract,"""Transcriptome analysis of glioma cells for the dynamic response to gamma-irradiation and dual regulation of apoptosis genes: a new insight into radiotherapy for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24176853,characterize,characterized,"importance for glioblastoma therapy; however, the recurrence of glioma characterized"
Abstract,"""Transcriptome analysis of glioma cells for the dynamic response to gamma-irradiation and dual regulation of apoptosis genes: a new insight into radiotherapy for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24176853,contribute,contribute,transcription in glioblastomas can contribute to the understanding of radioresistance mechanisms.
Abstract,"""Objective assessment of intraoperative tumor fluorescence reveals biological heterogeneity within glioblastomas: a biometric study.""",https://pubmed.ncbi.nlm.nih.gov/32020478,undergo,undergoing,25 adult glioblastoma subjects undergoing resection were prospectively accrued.
Abstract,"""Integrated morphologic analysis for the identification and characterization of disease subtypes.""",https://pubmed.ncbi.nlm.nih.gov/22278382,use,using,"analysis of glioblastoma, using data from the cancer genome atlas to"
Abstract,"""Integrated morphologic analysis for the identification and characterization of disease subtypes.""",https://pubmed.ncbi.nlm.nih.gov/22278382,identify,identify,to 162 glioblastomas from the cancer genome atlas to identify morphology-
Abstract,"""Integrated morphologic analysis for the identification and characterization of disease subtypes.""",https://pubmed.ncbi.nlm.nih.gov/22278382,identify,identified,analysis of glioblastoma identified three prognostically significant patient clusters (median survival
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,amplify,amplified,"of all glioblastomas have amplified the egfr gene, and about half"
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,remain,remain,"versus primary glioblastomas remain controversial, but such data are highly relevant"
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,assess,assessed,-amplified glioblastomas from 106 patients were assessed for egfrviii positivity.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,evaluate,evaluated,to recurrent glioblastomas were evaluated in 40 patients with egfr-amplified
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,acquire,acquired,-nonamplified glioblastomas acquired egfr amplification or egfrviii at recurrence.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,maintain,maintain,-positive glioblastomas maintain egfrviii positivity at recurrence.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,receive,receive,with recurrent glioblastoma to receive egfrviii-targeting agents.
Title,"""Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.""",https://pubmed.ncbi.nlm.nih.gov/23494632,have,have,secondary glioblastomas with idh1/2 mutations have longer glioma history from preceding
Abstract,"""Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25012071,exist,exist,"grade iv glioblastomas exist in two forms, primary (de novo"
Abstract,"""Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25012071,arise,arise,"novo) glioblastomas (pgbm) that arise without precursor lesions,"
Abstract,"""Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25012071,develop,develop,common secondary glioblastomas (sgbm) which develop from earlier lower grade
Abstract,"""Towards a Computer Aided Prognosis for Brain Glioblastomas Tumor Growth Estimation.""",https://pubmed.ncbi.nlm.nih.gov/26441424,extract,extracted,the brain glioblastomas tumor region would be extracted using a fast distribution
Abstract,"""Towards a Computer Aided Prognosis for Brain Glioblastomas Tumor Growth Estimation.""",https://pubmed.ncbi.nlm.nih.gov/26441424,prove,proved,for brain glioblastomas tumor growth model proved a good agreement.
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,know,known,with overlapping glioblastomas (former known as gliomatosis cerebri according to the
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,show,showed,with overlapping glioblastomas (og) who showed who iv in the
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,accord,according,of overlapping glioblastomas in the mri according to who criteria (3
Abstract,"""Positive influence of partial resection on overall survival of patients with overlapping glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28837843,know,known,"with overlapping glioblastomas (former known as gliomatosis cerebri), although"
Abstract,"""Robust discrimination of glioblastomas from metastatic brain tumors on the basis of single-voxel (1)H MRS.""",https://pubmed.ncbi.nlm.nih.gov/22081447,obtain,obtained,discrimination between glioblastomas and metastases were obtained using a small number of
Abstract,"""Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20.""",https://pubmed.ncbi.nlm.nih.gov/25602259,validate,validated,"prognosticator in glioblastomas, this effect being validated in an independent set"
Abstract,"""Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/21538026,contain,contains,subgroup of glioblastomas contains areas with histological features of oligodendroglial differentiation (
Abstract,"""Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/21538026,analyze,analyzed,classic' glioblastoma parts of 13 gbmo were analyzed separately by interphase
Abstract,"""Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30165229,remain,remains,tumors from glioblastomas on conventional magnetic resonance imaging remains particularly challenging.
Abstract,"""Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30165229,undergo,underwent,patients with glioblastomas underwent conventional magnetic resonance imaging and ce-fiesta
Abstract,"""Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30165229,focus,focusing,"tumors from glioblastomas, especially when focusing on differences in the peritumoral"
Title,"""Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns.""",https://pubmed.ncbi.nlm.nih.gov/8381255,follow,follow,extirpation of glioblastomas: mr and ct follow-up of residual
Abstract,"""Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns.""",https://pubmed.ncbi.nlm.nih.gov/8381255,define,define,mr after glioblastoma resection and to define the pattern of tumor regrowth
Abstract,"""Extirpation of glioblastomas: MR and CT follow-up of residual tumor and regrowth patterns.""",https://pubmed.ncbi.nlm.nih.gov/8381255,study,studied,patients with glioblastoma were studied prospectively with ct and mr. the
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,define,defined,"in secondary glioblastoma, have not yet been defined."
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,evolve,evolved,", primary glioblastomas, and secondary glioblastomas that had evolved from lower"
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,evolve,evolved,and secondary glioblastomas that had evolved from lower grade astrocytomas.
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,identify,identified,in primary glioblastomas identified two sites of minimally deleted regions at 22q12.3
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,share,shared,23 secondary glioblastomas affected shared a deletion in the same small (
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,rule,ruled,of primary glioblastomas cannot be ruled out.
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,analyze,analyzed,"in human glioblastomas, we analyzed a cohort of astrocytic tumors for"
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,evolve,evolved,"64 primary glioblastomas, and 28 secondary glioblastomas that had evolved from"
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,evolve,evolved,28 secondary glioblastomas that had evolved from either 24 low-grade
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,compare,compared,"of secondary glioblastomas as compared to other types of tumors, and"
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,associate,associated,in secondary glioblastoma were further associated with wild-type p53.
Title,"""Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes.""",https://pubmed.ncbi.nlm.nih.gov/22806339,qualitative,qualitative,butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes
Abstract,"""Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomes.""",https://pubmed.ncbi.nlm.nih.gov/22806339,perform,performed,"of butterfly glioblastomas, we performed a ten year retrospective analysis of"
Abstract,"""Proliferative activity in human glioblastomas: evaluation of different Ki67 equivalent antibodies.""",https://pubmed.ncbi.nlm.nih.gov/9350303,include,included,: eleven glioblastomas were included in the study.
Abstract,"""Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17387387,perform,performed,"astrocytomas to glioblastomas, histopathologic and comparative genomic hybridization analyses were performed"
Abstract,"""Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/15666327,undergo,underwent,patients with glioblastomas and 916 patients with brain metastases who underwent radiotherapy
Abstract,"""Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/15666327,determine,determined,patients with glioblastomas or brain metastases was not determined by age-
Abstract,"""Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle.""",https://pubmed.ncbi.nlm.nih.gov/18308523,cluster,clustering,"show that glioblastomas, although clustering at the high end of rates"
Abstract,"""Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle.""",https://pubmed.ncbi.nlm.nih.gov/18308523,identify,identified,that individual glioblastomas may be identified as having been radio-resistant
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,determine,determine,mutations in glioblastomas and to determine whether gene mutation is inevitably associated
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,have,had,"in 44 glioblastomas, half of which had egfr amplification."
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,examine,examined,additional 26 glioblastomas with egfr amplification were then examined to establish more
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,have,have,suggests that glioblastomas with egfr amplification have the capacity to produce a
Abstract,"""Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.""",https://pubmed.ncbi.nlm.nih.gov/16808884,support,supports,bearing intracranial glioblastomas and supports the development of dc-based clinical
Abstract,"""Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.""",https://pubmed.ncbi.nlm.nih.gov/16808884,respond,respond,patients with glioblastomas that do not respond to standard therapies.
Abstract,"""Postoperative irradiation of glioblastomas. Results in a randomized series.""",https://pubmed.ncbi.nlm.nih.gov/216238,present,presented,patients with glioblastoma is presented.
Title,"""Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods.""",https://pubmed.ncbi.nlm.nih.gov/23950891,use,using,analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion mri:
Abstract,"""Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods.""",https://pubmed.ncbi.nlm.nih.gov/23950891,grade,grade,histologically confirmed glioblastoma (who grade iv) were examined with conventional
Abstract,"""Analysis of some factors effecting survival in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/220763,differ,differ,and secondary glioblastomas do not differ; anaplastic astrocytomas show definitely longer
Abstract,"""Survival and quality of life after continuous accelerated radiotherapy of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/3037617,include,including,resection of glioblastoma with different total doses and fractionation schedules including 38
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,grade,grade,"glioblastoma multiforme (who grade iv), the most"
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,occur,occur,"of secondary glioblastomas but rarely occur in primary glioblastomas, suggesting the"
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,suggest,suggesting,"in primary glioblastomas, suggesting the presence of different genetic pathways ("
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,screen,screened,and secondary glioblastomas were screened by immunohistochemistry for mdm2 overexpression and by
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,contain,contained,15 primary glioblastomas overexpressing mdm2 contained a p53 mutation.
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,lack,lack,of primary glioblastomas that typically lack p53 mutations.
Abstract,"""Role of MIB1 in predicting survival in patients with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16234986,predict,predicted,"survival with glioblastoma was predicted by kps, age, extent of"
Title,"""Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome.""",https://pubmed.ncbi.nlm.nih.gov/10987250,show,shows,expression in glioblastomas shows regional variation and down-regulation with therapy
Abstract,"""Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome.""",https://pubmed.ncbi.nlm.nih.gov/10987250,range,ranging,", the glioblastomas (gbms), ranging from 26% to"
Title,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,identify,identified,pathway in glioblastomas identified by gene expression-based classification using tgfbeta
Abstract,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,report,reported,overproduction in glioblastoma and other high-grade gliomas has been reported
Abstract,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,analyze,analyzed,"% of glioblastoma samples analyzed showed strong tgfbeta activation, while the"
Abstract,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,cause,cause,"activation in glioblastomas, which may cause potential differences in responses to"
Abstract,"""Primary cerebellar glioblastomas multiforme in children. Report of four cases.""",https://pubmed.ncbi.nlm.nih.gov/10067927,have,has,"with cerebellar glioblastomas is extremely poor, and the tumor has a"
Title,"""Histological heterogeneity of human glioblastomas investigated with an unsupervised neural network (SOM).""",https://pubmed.ncbi.nlm.nih.gov/15736037,investigate,investigated,of human glioblastomas investigated with an unsupervised neural network (som)
Abstract,"""Histological heterogeneity of human glioblastomas investigated with an unsupervised neural network (SOM).""",https://pubmed.ncbi.nlm.nih.gov/15736037,preclude,precludes,variability of glioblastomas (gb) precludes the modern assimilation of theses
Title,"""Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15484695,correlate,correlates,nuclei in glioblastomas correlates with preoperative data from proton-mr-
Abstract,"""Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15484695,represent,representing,histomorphology of glioblastomas representing the most frequent type of brain tumors was
Abstract,"""Morphology of proliferating and non-proliferating tumor cell nuclei in glioblastomas correlates with preoperative data from proton-MR-spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15484695,support,supporting,characteristics of glioblastomas supporting the biological relevance of spectroscopic data for the
Title,"""[Intracranial multiform glioblastomas of a young subject, manifesting themselves originally by a lower radiculospinal compression].""",https://pubmed.ncbi.nlm.nih.gov/4322824,manifest,manifesting,"intracranial multiform glioblastomas of a young subject, manifesting themselves originally by"
Abstract,"""Fluorescence in situ hybridization study of aneuploidy of chromosomes 7, 10, X, and Y in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10616524,use,using,20 secondary glioblastomas using fluorescence in situ hybridization (fish) on
Abstract,"""Fluorescence in situ hybridization study of aneuploidy of chromosomes 7, 10, X, and Y in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10616524,allow,allow,"of a glioblastoma subtype; therefore, they do not allow the"
Abstract,"""Computer-assisted discrimination of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9349896,compare,compare,series of glioblastomas and compare the data with those from a set
Abstract,"""Computer-assisted discrimination of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9349896,form,formed,", the glioblastomas formed a group at a greater distance from the"
Title,"""p53 status has no prognostic significance in glioblastomas treated with radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/9401801,treat,treated,significance in glioblastomas treated with radiotherapy.
Abstract,"""p53 status has no prognostic significance in glioblastomas treated with radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/9401801,receive,received,) with glioblastomas who have received radiotherapy.
Abstract,"""p53 status has no prognostic significance in glioblastomas treated with radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/9401801,involve,involved,presence in glioblastomas of genetic abnormalities that are also involved in the
Abstract,"""[2D-histograms of the nucleus area and nucleus shape in the diagnosis of astrocytomas and glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/3012906,investigate,investigated,and 2 glioblastomas were investigated by a system of automated microscope picture
Title,"""Noninvasive Tumor Grading of Glioblastomas Before Surgery Using Arterial Spin Labeling. A Cohort Study.""",https://pubmed.ncbi.nlm.nih.gov/26860009,use,using,grading of glioblastomas before surgery using arterial spin labeling.
Abstract,"""[The prognostic importance of cancer-associated proteins and apoptosis in glioblastomas of the cerebral hemispheres].""",https://pubmed.ncbi.nlm.nih.gov/10335568,produce,produces,in the glioblastomas produces no noticeable effect on the patients survival.
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,test,tested,markers for glioblastomas has been broadly tested but the results obtained are
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,study,studied,", 302 glioblastoma specimens were studied to evaluate a possible association between"
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,appear,appear,"significant for glioblastoma outcome, they appear to be closely related to"
Abstract,"""Immunohistochemical markers for prognosis of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12187957,propose,proposed,", the glioblastoma subdivision on three cytological subsets proposed by us is"
Abstract,"""Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.""",https://pubmed.ncbi.nlm.nih.gov/9840536,have,had,the glioblastomas had a significantly higher percentage of mt positive cells
Abstract,"""Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.""",https://pubmed.ncbi.nlm.nih.gov/9840536,survive,survive,astrocytoma and glioblastoma patients did not survive as long as the mt
Abstract,"""Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time.""",https://pubmed.ncbi.nlm.nih.gov/12809355,show,showed,set of glioblastoma cases showed a statistically significant relation with the survival
Abstract,"""Surgical treatment of anterior callosal tumors.""",https://pubmed.ncbi.nlm.nih.gov/9273869,adopt,adopted,"cases with glioblastomas, a radiation treatment was adopted."
Abstract,"""A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12386559,base,based,grade of glioblastomas based on the regional cerebral blood volume (rcbv
Abstract,"""A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12386559,depend,depends,enhancement of glioblastomas depends mainly on their vascularisation or anaplastic grade.
Abstract,"""A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12386559,study,studied,"with brain glioblastomas were studied with perfusion, diffusion and t1-"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,mark,marked,aims: glioblastomas display marked phenotypic and molecular heterogeneity.
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,show,shows,"protein in glioblastomas also shows great intratumour heterogeneity, but the significance"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,divide,divided,", paraffin glioblastomas were divided into positive (homogeneous staining) and"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,find,found,"in homogeneous glioblastomas, no correlation was found between pten protein expression"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,find,found,"the heterogeneous glioblastomas, loh was found significantly more frequently (p"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,present,presenting,patients with glioblastomas presenting either loh of 10q23 or heterogeneous pten expression
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,treat,treated,grade iv glioblastoma treated between 1993 and 1997.
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,find,found,secondary glioblastomas were found in only 4% of the standard
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,show,show,primary glioblastomas typically show egfr over expression and mutation (variant
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,involve,involves,to secondary glioblastoma involves early p53 mutation.
Abstract,"""[Glioblastomas: clinical study and search for prognostic factors].""",https://pubmed.ncbi.nlm.nih.gov/12595806,evolve,evolve,subtypes of glioblastomas are distinct disease entities which evolve through different genetic
Abstract,"""[Postoperative assessment of the efficiency of the radical removal of glioblastomas in the cerebral hemispheres].""",https://pubmed.ncbi.nlm.nih.gov/14959651,make,makes,portions of glioblastomas makes it possible to apply these two methods as
Abstract,"""Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance.""",https://pubmed.ncbi.nlm.nih.gov/199052,analyze,analyzed,for primary glioblastoma is analyzed.
Abstract,"""MIB-I as a proliferative activity marker of the multiform glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11820610,analyze,analyzed,with multiform glioblastomas were analyzed.
Abstract,"""Heterogeneity of subcellular localization of p53 protein in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8261427,know,known,in human glioblastomas with known genetic profiles of p53 mutations and allele
Abstract,"""[Interest of clinical classification in prognosis and therapeutics of multiform glioblastomas of adult patients (author's transl)].""",https://pubmed.ncbi.nlm.nih.gov/6259742,have,had,whose multiform glioblastoma had an histological confirmation.
Abstract,"""[Prediction of clinical course of glioblastomas by MRI during radiotherapy].""",https://pubmed.ncbi.nlm.nih.gov/21221885,predict,predict,radiotherapy for glioblastomas pre and during radiotherapy to predict the clinical course
Abstract,"""[Prediction of clinical course of glioblastomas by MRI during radiotherapy].""",https://pubmed.ncbi.nlm.nih.gov/21221885,allow,allow,"radiotherapy for glioblastomas allow for prognostic appraisal, and potentially early modification"
Abstract,"""Synchronous occurrence of glioblastoma multiforme in a husband and wife.""",https://pubmed.ncbi.nlm.nih.gov/3018184,develop,developed,glioblastomas developed within two years of each other in an
Abstract,"""[Follow-up study of malignant astrocytomas showing complete response after initial treatment].""",https://pubmed.ncbi.nlm.nih.gov/8015675,grade,grade,and 24 glioblastomas (who grade iv).
Abstract,"""Near-Infrared Fluorescent Peptides with High Tumor Selectivity: Novel Probes for Image-Guided Surgical Resection of Orthotopic Glioma.""",https://pubmed.ncbi.nlm.nih.gov/30517013,surround,surrounding,excision of glioblastomas with maximal retention of surrounding normal tissues can have
Title,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,promote,promotes,upregulated in glioblastomas and promotes tumor cell adhesion.
Abstract,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,relate,related,prognosis of glioblastoma patients is related to diffuse brain invasion and interaction
Abstract,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,compare,compared,protein in glioblastomas as compared to normal cortex.
Abstract,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,remain,remained,migration of glioblastoma cells on this substrate remained unchanged.
Abstract,"""Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.""",https://pubmed.ncbi.nlm.nih.gov/12878856,have,have,"morphologically indistinguishable glioblastomas have distinct classes of causal oncogene activation, and"
Abstract,"""Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.""",https://pubmed.ncbi.nlm.nih.gov/12878856,limit,limited,application for glioblastoma has been severely limited by an inability to determine
Abstract,"""Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.""",https://pubmed.ncbi.nlm.nih.gov/12878856,detect,detecting,subsets of glioblastoma and detecting pathway profiles that can be used to
Abstract,"""Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8200000,remain,remains,patients with glioblastomas remains poor.
Title,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,alkylate,alkylating,resistance of glioblastoma cells to the mono-alkylating agent temozolomide.
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,alkylate,alkylating,resistance of glioblastoma cells to the mono-alkylating agent temozolomide is
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,investigate,investigated,resistance of glioblastoma cell lines to temozolomide was investigated.
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,show,show,"in most glioblastomas, we next show that the resistance of glioblastoma"
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,temozolomide,temozolomide,resistance of glioblastoma cells to temozolomide and to a combined treatment of
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,identify,identifies,response of glioblastoma cells to treatment and identifies the cut domains as
Abstract,"""Gyriform infiltration as imaging biomarker for molecular glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35364762,lack,lack,"-type glioblastoma) frequently lack contrast enhancement, which can wrongly"
Abstract,"""Gyriform infiltration as imaging biomarker for molecular glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35364762,calculate,calculated,of molecular glioblastoma were calculated.
Abstract,"""Gyriform infiltration as imaging biomarker for molecular glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35364762,help,help,of molecular glioblastomas that can help distinguishing these tumors from idh-
Abstract,"""Calcification in glioblastoma multiforme of the cervical spinal cord.""",https://pubmed.ncbi.nlm.nih.gov/3014673,accompany,accompanied,patient having glioblastoma accompanied with calcification in the cervical spinal cord is
Abstract,"""Calcification in glioblastoma multiforme of the cervical spinal cord.""",https://pubmed.ncbi.nlm.nih.gov/3014673,contain,containing,in differentiating glioblastomas containing calcified masses from benign tumors with areas of
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,treat,treated,patients with glioblastoma multiforme treated with alkylating agents.
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,analyze,analyzed,53 primary glioblastomas by the immunohistochemistry (ihc) and analyzed the
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,show,showed,-immunonegative glioblastomas showed significantly longer progression-free survival (pfs
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,treat,treated,in 41 glioblastomas treated with temozolomide (tmz) therapy (mgmt
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,receive,receiving,with primary glioblastoma receiving tmz and suggest the use of mgmt-
Title,"""Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome.""",https://pubmed.ncbi.nlm.nih.gov/22903238,affect,affecting,pediatric glioblastoma: clinico-radiological profile and factors affecting the
Abstract,"""Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome.""",https://pubmed.ncbi.nlm.nih.gov/22903238,define,defined,in pediatric glioblastoma are not as well defined as in adults.
Abstract,"""Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome.""",https://pubmed.ncbi.nlm.nih.gov/22903238,study,studied,of intracranial glioblastoma were studied.
Abstract,"""Pediatric glioblastoma: clinico-radiological profile and factors affecting the outcome.""",https://pubmed.ncbi.nlm.nih.gov/22903238,associate,associated,: pediatric glioblastomas are associated with longer progression-free as well
Abstract,"""Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/16118272,examine,examined,"however, glioblastomas were examined only recently."
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,grade,grade,% of glioblastomas (who grade iv).
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,progress,progressed,novo) glioblastomas and in 21 secondary glioblastomas that had progressed from
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,progress,progressed,21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,be,was,"majority of glioblastomas with loss of rb1 expression, there was promoter"
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,microdissecte,microdissected,"in three glioblastomas, areas with and without rb1 expression were microdissected"
Abstract,"""Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.""",https://pubmed.ncbi.nlm.nih.gov/25529918,grade,grade,"in glioblastomas (gbm, who grade iv), the"
Abstract,"""Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.""",https://pubmed.ncbi.nlm.nih.gov/25529918,decrease,decreased,in human glioblastoma t98g cells decreased their proliferation and migration and
Abstract,"""Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.""",https://pubmed.ncbi.nlm.nih.gov/25529918,strengthen,strengthen,proliferation of glioblastoma t98g cells and strengthen the antiproliferative effect evoked
Abstract,"""Role of micro-RNA (miRNA) in pathogenesis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26004603,play,play,"pathogenesis of glioblastoma, as mirnas play a critical role in the"
Abstract,"""Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17369134,consider,considered,"dissemination of glioblastomas is considered rare, and unambiguous pathologic or molecular"
Abstract,"""Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17369134,use,using,of 8 glioblastomas with symptomatic leptomeningeal dissemination by using fluorescence in situ
Abstract,"""[Glioblastomas are resistant to apoptosis but less resistant to the autophagic process].""",https://pubmed.ncbi.nlm.nih.gov/18405003,represent,represent,of which glioblastomas represent the ultimate grade of malignancy are characterized by
Abstract,"""[Glioblastomas are resistant to apoptosis but less resistant to the autophagic process].""",https://pubmed.ncbi.nlm.nih.gov/18405003,relate,related,resistance of glioblastomas to pro-apoptotic-related therapies.
Abstract,"""[Prognostic implications of the proliferation index (H3-TdR-labeling index) and ploidy in neuroectodermal tumors (astrocytomas and glioblastomas)].""",https://pubmed.ncbi.nlm.nih.gov/1313162,obtain,obtain,astrocytomas and glioblastomas to obtain reliable prognostic information.
Title,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,promote,promotes,upregulated in glioblastomas and promotes migration.
Abstract,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,use,using,vat-1 in glioblastoma tissue and cell lines on mrna levels using reverse
Abstract,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,compare,compared,found in glioblastoma tissues and cell lines compared with normal human brain
Abstract,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,involve,involved,"overexpressed in glioblastomas and functionally involved in glioma cell migration, representing"
Abstract,"""Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24129546,identify,identified,cases of glioblastoma identified between 2005 and 2012.
Abstract,"""Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24129546,identify,identify,markers in glioblastoma may help identify new therapeutic targets.
Abstract,"""Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/6297227,study,studied,reproliferation of glioblastomas after radiation and chemotherapy has been studied in 25
Abstract,"""Tibolone Effects on Human Glioblastoma Cell Lines.""",https://pubmed.ncbi.nlm.nih.gov/31499479,grow,grown,u87 human glioblastoma cell lines were grown with different doses of tib
Abstract,"""MGMT methylation status: the advent of stratified therapy in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/17325429,test,testing,newly diagnosed glioblastoma testing the addition of the alkylating agent temozolomide to
Abstract,"""MGMT methylation status: the advent of stratified therapy in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/17325429,become,become,"agents in glioblastoma patients, but many others may hopefully become part"
Abstract,"""Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.""",https://pubmed.ncbi.nlm.nih.gov/16596424,investigate,investigated,and 115 glioblastomas) were investigated using immunohistochemistry with an anti-
Abstract,"""Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.""",https://pubmed.ncbi.nlm.nih.gov/16596424,express,expressed,"of 115 glioblastomas (47.0%), podoplanin was expressed on"
Abstract,"""Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.""",https://pubmed.ncbi.nlm.nih.gov/16596424,proliferate,proliferating,"cells and glioblastoma cells, especially around necrotic areas and proliferating endothelial"
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,occur,occur,"glioblastomas, the most aggressive primary brain tumors, occur"
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,induce,induce,migrate to glioblastomas and induce tumor cell death.
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,divert,diverted,at a glioblastoma are diverted from their normal migratory path to the
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,result,resulted,induced cortical glioblastomas resulted in decreased subventricular proliferation in adult (postnatal
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,have,had,npcs to glioblastomas and had larger tumors than young mice.
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,isolate,isolated,to kill glioblastomas was similar in npcs isolated from young and adult
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,depend,depended,npcs to glioblastomas depended on the expression of d-type cyclins
Abstract,"""The antitumorigenic response of neural precursors depends on subventricular proliferation and age.""",https://pubmed.ncbi.nlm.nih.gov/18757298,compare,compared,npcs to glioblastomas and the generation of larger tumors compared with wild
Abstract,"""Hypermethylation of testis derived transcript gene promoter significantly correlates with worse outcomes in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/23769558,identify,identify,nine secondary glioblastomas (sgbms) with the expectation to identify valuable
Abstract,"""Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/28756228,temozolomide,temozolomide,resistance of glioblastoma to radiotherapy and to temozolomide.
Abstract,"""Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/28756228,show,showed,results: glioblastoma tissues showed strong cytoplasmic and nuclear ldh5 expression in
Abstract,"""DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/35868257,remain,remains,stratification of glioblastomas remains inconclusive.
Abstract,"""DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/35868257,subject,subjected,newly diagnosed glioblastoma subjected to global dna methylation profiling.
Abstract,"""[Ultrastructure of capillary permeability in human brain tumors. Part 1: Gliomas associated with cerebral edema (low density area)].""",https://pubmed.ncbi.nlm.nih.gov/2989720,astrocytoma,astrocytoma,between the glioblastomas with remarkable edema (4 cases) and astrocytoma
Abstract,"""[Ultrastructure of capillary permeability in human brain tumors. Part 1: Gliomas associated with cerebral edema (low density area)].""",https://pubmed.ncbi.nlm.nih.gov/2989720,increase,increasing,"vessels of glioblastomas with severe perifocal edema, in addition to increasing"
Abstract,"""Metabolic Vulnerabilities in Brain Cancer.""",https://pubmed.ncbi.nlm.nih.gov/33781499,alter,altered,glioblastomas (gbms) exhibit altered metabolism to support a
Abstract,"""VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells.""",https://pubmed.ncbi.nlm.nih.gov/17618600,express,expressing,"from human glioblastomas and a retrovirus expressing vegf, we examined the"
Abstract,"""Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25434382,develop,develop,and secondary glioblastomas (gbms) that develop from low-grade
Abstract,"""Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25434382,represent,represent,metabolic enzyme glioblastomas (idh1) represent a distinguishing feature of low
Title,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,reveal,reveal,recurrent glioblastomas reveal molecular subtypes associated with mechanistic implications of drug
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,achieve,achieved,"recurrence of glioblastomas could be achieved by transcriptomic reprograming of tumors,"
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,perform,performed,"of recurrent glioblastomas, gene expression profiling was performed on the 43"
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,include,including,cases of glioblastomas including 15 paired primary and recurrent cases.
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,show,showed,the recurrent glioblastomas showed two distinct expression types.
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,choose,choose,that recurrent glioblastomas may choose two different strategies for transcriptomic reprograming to
Abstract,"""Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.""",https://pubmed.ncbi.nlm.nih.gov/21829433,reproduce,reproduce,subgroups of glioblastoma are difficult to reproduce.
Abstract,"""Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.""",https://pubmed.ncbi.nlm.nih.gov/21829433,suggest,suggests,"inconsistencies in glioblastoma but also suggests that biological variability, abnormal data"
Abstract,"""KLF6 depletion promotes NF-kappaB signaling in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28166199,predict,predicts,the analyzed glioblastomas and predicts unfavorable patient prognosis suggesting that haploinsufficiency is
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,transplant,transplanted,u251 human glioblastoma cell lines and subcutaneously transplanted u87 cells in scid
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,lead,lead,cytotoxicity toward glioblastoma cells in vitro and its intratumoral injections lead to
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,internalize,internalize,capability of glioblastoma cancer stem cells to internalize a fluorescent-labeled
Abstract,"""Comparative immunohistochemical analysis of aurora-A and aurora-B expression in human glioblastomas. Associations with proliferative activity and clinicopathological features.""",https://pubmed.ncbi.nlm.nih.gov/19616898,attempt,attempted,"with primary glioblastomas, and attempted to identify any associations with ki-67"
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,suggest,suggesting,"tumors including glioblastomas, suggesting an oncogenic role for the long noncoding"
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,remain,remains,h19 in glioblastomas remains unclear.
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,relate,related,"expression in glioblastoma cell lines, which was related to hypoxia-"
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,depend,depending,in human glioblastoma samples depending on pten status.
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,suggest,suggest,effects in glioblastomas and suggest h19 might be a promising therapeutic target
Abstract,"""Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.""",https://pubmed.ncbi.nlm.nih.gov/30840759,support,supporting,profile of glioblastomas in latin america possibly supporting new target therapies.
Abstract,"""Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model.""",https://pubmed.ncbi.nlm.nih.gov/19489983,characterize,characterized,objectives: glioblastomas are aggressive primary brain cancers that are characterized by
Abstract,"""Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model.""",https://pubmed.ncbi.nlm.nih.gov/19489983,degrade,degrade,ability of glioblastoma cells to degrade and migrate through the extracellular matrix
Title,"""Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type.""",https://pubmed.ncbi.nlm.nih.gov/33972663,ensure,ensures,network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate
Abstract,"""Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type.""",https://pubmed.ncbi.nlm.nih.gov/33972663,augment,augmented,"-mutant glioblastomas, or augmented by adding both real and synthetic"
Title,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,harbor,harboring,of cerebral glioblastomas harboring p53 mutations.
Abstract,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,determine,determined,patients with glioblastomas whose p53 status was determined by a sensitive yeast
Abstract,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,result,results,"response in glioblastomas, and this results in significantly longer survival."
Abstract,"""Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.""",https://pubmed.ncbi.nlm.nih.gov/16550738,affect,affected,specimens of glioblastoma-affected patients.
Abstract,"""Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.""",https://pubmed.ncbi.nlm.nih.gov/16550738,result,resulted,"of the glioblastomas, 63% resulted as cox-2-positive."
Abstract,"""Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.""",https://pubmed.ncbi.nlm.nih.gov/16550738,express,express,show that glioblastoma can immunohistochemically express cox-2 and that its expression is
Title,"""Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth.""",https://pubmed.ncbi.nlm.nih.gov/17543444,sphere,spheres,aspirations of glioblastomas migrate and form spheres with radial outgrowth.
Abstract,"""Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth.""",https://pubmed.ncbi.nlm.nih.gov/17543444,limit,limited,such as glioblastomas are limited by the small size of surgically resected
Abstract,"""Tumor cells from ultrasonic aspirations of glioblastomas migrate and form spheres with radial outgrowth.""",https://pubmed.ncbi.nlm.nih.gov/17543444,debulke,debulked,"however, glioblastomas are also frequently debulked via ultrasonic aspiration."
Abstract,"""Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/9191875,express,express,malignant glioblastoma may over-express the epidermal-growth-
Abstract,"""Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/9191875,enter,entered,"-positive glioblastomas entered the study, which was designed to evaluate"
Abstract,"""Glioblastoma treatment guidelines: Consensus by the Spanish Society of Neurosurgery Tumor Section.""",https://pubmed.ncbi.nlm.nih.gov/32690400,start,starts,introduction: glioblastoma (gbm) treatment starts in most patients with
Abstract,"""Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10682270,determine,determined,and multiforme glioblastomas was determined by immunohistochemistry; the staining intensity and
Abstract,"""Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10682270,unstaine,unstained,"in multiforme glioblastomas, some of which were unstained; a highly"
Abstract,"""Multidimensional communication in the microenvirons of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29985475,recruit,recruit,glioblastoma cells recruit innate immune cells and change their phenotype
Abstract,"""Multidimensional communication in the microenvirons of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29985475,induce,induced,", after glioblastoma-induced phenotypic modifications, normal cells cooperate with"
Abstract,"""Multidimensional communication in the microenvirons of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29985475,involve,involves,this glioblastoma takeover of the brain involves multiple modes of communication
Title,"""Identification of glioblastoma immune subtypes and immune landscape based on a large cohort.""",https://pubmed.ncbi.nlm.nih.gov/34412691,base,based,identification of glioblastoma immune subtypes and immune landscape based on a large
Abstract,"""The role of integrins in glioma biology and anti-glioma therapies.""",https://pubmed.ncbi.nlm.nih.gov/21827415,add,added,"agent in glioblastoma, but, when added to standard radiochemotherapy,"
Abstract,"""The role of integrins in glioma biology and anti-glioma therapies.""",https://pubmed.ncbi.nlm.nih.gov/21827415,complete,completed,newly diagnosed glioblastoma patients with mgmt gene promoter methylation has recently completed
Title,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,define,defined,subtypes of glioblastoma defined by array-based comparative genomic hybridization (
Abstract,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,use,using,investigated 70 glioblastomas using the array-based comparative genomic hybridization (
Abstract,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,subdivide,subdivided,suggests that glioblastomas can be subdivided into clinically relevant genetic subsets.
Abstract,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,provide,provide,"screening of glioblastomas could provide clinically useful information and, perhaps,"
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,aim,aimed,"features of glioblastoma, we aimed to assess the role of mgmt"
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,use,used,-mutant glioblastomas and used 173 idh-wildtype glioblastomas for comparison
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,show,showed,"-wildtype glioblastomas, idh-mutant glioblastomas showed significantly higher ("
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,show,showed,-mutant glioblastomas showed significantly higher (p < 0.0001) mgmt
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,receive,receiving,-mutant glioblastomas receiving temozolomide therapy (cohort a); this
Abstract,"""STAT3 as a Therapeutic Target for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20879983,express,express,derived primary glioblastomas and cell lines express constitutively activated signal transducers and
Abstract,"""STAT3 as a Therapeutic Target for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20879983,target,targeting,"stat3 in glioblastoma, and targeting stat3 for glioblastoma therapy."
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,evaluate,evaluate,"unilateral and glioblastoma with bilateral corpus callosum infiltration, and to evaluate"
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,include,included,newly diagnosed glioblastoma from 2010 to 2019 were included.
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,have,had,glioblastoma with corpus callosum affection had significantly lower median overall
Abstract,"""Prognostic differences and implications on treatment strategies between butterfly glioblastoma and glioblastoma with unilateral corpus callosum infiltration.""",https://pubmed.ncbi.nlm.nih.gov/36357498,reveal,revealed,analysis of glioblastoma with unilateral corpus callosum infiltration revealed a significant difference
Abstract,"""Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28030635,attribute,attributed,resistance of glioblastomas has been attributed to the presence of tumor initiating
Title,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,treat,treated,newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: a multicenter cohort study
Abstract,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,involve,involves,treatment of glioblastomas involves maximal safe resection and adjuvant temozolomide chemo-
Abstract,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,mean,mean,147 adult glioblastoma patients (mean age 53 years) that underwent
Abstract,"""[Genetic disorders in primary brain glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/30475532,characterize,characterized,glioblastomas are characterized by a variety of genetic and epigenetic
Abstract,"""[Genetic disorders in primary brain glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/30475532,allow,allowed,patients with glioblastomas allowed revealing changes relevant to this disease and determining
Abstract,"""Perfusion Parameter Obtained on 3-Tesla Magnetic Resonance Imaging and the Ki-67 Labeling Index Predict the Overall Survival of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33567368,undergo,underwent,"patients with glioblastomas underwent pulsed arterial spin-labeling, dti,"
Abstract,"""Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.""",https://pubmed.ncbi.nlm.nih.gov/25712375,test,tested,"cafs in glioblastoma, we tested the effect of caf conditioned media"
Abstract,"""Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.""",https://pubmed.ncbi.nlm.nih.gov/25712375,perform,performed,"in human glioblastomas, immunofluorescence staining was performed on tissue samples from"
Abstract,"""Clinical significance of angiopoietin-like protein 3 expression in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26639238,provide,provides,angptl3 in glioblastomas and provides an independent predictive factor.
Title,"""Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.""",https://pubmed.ncbi.nlm.nih.gov/23333277,recapitulate,recapitulate,specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human
Abstract,"""Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.""",https://pubmed.ncbi.nlm.nih.gov/23333277,use,using,of orthotopic glioblastoma (gbm) xenograft models using surgical samples of
Abstract,"""Clinical and immunohistochemical prognostic factors in adult glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19788052,operate,operated,"adult supratentorial glioblastomas operated over a span of 1 year, with"
Abstract,"""Resection versus biopsy in patients with glioblastoma (RESBIOP study): study protocol for an international multicentre prospective cohort study (ENCRAM 2202).""",https://pubmed.ncbi.nlm.nih.gov/39260848,treat,treated,patients with glioblastoma will be treated with resection or biopsy and matched
Abstract,"""Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level.""",https://pubmed.ncbi.nlm.nih.gov/37847481,decrease,decrease,cerebral hemispheric glioblastomas (gbms) often decrease the karnofsky performance status
Title,"""Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.""",https://pubmed.ncbi.nlm.nih.gov/15494095,use,using,profiles of glioblastomas using array-based comparative genomic hybridization.
Abstract,"""Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.""",https://pubmed.ncbi.nlm.nih.gov/15494095,base,based,19 independent glioblastomas by array-based comparative genomic hybridization analysis.
Abstract,"""Glioblastoma with Probable Intratumoral Adenocarcinoma Metastasis: A Rare Report with Review of Literature.""",https://pubmed.ncbi.nlm.nih.gov/38378180,support,supporting,"ruling out glioblastoma with true epithelial metaplasia, and supporting the diagnosis"
Title,"""Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/20708556,include,including,"therapeutics in glioblastomas, including targeted molecular therapies, current and future"
Abstract,"""Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/20708556,target,targeted,"therapies for glioblastoma, with an emphasis on targeted agents."
Abstract,"""Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8091951,suggest,suggests,regions of glioblastomas suggests that mib 1 staining of microwave-processed
Abstract,"""Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36585418,identify,identified,"analysis from glioblastoma patient datasets, we identified atp binding cassette subfamily"
Abstract,"""Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/7709789,treat,treated,patients with glioblastoma treated by iort (mean 18.3 gy) combined
Abstract,"""Activation of EGFR signaling from pilocytic astrocytomas to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24170555,analyze,analyze,egfr in glioblastomas (gbms) but do not analyze all grades
Title,"""Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.""",https://pubmed.ncbi.nlm.nih.gov/19287454,display,display,within human glioblastomas and display different tumorigenicity and independent genomic evolution.
Abstract,"""Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.""",https://pubmed.ncbi.nlm.nih.gov/19287454,contain,contain,"glioblastomas (gbms) contain transformed, self-maintaining"
Abstract,"""Quantifying Uncertainty and Robustness in a Biomathematical Model-Based Patient-Specific Response Metric for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30758984,know,known,"purpose: glioblastomas, lethal primary brain tumors, are known for"
Title,"""Long-Term Time Series Forecasting and Updates on Survival Analysis of Glioblastoma Multiforme: A 1975-2018 Population-Based Study.""",https://pubmed.ncbi.nlm.nih.gov/35172317,base,based,analysis of glioblastoma multiforme: a 1975-2018 population-based
Abstract,"""Recent advances in the molecular genetics of primary gliomas.""",https://pubmed.ncbi.nlm.nih.gov/12778011,remain,remain,", particularly glioblastomas, remain a challenge for oncology."
Title,"""Age as a predictive factor in glioblastomas: population-based study.""",https://pubmed.ncbi.nlm.nih.gov/19325245,base,based,factor in glioblastomas: population-based study.
Abstract,"""Age as a predictive factor in glioblastomas: population-based study.""",https://pubmed.ncbi.nlm.nih.gov/19325245,diagnose,diagnosed,evaluated 715 glioblastoma patients diagnosed during 1980-1994 in the canton
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,remain,remains,) of glioblastoma patients remains approximately 15 months.
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,compare,compared,prognosis of glioblastoma patients in china and compared the survival outcomes among
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,undergo,underwent,for 967 glioblastoma patients who underwent surgery at huashan hospital and had
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,have,had,newly diagnosed glioblastomas and had available data of survival and personal information
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,collect,collected,of 778 glioblastoma patients were collected from three separate online databases (
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,improve,improved,os of glioblastoma patients from huashan hospital improved from 15.6 (2010
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,adjust,adjusting,benefits to glioblastoma patients after adjusting to validated prognostic factors.
Abstract,"""The prognosis of glioblastoma: a large, multifactorial study.""",https://pubmed.ncbi.nlm.nih.gov/34236262,remain,remains,"prognosis of glioblastoma patients remains poor, gradual progress is being made"
Title,"""Gene therapy of glioblastomas: from suicide to homicide.""",https://pubmed.ncbi.nlm.nih.gov/11545030,homicide,homicide,therapy of glioblastomas: from suicide to homicide.
Title,"""3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.""",https://pubmed.ncbi.nlm.nih.gov/10624854,plan,planned,patterns of glioblastomas after ct-planned postoperative irradiation.
Abstract,"""3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation.""",https://pubmed.ncbi.nlm.nih.gov/10624854,document,documented,-confirmed glioblastoma multiforma and documented recurrence who were irradiated in our
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,use,using,and recurrent glioblastomas using targeted sequencing and investigate the differences in mutational
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,develop,developed,: fourteen glioblastoma patients who developed local (n=10) or distal
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,demonstrate,demonstrated,locally recurrent glioblastomas demonstrated concordant mutational profiles between the primary and recurrent
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,show,showed,distally recurrent glioblastomas showed changes in mutational profiles with newly acquired mutations
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,exhibit,exhibit,distally recurrent glioblastomas exhibit different evolutionary patterns.
Title,"""Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.""",https://pubmed.ncbi.nlm.nih.gov/26450533,use,using,patients with glioblastomas using diffusion tensor imaging and dynamic susceptibility contrast mri
Abstract,"""Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.""",https://pubmed.ncbi.nlm.nih.gov/26450533,exhibit,exhibiting,patients with glioblastomas exhibiting enhancing lesions within 6 months after completion of
Abstract,"""Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25724425,undergo,underwent,supratentorial primary glioblastomas that underwent surgical resection with intraoperative carmustine wafers implantation
Abstract,"""EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco.""",https://pubmed.ncbi.nlm.nih.gov/28785587,diagnose,diagnosed,in 65 glioblastoma tumors diagnosed at the university hospital of fez between
Abstract,"""TP53 mutations in malignant astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/9529927,identify,identified,%) glioblastomas; the mutations were most frequently identified in the
Abstract,"""Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/2821446,study,studied,for supratentorial glioblastomas or anaplastic astrocytomas were studied to evaluate the effect
Abstract,"""Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/2821446,associate,associated,of supratentorial glioblastomas and anaplastic astrocytomas is feasible and is directly associated
Abstract,"""MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome.""",https://pubmed.ncbi.nlm.nih.gov/18000822,grade,grade,"and recurrent glioblastomas (gbm, who grade iv) of patients"
Abstract,"""The Glycoprotein M6a Is Associated with Invasiveness and Radioresistance of Glioblastoma Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/35883571,target,target,"treatment of glioblastoma since it would simultaneously target proliferation, invasion,"
Abstract,"""Cancer stem cells: cell culture, markers, and targets for new therapies.""",https://pubmed.ncbi.nlm.nih.gov/19760641,describe,describing,"focus on glioblastomas, describing recent progress and problems in characterizing these"
Abstract,"""Radiation of infratentorial and supratentorial brain-stem tumors.""",https://pubmed.ncbi.nlm.nih.gov/167136,extend,extended,that all glioblastomatous tumors extended beyond the treatment field; this suggested
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,investigate,investigated,mirnas on glioblastoma radioresistance was investigated.
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,promote,promotes,mir425 in glioblastoma promotes radioresistance through upregulation of the cell-cycle
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,suggest,suggesting,"antagomirs sensitizes glioblastoma cells to irradiation, suggesting their potential as targets"
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,correlate,correlate,expressed in glioblastoma patient specimens and correlate with tgfβ signaling.
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,provide,provide,radioresistance in glioblastomas and provide insight into the therapeutic application of tgfβ
Abstract,"""Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study.""",https://pubmed.ncbi.nlm.nih.gov/2161084,differ,differ,"astrocytomas and glioblastoma multiforme differ in their clinical courses, histological distinction"
Abstract,"""Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study.""",https://pubmed.ncbi.nlm.nih.gov/2161084,stain,stained,and 38 glioblastomas were stained by an indirect immunoperoxidase technique using the
Abstract,"""Application of novel PACS-based informatics platform to identify imaging based predictors of CDKN2A allelic status in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/38135704,use,using,biomarkers in glioblastomas using a new informatics workflow that enables rapid analysis
Title,"""When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.""",https://pubmed.ncbi.nlm.nih.gov/29727799,start,start,"did the glioblastoma start growing, and how much time can be"
Abstract,"""When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.""",https://pubmed.ncbi.nlm.nih.gov/29727799,use,used,model of glioblastoma growth was used to investigate two questions often asked
Abstract,"""When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.""",https://pubmed.ncbi.nlm.nih.gov/29727799,base,based,from 106 glioblastoma patients based on repeated volume segmentations.
Abstract,"""When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.""",https://pubmed.ncbi.nlm.nih.gov/29727799,range,ranging,"of the glioblastomas at diagnosis was median 330 days, but ranging"
Abstract,"""When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.""",https://pubmed.ncbi.nlm.nih.gov/29727799,originate,originate,"postulate that glioblastoma might originate median 330 days before the diagnosis,"
Abstract,"""When did the glioblastoma start growing, and how much time can be gained from surgical resection? A model based on the pattern of glioblastoma growth in vivo.""",https://pubmed.ncbi.nlm.nih.gov/29727799,suggest,suggesting,"benefit of glioblastoma resection is much higher with higher eors, suggesting"
Abstract,"""Clonal analysis in glioblastoma with epithelial differentiation.""",https://pubmed.ncbi.nlm.nih.gov/11145202,associate,associated,differentiation in glioblastomas (gbm) may be associated with circumscribed growth
Title,"""The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.""",https://pubmed.ncbi.nlm.nih.gov/26914704,modify,modified,mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Abstract,"""The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.""",https://pubmed.ncbi.nlm.nih.gov/26914704,exhibit,exhibited,glioblastomas (gbm) exhibited the highest frequency of tertp
Title,"""Functional outcomes, extent of resection, and bright/vague fluorescence interface in resection of glioblastomas involving the motor pathways assisted by 5-ALA.""",https://pubmed.ncbi.nlm.nih.gov/36087121,involve,involving,resection of glioblastomas involving the motor pathways assisted by 5-ala
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,have,have,"background: glioblastomas have a high degree of malignancy, high recurrence"
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,improve,improving,"markers of glioblastomas is of great significance for improving the diagnosis,"
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,express,expressed,: eight glioblastoma-specific differentially expressed genes were screened using geo
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,reveal,revealing,"to analyze glioblastoma samples in 34 microarray datasets, revealing novel diagnostic"
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,provide,providing,patients with glioblastoma and providing a new direction for screening tumor markers
Abstract,"""Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/38085571,induce,induce,investigated how glioblastomas induce reactive astrogliosis in the neighboring microenvironment and explore
Abstract,"""Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/38085571,trigger,triggers,"acetate from glioblastoma cells, which triggers reactive astrogliosis in neighboring astrocytes"
Abstract,"""Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/38085571,assess,assessed,region of glioblastomas and assessed the correlation between the volume of 11c
Abstract,"""Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/38085571,exhibit,exhibit,glioblastoma cells exhibit increased acetate production as a result of
Abstract,"""Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/38085571,induce,induces,derived from glioblastoma cells induces reactive astrogliosis in neighboring astrocytes by increasing
Abstract,"""Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/38085571,induce,inducing,derived from glioblastoma cells in inducing reactive astrogliosis and underscore the potential
Abstract,"""Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15639528,determine,determine,limited in glioblastomas and to determine whether the fa value of a
Abstract,"""Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15639528,measure,measured,patients with glioblastoma and measured the fa values of tumor and normal
Abstract,"""Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15639528,compare,compared,regions and glioblastoma lesion were compared.
Abstract,"""Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15639528,determine,determined,value of glioblastoma as determined by dti prior to surgery is a
Abstract,"""Bevacizumab for glioblastoma: current indications, surgical implications, and future directions.""",https://pubmed.ncbi.nlm.nih.gov/25581938,neutralize,neutralizing,treating recurrent glioblastomas with the antiangiogenic drug bevacizumab—a neutralizing antibody
Abstract,"""Bevacizumab for glioblastoma: current indications, surgical implications, and future directions.""",https://pubmed.ncbi.nlm.nih.gov/25581938,design,designed,"bevacizumab for glioblastoma treatment to date, ongoing trials designed to address"
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,show,shown,radiotherapy for glioblastoma was recently shown to improve median and 2-
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,perform,performed,patients with glioblastoma at our institute was performed.
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,treat,treated,pathologically confirmed glioblastoma were treated with radiotherapy (daily fractions of 2
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,share,share,"temozolomide for glioblastoma in korean patients, who share a common genetic"
Abstract,"""Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.""",https://pubmed.ncbi.nlm.nih.gov/19640635,use,using,"the recurrent glioblastomas refractory to temozolomide, further clinical trials using other"
Abstract,"""Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.""",https://pubmed.ncbi.nlm.nih.gov/34827559,spread,spreading,subpopulation in glioblastoma that are responsible for therapy resistance and tumor spreading
Abstract,"""Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study.""",https://pubmed.ncbi.nlm.nih.gov/34827559,regard,regarding,"effects in glioblastoma stem cells in vitro, regarding dependence on aldh1a3"
Title,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,derive,derived,cd133(-) glioblastoma-derived cancer stem cells show differential growth characteristics
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,show,show,"although glioblastomas show the same histologic phenotype, biological hallmarks such"
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,originate,originate,"subtypes of glioblastomas might originate from different cells of origin, we"
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,favor,favoring,from 22 glioblastomas under medium conditions favoring the growth of neural and
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,show,show,secondary glioblastoma (n = 7)-derived cells did not show any
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,contain,contained,11/15 primary glioblastomas contained a significant cd133(+) subpopulation that displayed neurosphere
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,grow,grew,from primary glioblastomas grew adherently in vitro and were driven by cd133(-
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,characterize,characterized,"cd133(-) glioblastomas were characterized by a lower proliferation index, whereas"
Abstract,"""Primary cerebellar glioblastomas in children: clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/32845414,remain,remain,pediatric cerebellar glioblastomas (pcgbms) are rare and their characteristics remain
Abstract,"""Primary cerebellar glioblastomas in children: clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/32845414,undergo,underwent,pediatric cerebellar glioblastomas who underwent surgery from 2008 to 2019 in our
Title,"""Glioblastoma and dementia may share a common cause.""",https://pubmed.ncbi.nlm.nih.gov/20181435,share,share,glioblastoma and dementia may share a common cause.
Abstract,"""Glioblastoma and dementia may share a common cause.""",https://pubmed.ncbi.nlm.nih.gov/20181435,share,share,'s and glioblastoma may share an as yet unknown peripheral tissue pathway
Abstract,"""The Multipotential of Leucine-Rich alpha-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32647893,perform,performed,biomarker for glioblastoma was performed.
Abstract,"""The Multipotential of Leucine-Rich alpha-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32647893,show,showed,glioblastoma showed a significantly higher lrg1 expression than lower-
Abstract,"""The Multipotential of Leucine-Rich alpha-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32647893,correlate,correlated,-wildtype glioblastoma and correlated with gross total resection (p =
Abstract,"""IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/25455102,base,based,screened primary glioblastoma multiforme (gbm) in a population-based
Title,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,reveal,reveals,paired idhwt glioblastomas reveals recurrent alterations of mpdz at relapse after radiotherapy
Abstract,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,screen,screened,frozen idhwt glioblastoma samples were screened by cgh array.
Abstract,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,include,included,nineteen idhwt glioblastoma patients were included.
Abstract,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,suggest,suggesting,"chemotherapy in glioblastoma idhwt patients, suggesting that mpdz impairment could contribute"
Abstract,"""MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30343277,exist,exists,"patients with glioblastoma, no consensus exists as to which assay is"
Abstract,"""MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30343277,accord,according,patients with glioblastoma according to assay results.
Abstract,"""[Immunohistochemical changes in apoptosis in glioblastoma of the cerebral hemispheres].""",https://pubmed.ncbi.nlm.nih.gov/9702296,indicate,indicating,"found in glioblastomas, this indicating a non-uniform role of"
Abstract,"""Endothelial cell ferroptosis influences IDH wild-type glioblastoma growth in recurrent glioblastoma multiforme patients.""",https://pubmed.ncbi.nlm.nih.gov/38985083,know,known,"glioblastomas are known for their poor clinical prognosis, with"
Abstract,"""Endothelial cell ferroptosis influences IDH wild-type glioblastoma growth in recurrent glioblastoma multiforme patients.""",https://pubmed.ncbi.nlm.nih.gov/38985083,require,requires,treatment of glioblastomas requires careful consideration of its effects on endothelial cells
Abstract,"""Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18709645,repress,represses,"downregulated in glioblastoma, and ndrg2 overexpression represses glioblastoma cell proliferation in"
Abstract,"""Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18709645,compare,compared,in primary glioblastomas as compared to diffuse and anaplastic astrocytomas.
Abstract,"""Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18709645,detect,detected,"to primary glioblastomas, ndrg2 promoter hypermethylation was detected in only 1"
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,remain,remained,effect on glioblastomas remained unclear.
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,base,based,the multicenter glioblastoma cohorts based on the oxidative-stress-responsive
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,discover,discovered,potential in glioblastoma and discovered sod3's potential role in regulating macrophage
Abstract,"""Histological changes in glioblastoma after intratumoral injection of autologous lymphocytes and human lymphoblastoid interferon.""",https://pubmed.ncbi.nlm.nih.gov/2166927,study,studied,seven glioblastomas were studied between 1 and 6 months after intratumoral
Abstract,"""Histological changes in glioblastoma after intratumoral injection of autologous lymphocytes and human lymphoblastoid interferon.""",https://pubmed.ncbi.nlm.nih.gov/2166927,suggest,suggesting,"lymphocytes and glioblastoma cells, suggesting a killing phenomenon."
Abstract,"""Histological changes in glioblastoma after intratumoral injection of autologous lymphocytes and human lymphoblastoid interferon.""",https://pubmed.ncbi.nlm.nih.gov/2166927,activate,activated,patients with glioblastoma by means of intratumoral administration of activated lymphoid cells
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,associate,associated,"yet, glioblastoma-associated changes in peripheral blood immune composition are"
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,hypothesize,hypothesized,administration in glioblastoma patients have been hypothesized to limit the effectiveness of
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,have,had,results: glioblastoma patients had significantly fewer naive cd4+ t cells
Abstract,"""The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.""",https://pubmed.ncbi.nlm.nih.gov/38318180,influence,influenced,"cells in glioblastoma patients were influenced by age and dexamethasone treatment,"
Title,"""IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.""",https://pubmed.ncbi.nlm.nih.gov/38326875,stratify,stratified,idhwt glioblastomas can be stratified by their transcriptional response to standard
Abstract,"""IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.""",https://pubmed.ncbi.nlm.nih.gov/38326875,lack,lacking,background: glioblastoma (gbm) brain tumors lacking idh1 mutations (
Abstract,"""Correlation between preoperative magnetic resonance spectroscopic data on high grade gliomas and morphology of Ki-67-positive tumor cell nuclei.""",https://pubmed.ncbi.nlm.nih.gov/12882084,investigate,investigated,"; 29 glioblastomas, world health organization grade 4) were investigated"
Title,"""Predicting survival in glioblastomas using diffusion tensor imaging metrics.""",https://pubmed.ncbi.nlm.nih.gov/20882608,use,using,survival in glioblastomas using diffusion tensor imaging metrics.
Abstract,"""Glioblastoma oncometry.""",https://pubmed.ncbi.nlm.nih.gov/2176356,see,seen,appearance of glioblastomas seen at the completion of radiation therapy.
Title,"""Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors.""",https://pubmed.ncbi.nlm.nih.gov/28212808,improve,improving,amplification in glioblastoma in vivo: improving patient selection to mdm2-
Abstract,"""Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors.""",https://pubmed.ncbi.nlm.nih.gov/28212808,exhibit,exhibited,% of glioblastomas exhibited high mdm2 amplification (in vivo) with
Abstract,"""End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29023236,facilitate,facilitating,ttfields in glioblastoma patients by facilitating the creation of fea models derived
Abstract,"""Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.""",https://pubmed.ncbi.nlm.nih.gov/15809762,consist,consisting,"treatment of glioblastoma multiforme consisting of surgical resection, radiation and/or chemotherapy"
Abstract,"""Perillyl alcohol induces apoptosis in human glioblastoma multiforme cells.""",https://pubmed.ncbi.nlm.nih.gov/15809762,treat,treated,glioblastoma cell lines treated with poh showed morphological alterations characteristic
Abstract,"""The histological representativeness of glioblastoma tissue samples.""",https://pubmed.ncbi.nlm.nih.gov/33085022,know,known,background: glioblastomas (gbms) are known for having a vastly
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,continue,continues,"patients with glioblastoma continues to be limited, despite an aggressive,"
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,induce,inducing,"agent in glioblastoma, is cytotoxic to cells by inducing dna damage"
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,methylate,methylated,"subset of glioblastomas, the mgmt promoter is methylated, impairing the"
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,provide,providing,% of glioblastomas providing an inherent resistance to alkylating agents and challenging
Abstract,"""Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/34732244,predict,predict,"management of glioblastoma patients, new biomarkers that could predict patient survival"
Abstract,"""Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22926763,evaluate,evaluated,biomarkers in glioblastomas was evaluated.
Abstract,"""Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22926763,overexpresse,overexpressed,") of glioblastomas, while cd151 was rarely overexpressed in most of"
Abstract,"""Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11355148,include,included,patients with glioblastoma multiforme were included.
Abstract,"""Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11355148,show,show,-six glioblastomas did not show allelic loss for any locus.
Abstract,"""Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11355148,characterize,characterized,prognosis in glioblastomas characterized by loh 11p15.
Abstract,"""Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/17516028,arise,arise,is that glioblastoma may arise from transformed stem cells in the ventricular
Abstract,"""Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/17516028,have,had,"posterior temporal glioblastoma had undergone surgery, radiation, and chemotherapy."
Abstract,"""Organotypic distribution of stem cell markers in formalin-fixed brain harboring glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/17516028,arise,arise,that some glioblastomas may arise from the neurogenic zone of the lateral
Abstract,"""The glioblastoma multiforme in Georgia, 1977-1981.""",https://pubmed.ncbi.nlm.nih.gov/2990658,see,seen,of the glioblastoma multiforme as it is seen at the primary care
Abstract,"""Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.""",https://pubmed.ncbi.nlm.nih.gov/12182418,remain,remains,necrosis in glioblastomas remains unelucidated.
Abstract,"""Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.""",https://pubmed.ncbi.nlm.nih.gov/12182418,result,results,"patients with glioblastomas, because the hypoxia that results from procoagulation selects"
Abstract,"""Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.""",https://pubmed.ncbi.nlm.nih.gov/12182418,base,based,development in glioblastomas that is evidence-based is likely to provide
Title,"""Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.""",https://pubmed.ncbi.nlm.nih.gov/20118769,distinguish,distinguished,versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of
Abstract,"""Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.""",https://pubmed.ncbi.nlm.nih.gov/20118769,share,share,and rhabdoid glioblastomas are rare entities that share some overlapping morphologic features
Title,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,stratify,stratified,from independent glioblastoma cohorts stratified by age and idh mutation status.
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,derive,derived,r132h1 immunonegative glioblastomas derived from patients aged 60 years and older enrolled
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,study,studied,"population of glioblastomas, we studied 80 idh-wildtype glioblastomas from"
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,age,aged,-wildtype glioblastomas from patients aged 18-60 years.
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,include,included,with primary glioblastomas included in these cohorts.
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,corroborate,corroborated,"in primary glioblastomas, was corroborated by gene expression data extracted from"
Abstract,"""Prognostic value of ALDH1A3 promoter methylation in gliob;astoma: a single center experience in Western China.""",https://pubmed.ncbi.nlm.nih.gov/25684492,remain,remains,of primary glioblastomas (gbms) in western china remains unclear.
Abstract,"""Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18298442,investigate,investigated,value in glioblastomas (gbs) was also investigated.
Abstract,"""Fascin expression [corrected] in glial tumors and its prognostic significance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18298442,know,known,"including 44 glioblastomas with known survival time, 18 anaplastic astrocytomas ("
Abstract,"""Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.""",https://pubmed.ncbi.nlm.nih.gov/34850045,define,defining,of some glioblastomas but defining molecular alterations of this histologic variant remains
Title,"""Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32791527,reveal,reveals,and recurrent glioblastomas reveals a reduced level of pentraxin 3 in recurrent
Abstract,"""Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32791527,identify,identified,and recurrent glioblastoma samples from 18 patients were identified and expression profiling
Abstract,"""Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32791527,set,set,in recurrent glioblastomas and the gene set analysis results suggest an altered
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,progress,progressed,in secondary glioblastomas that have progressed from low-grade or anaplastic
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,misclassifie,misclassified,to secondary glioblastomas and are probably misclassified.
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,account,account,", secondary glioblastomas account for approximately 10% of all glioblastomas."
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,derive,derived,and secondary glioblastomas derived thereof suggests these tumors share a common progenitor
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,suggest,suggests,in primary glioblastomas suggests a different cell of origin; both glioblastoma
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,acquire,acquire,; both glioblastoma subtypes acquire a similar histological phenotype as a result
Abstract,"""Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance.""",https://pubmed.ncbi.nlm.nih.gov/39115615,identify,identify,whether molecular glioblastomas (gbms) identify with a similar dismal prognosis
Abstract,"""Safety of stereotactic laser ablations performed as treatment for glioblastomas in a conventional magnetic resonance imaging suite.""",https://pubmed.ncbi.nlm.nih.gov/27690648,perform,performed,sla for glioblastoma (gbm) treatment was performed entirely within a
Abstract,"""Quantitative evaluation of nucleolar features on cytologic material in brain tumor diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/7851047,differ,differ,"astrocytomas and glioblastomas, did not significantly differ from low-grade"
Abstract,"""Quantitative evaluation of nucleolar features on cytologic material in brain tumor diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/7851047,marginate,marginated,glioblastomas had marginated nucleoli much more frequently than anaplastic astrocytomas
Abstract,"""Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.""",https://pubmed.ncbi.nlm.nih.gov/19430729,confirm,confirmed,mrna on glioblastomas confirmed the immunohistochemical expression of timp-1.
Abstract,"""Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.""",https://pubmed.ncbi.nlm.nih.gov/19430729,have,had,showed that glioblastoma patients with the lowest timp-1 expression had a significantly
Abstract,"""Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.""",https://pubmed.ncbi.nlm.nih.gov/19430729,suggest,suggesting,"survival in glioblastoma patients, suggesting a role for timp-1 as a"
Title,"""Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report.""",https://pubmed.ncbi.nlm.nih.gov/23421452,detect,detected,of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic
Abstract,"""Subependymal spread of recurrent glioblastoma detected with the intraoperative use of 5-aminolevulinic acid: case report.""",https://pubmed.ncbi.nlm.nih.gov/23421452,occur,occur,recurrent glioblastoma (gbm) can occur locally or at distant
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,-,-,both human glioblastoma cells and pre-established human glioblastoma mouse model
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,compare,compared,established human glioblastoma mouse model compared with an srrv system.
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,inject,injected,"u-87 mg glioblastomas, the group of mice injected with sprrv expressing"
Abstract,"""Proliferative index in astrocytic tumours.""",https://pubmed.ncbi.nlm.nih.gov/18306542,immunostaine,immunostained,", and glioblastoma multiforme (grade iv), were immunostained by"
Title,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,dictate,dictates,required for glioblastoma development but its inhibition dictates glioma stem cell responsivity
Abstract,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,inhibit,inhibiting,"effects in glioblastoma stem cells (gscs) inhibiting clic1 activity,"
Abstract,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,use,using,"from human glioblastomas, in vitro using 2d and 3d cultures and"
Abstract,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,act,acts,"subset of glioblastomas, it acts as a booster of proliferation in"
Abstract,"""Microenvironmental reorganization in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging.""",https://pubmed.ncbi.nlm.nih.gov/38622132,compare,compare,"model of glioblastoma, and compare this response to a mouse model"
Abstract,"""Microenvironmental reorganization in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging.""",https://pubmed.ncbi.nlm.nih.gov/38622132,undergo,undergo,show that glioblastomas undergo extensive spatial reorganization of immune cell populations and
Title,"""MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.""",https://pubmed.ncbi.nlm.nih.gov/29191871,provide,provide,macrophages in glioblastoma and provide an improved signature for survival prognostication.
Abstract,"""MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.""",https://pubmed.ncbi.nlm.nih.gov/29191871,associate,associated,": in glioblastoma, tumor-associated macrophages have tumor-promoting"
Abstract,"""MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.""",https://pubmed.ncbi.nlm.nih.gov/29191871,differ,differ,subtypes of glioblastoma that differ in the content of tumor-associated
Abstract,"""MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.""",https://pubmed.ncbi.nlm.nih.gov/29191871,divide,divided,glioblastomas were divided into subtypes based on the telomere maintenance
Abstract,"""MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.""",https://pubmed.ncbi.nlm.nih.gov/29191871,associate,associated,conclusions: glioblastomas with tumor-associated macrophages are associated with routine
Abstract,"""Sparc-like protein 1 is a new marker of human glioma progression.""",https://pubmed.ncbi.nlm.nih.gov/22909274,accept,accepted,"de novo glioblastoma, it is currently accepted that these malignancies mainly"
Abstract,"""Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.""",https://pubmed.ncbi.nlm.nih.gov/28358371,affect,affect,glioblastomas are incurable primary brain tumors that affect patients of
Abstract,"""Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.""",https://pubmed.ncbi.nlm.nih.gov/28358371,alter,altered,together with glioblastoma stem-like cells efficiently altered the tumor development
Abstract,"""Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.""",https://pubmed.ncbi.nlm.nih.gov/2895977,have,had,"of ten glioblastomas had an identifiable aneuploid peak, while all four"
Title,"""Factors involved in maintaining Karnofsky Performance Status ( 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/39799218,treat,treated,") in glioblastoma, idh-wildtype patients treated with temozolomide and"
Abstract,"""Factors involved in maintaining Karnofsky Performance Status ( 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/39799218,treat,treated,"patients with glioblastomas, idh-wildtype, who were treated with"
Abstract,"""CD98 immunoreactivity in multinucleated giant cells of glioblastomas: an immunohistochemical double labeling study.""",https://pubmed.ncbi.nlm.nih.gov/18021193,investigate,investigate,") in glioblastomas, we investigate the cd98 immunoreactivity of mngcs and"
Abstract,"""CD98 immunoreactivity in multinucleated giant cells of glioblastomas: an immunohistochemical double labeling study.""",https://pubmed.ncbi.nlm.nih.gov/18021193,include,including,with primary glioblastomas including mngcs.
Abstract,"""Evaluation of glioblastomas and lymphomas with whole-brain CT perfusion: Comparison between a delay-invariant singular-value decomposition algorithm and a Patlak plot.""",https://pubmed.ncbi.nlm.nih.gov/26947963,show,showed,"results: glioblastomas showed significantly higher rflow (3.05±0.49, mean±standard deviation"
Title,"""Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.""",https://pubmed.ncbi.nlm.nih.gov/9720494,generate,generated,phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer
Abstract,"""Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.""",https://pubmed.ncbi.nlm.nih.gov/9720494,show,show,or not glioblastomas also show oligodendroglial differentiation remains a matter of controversy
Abstract,"""Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.""",https://pubmed.ncbi.nlm.nih.gov/9720494,represent,represent,that some glioblastomas (gbms) may also represent the ultimate level
Abstract,"""Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy.""",https://pubmed.ncbi.nlm.nih.gov/9720494,display,displayed,"these 164 glioblastomas, 6 (about 3.5%) displayed phenotypes"
Abstract,"""The relationship between genetic aberrations as detected by comparative genomic hybridization and vascularization in glioblastoma xenografts.""",https://pubmed.ncbi.nlm.nih.gov/11386408,characterize,characterized,glioblastomas (gbms) are histologically characterized by striking microvascular
Title,"""The Effect of Heterogenous Subregions in Glioblastomas on Survival Stratification: A Radiomics Analysis Using the Multimodality MRI.""",https://pubmed.ncbi.nlm.nih.gov/34318731,use,using,subregions in glioblastomas on survival stratification: a radiomics analysis using the
Title,"""Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/27026567,treat,treated,in recurrent glioblastoma treated with bevacizumab.
Abstract,"""Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/27026567,appear,appears,": in glioblastoma, tumor progression appears to be triggered by expression"
Abstract,"""Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/27026567,estimate,estimate,"in recurrent glioblastoma, and (2) to estimate whether leakage"
Abstract,"""Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/27026567,treat,treated,24 recurrent glioblastomas treated with bevacizumab as second line chemotherapy.
Abstract,"""Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusion MRI predicts survival in recurrent glioblastoma treated with bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/27026567,treat,treated,in recurrent glioblastomas treated with bevacizumab.
Title,"""Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.""",https://pubmed.ncbi.nlm.nih.gov/17483362,reverse,reversed,deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed
Abstract,"""Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir.""",https://pubmed.ncbi.nlm.nih.gov/17483362,have,have,glioblastomas frequently have loss of the phosphatase and tensin homologue
Title,"""Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study.""",https://pubmed.ncbi.nlm.nih.gov/27849434,dehydrogenase,dehydrogenase,-mutated glioblastomas than in isocitrate dehydrogenase wild-type glioblastomas:
Abstract,"""Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study.""",https://pubmed.ncbi.nlm.nih.gov/27849434,recruit,recruited,patients with glioblastoma were prospectively recruited and imaged preoperatively.
Abstract,"""Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study.""",https://pubmed.ncbi.nlm.nih.gov/27849434,have,have,-mutated glioblastomas have a less invasive phenotype compared with idh wild
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,target,targeted,") in glioblastoma pathogenesis, egfr targeted therapies have achieved limited clinical"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,express,expressing,"revealed that glioblastoma cells over-expressing egfrviii, an oncogenic variant"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,cause,caused,"expression in glioblastoma cells caused increased levels of ros, dna strand"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,correlate,correlated,"of primary glioblastoma lines, sensitivity to parp1 inhibition correlated with the"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,correlate,correlated,genes in glioblastomas with high egfr expression correlated with improved patient survival
Title,"""Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.""",https://pubmed.ncbi.nlm.nih.gov/21203936,signal,signaling,cells in glioblastoma--molecular signaling and therapeutic targeting.
Title,"""Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid-Coated Superparamagnetic Iron Oxide.""",https://pubmed.ncbi.nlm.nih.gov/34366665,use,using,-resistant glioblastoma by using pd-l1 antibodies conjugated with lipid
Abstract,"""Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid-Coated Superparamagnetic Iron Oxide.""",https://pubmed.ncbi.nlm.nih.gov/34366665,use,using,expression in glioblastoma or temozolomide-resistant glioblastoma by using mri.
Abstract,"""Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid-Coated Superparamagnetic Iron Oxide.""",https://pubmed.ncbi.nlm.nih.gov/34366665,use,using,-resistant glioblastoma by using mri.
Abstract,"""Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid-Coated Superparamagnetic Iron Oxide.""",https://pubmed.ncbi.nlm.nih.gov/34366665,confirm,confirmed,-resistant glioblastoma cells and tumor tissue were confirmed through prussian blue
Abstract,"""Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/6306179,randomize,randomized,with supratentorial glioblastomas and malignant astrocytomas were randomized to one of three
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,store,stored,deregulated in glioblastomas and highly stable in stored tissue specimens.
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,include,included,from 40 glioblastoma patients were included retrospectively; patients were comparable on
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,survival,survival,dendrograms dichotomized glioblastomas into prognostic subgroups with a significant association to survival
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,stratify,stratifying,biomarkers in glioblastoma stratifying patients into short- and long-term survivors
Abstract,"""Clinical implications of multiple glioblastomas: An analysis of prognostic factors and survival to distinguish from their single counterparts.""",https://pubmed.ncbi.nlm.nih.gov/31515159,have,has,purpose: glioblastoma (gbm) has the highest fatality rate among
Abstract,"""Patterns of care and survival for glioblastoma patients in the Veterans population.""",https://pubmed.ncbi.nlm.nih.gov/21881877,follow,followed,", supratentorial glioblastoma multiforme in male veterans actively followed by the vaccr"
Abstract,"""Patterns of care and survival for glioblastoma patients in the Veterans population.""",https://pubmed.ncbi.nlm.nih.gov/21881877,diagnose,diagnosed,veterans with glioblastomas diagnosed between 1997 and 2006.
Title,"""Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion.""",https://pubmed.ncbi.nlm.nih.gov/39387957,involve,involving,malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative
Abstract,"""Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion.""",https://pubmed.ncbi.nlm.nih.gov/39387957,influence,influenced,background: glioblastoma's infiltrative growth and heterogeneity are influenced by neural
Abstract,"""Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion.""",https://pubmed.ncbi.nlm.nih.gov/39387957,exhibit,exhibit,"discussion: glioblastomas with svz infiltration exhibit distinct imaging characteristics, including"
Abstract,"""MR-guided laser irradiation of recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16270287,use,using,with recurrent glioblastoma multiforme using nd:yag laser irradiation in the
Abstract,"""Discriminating pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors by means of susceptibility-weighted imaging.""",https://pubmed.ncbi.nlm.nih.gov/25465712,enhance,enhancing,-enhancing glioblastomas and 23 patients with rim-enhancing metastases underwent
Abstract,"""Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.""",https://pubmed.ncbi.nlm.nih.gov/9591629,have,had,four glioblastomas of 122 had patterns suggestive of homozygous deletions at
Abstract,"""Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.""",https://pubmed.ncbi.nlm.nih.gov/9591629,lose,lost,"most glioblastomas lost one entire chromosome 10, while astrocytomas preferentially"
Abstract,"""FDG-PET as a prognostic factor in high-grade astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/11206011,classify,classified,patients with glioblastoma (grade 4) were classified according to a
Abstract,"""FDG-PET as a prognostic factor in high-grade astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/11206011,consider,considered,"astrocytomas and glioblastomas were considered separately, metabolic grade is of predictive"
Abstract,"""Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results.""",https://pubmed.ncbi.nlm.nih.gov/18647495,receive,receiving,"study, glioblastomas with low mgmt expression receiving surgical resection, radiotherapy"
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,infiltrate,infiltrating,"tumors are glioblastomas, and 30% are diffusely infiltrating lower-"
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,improve,improved,"patients with glioblastoma, the combination of temozolomide with radiotherapy improved survival"
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,follow,followed,therapy for glioblastoma is surgery followed by radiation and the alkylating chemotherapeutic
Abstract,"""Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11995813,define,defined,lis in glioblastomas could be defined.
Title,"""Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-kappaB.""",https://pubmed.ncbi.nlm.nih.gov/20454998,regulate,regulated,growth of glioblastoma cells through down-regulated nf-kappab.
Abstract,"""Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-kappaB.""",https://pubmed.ncbi.nlm.nih.gov/20454998,study,studied,role in glioblastomas have not been studied.
Abstract,"""Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-kappaB.""",https://pubmed.ncbi.nlm.nih.gov/20454998,rnai)-mediate,rnai)-mediated,"cypa in glioblastoma, stable rna interference (rnai)-mediated knockdown of cypa"
Abstract,"""Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33525678,remain,remains,autophagy in glioblastoma remains ambiguous.
Abstract,"""Comparison of cytologic composition with microfluorometric DNA analysis of the glioblastoma multiforme and anaplastic astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/2438028,compose,composed,of 16 glioblastoma multiforme predominantly composed of small anaplastic cells was investigated
Abstract,"""Comparison of cytologic composition with microfluorometric DNA analysis of the glioblastoma multiforme and anaplastic astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/2438028,have,had,cases of glioblastoma multiforme had a main population that was diploid-
Abstract,"""Comparison of cytologic composition with microfluorometric DNA analysis of the glioblastoma multiforme and anaplastic astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/2438028,have,have,"population in glioblastomas have a dna content diploid-near diploid,"
Title,"""Boron neutron capture therapy for glioblastoma: is it worth pursuing?""",https://pubmed.ncbi.nlm.nih.gov/18198928,pursue,pursuing,therapy for glioblastoma: is it worth pursuing?
Abstract,"""Treatment of malignant astrocytomas with repetitive resections: a longitudinal study.""",https://pubmed.ncbi.nlm.nih.gov/11344836,choose,chosen,cases of glioblastoma multiforme and 50 cases of anaplastic astrocytoma were chosen
Abstract,"""Treatment of malignant astrocytomas with repetitive resections: a longitudinal study.""",https://pubmed.ncbi.nlm.nih.gov/11344836,show,showed,patients with glioblastomas showed a median survival of 415 days.
Abstract,"""Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.""",https://pubmed.ncbi.nlm.nih.gov/17409412,represent,represent,glioblastomas represent an important cause of cancer-related mortality
Abstract,"""Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.""",https://pubmed.ncbi.nlm.nih.gov/17409412,distribute,distributed,"directly into glioblastomas, hsdscs distributed themselves extensively throughout the tumor mass"
Abstract,"""Infantile Optic Pathway Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31158532,remain,remain,gliomas and glioblastomas remain a rare entity within the infant population.
Abstract,"""Infantile Optic Pathway Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31158532,undescribe,undescribed,optic pathway glioblastoma in this population is a previously undescribed entity that
Abstract,"""Neoplastic Myelopathies.""",https://pubmed.ncbi.nlm.nih.gov/29613896,recognize,recognized,"grade iv glioblastomas, and newly recognized pediatric diffuse midline gliomas with"
Abstract,"""EGFR as a clinical marker in glioblastomas and other gliomas.""",https://pubmed.ncbi.nlm.nih.gov/28885661,include,including,", especially glioblastomas, including amplifications, deletions and single nucleotide polymorphisms"
Abstract,"""EGFR as a clinical marker in glioblastomas and other gliomas.""",https://pubmed.ncbi.nlm.nih.gov/28885661,discuss,discussed,glioblastomas are discussed as a separate entity due to their
Abstract,"""EGFR as a clinical marker in glioblastomas and other gliomas.""",https://pubmed.ncbi.nlm.nih.gov/28885661,target,targeted,"and specifically glioblastomas, as a means for targeted treatment and prognosis"
Abstract,"""Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/29286221,observe,observed,", with glioblastomas as the most frequently observed histologic subtype, are"
Abstract,"""Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/29286221,evaluate,evaluated,treated for glioblastoma were retrospectively evaluated.
Abstract,"""Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/9559943,remove,removed,from two glioblastomas surgically removed from a 64-year-old
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,grade,grade,for supratentorial glioblastoma (who grade iv) between 2013 and 2017
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,correlate,correlate,snp in glioblastoma samples did not correlate with presence of idh1 mutation
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,have,had,idh mutant glioblastoma had a distinctly higher survival profile than both rs11554137
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,harbor,harboring,patients with glioblastoma harboring the snp and patients with idh wild type
Abstract,"""Negative prognostic effect of low nuclear GLI1 expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28417299,focus,focusing,expression in glioblastoma focusing on the nuclear localization.
Abstract,"""Negative prognostic effect of low nuclear GLI1 expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28417299,grade,graded,"in 140 glioblastoma tissues, and the staining was graded."
Abstract,"""Negative prognostic effect of low nuclear GLI1 expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28417299,reveal,revealed,tcga-glioblastoma dataset revealed that low gli1 mrna level also correlated
Abstract,"""Negative prognostic effect of low nuclear GLI1 expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28417299,need,needs,expression in glioblastomas needs to be considered in studies of hedgehog signaling
Abstract,"""Stem cell niches in glioblastoma: a neuropathological view.""",https://pubmed.ncbi.nlm.nih.gov/24834433,study,studied,fifteen glioblastomas have been studied by immunohistochemistry and immunofluorescence for stemness
Title,"""Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.""",https://pubmed.ncbi.nlm.nih.gov/29159777,base,based,with recurrent glioblastoma: a decision-tree-based model.
Abstract,"""Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.""",https://pubmed.ncbi.nlm.nih.gov/29159777,treat,treated,recurrent supratentorial glioblastoma treated by surgical resection and standard combined chemoradiotherapy as
Abstract,"""Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model.""",https://pubmed.ncbi.nlm.nih.gov/29159777,inform,inform,in recurrent glioblastomas and should inform the treatment decisions.
Title,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,activate,activated,glioblastoma-activated pericytes support tumor growth via immunosuppression.
Abstract,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,restrict,restricts,involved in glioblastoma development restricts the design of efficient therapies.
Abstract,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,activate,activated,"glioblastoma-activated pericytes develop an immunosuppressive phenotype, reducing"
Title,"""Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR(Y1068) Phosphorylation.""",https://pubmed.ncbi.nlm.nih.gov/32371586,require,requires,"(abt-414)-induced glioblastoma cell death requires egfr overexpression, but not egfr(y1068"
Abstract,"""Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR(Y1068) Phosphorylation.""",https://pubmed.ncbi.nlm.nih.gov/32371586,exhibit,exhibit,glioblastomas commonly (40%) exhibit epidermal growth factor
Abstract,"""Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR(Y1068) Phosphorylation.""",https://pubmed.ncbi.nlm.nih.gov/32371586,target,targeting,"effects in glioblastoma, novel therapeutic agents targeting amplified egfr or egfrviii"
Abstract,"""Fibrin deposition in primary and metastatic human brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/8874864,detect,detected,in glioblastomas fibrin deposits could be detected within and around tumour
Abstract,"""Fibrin deposition in primary and metastatic human brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/8874864,accumulate,accumulated,areas in glioblastomas and to be accumulated at the interface of tumorous
Abstract,"""Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI.""",https://pubmed.ncbi.nlm.nih.gov/38960965,determine,determine,of heterotopic glioblastoma xenografts in mice to determine tumor cell proliferation (
Abstract,"""Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI.""",https://pubmed.ncbi.nlm.nih.gov/38960965,inject,injected,: human glioblastoma cells were injected subcutaneously into both flanks of immunodeficient
Abstract,"""Radiomics and visual analysis for predicting success of transplantation of heterotopic glioblastoma in mice with MRI.""",https://pubmed.ncbi.nlm.nih.gov/38960965,provide,provide,heterotopically implanted glioblastomas provide reproducible and quantifiable results to predict the success
Title,"""NIR-IIb Fluorescence Molecular Tomography of Glioblastomas Based on Heterogeneous Mouse Models and Adaptive Projection Match Pursuit Method.""",https://pubmed.ncbi.nlm.nih.gov/37093732,base,based,tomography of glioblastomas based on heterogeneous mouse models and adaptive projection match
Title,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,invasiveness,invasiveness,regulation of glioblastoma growth and invasiveness.
Abstract,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,correlate,correlated,"downregulation in glioblastomas, which correlated with shorter glioblastoma patient survival."
Abstract,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,show,showed,"-deficient glioblastoma cells showed elevated cofilin phosphorylation, an increase in"
Abstract,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,xenografte,xenografted,-depleted glioblastoma cells xenografted into the immunodeficient mouse brain was strongly
Abstract,"""Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas.""",https://pubmed.ncbi.nlm.nih.gov/12687302,meningioma,meningioma,14 with glioblastoma multiforme and 11 with grade i meningioma.
Abstract,"""Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas.""",https://pubmed.ncbi.nlm.nih.gov/12687302,take,taken,for the glioblastomas the solid portion was taken as the difference between
Abstract,"""Perfusion MRI in the evaluation of the relationship between tumour growth, necrosis and angiogenesis in glioblastomas and grade 1 meningiomas.""",https://pubmed.ncbi.nlm.nih.gov/12687302,find,found,"in the glioblastomas, we found an inverse relationship between blood volume"
Abstract,"""Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15558549,increase,increased,area in glioblastomas and meningiomas and as the area of increased t2
Abstract,"""Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15558549,see,saw,"meningiomas and glioblastomas, we saw a trend (without significance)"
Abstract,"""Epigenetic regulation of cancer stem cell and tumorigenesis.""",https://pubmed.ncbi.nlm.nih.gov/32723561,attract,attract,"brain, glioblastoma stem cells (gscs) attract extensive research interests"
Abstract,"""ONCOhabitats: A system for glioblastoma heterogeneity assessment through MRI.""",https://pubmed.ncbi.nlm.nih.gov/31160012,help,help,"assessment of glioblastoma, to help improving treatment and tumor follow-"
Abstract,"""ONCOhabitats: A system for glioblastoma heterogeneity assessment through MRI.""",https://pubmed.ncbi.nlm.nih.gov/31160012,base,based,system for glioblastoma analysis based on mri data.
Abstract,"""ONCOhabitats: A system for glioblastoma heterogeneity assessment through MRI.""",https://pubmed.ncbi.nlm.nih.gov/31160012,implement,implementing,"services for glioblastoma heterogeneity assessment, implementing consolidated state-of-"
Abstract,"""Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38858501,have,have,-type glioblastomas have a poor five-year survival rate along
Abstract,"""Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10077222,show,showed,primary glioblastomas showed a high frequency of genomic dna gains (
Abstract,"""Proton MR spectroscopic imaging of human glioblastomas at 1.5 Tesla.""",https://pubmed.ncbi.nlm.nih.gov/29372686,accompany,accompanied,"necrosis of glioblastoma accompanied by the tissue hypoxia, which were apparent"
Abstract,"""Proton MR spectroscopic imaging of human glioblastomas at 1.5 Tesla.""",https://pubmed.ncbi.nlm.nih.gov/29372686,surround,surrounding,showing the glioblastoma infiltration into the surrounding tissues.
Title,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,use,using,survivors of glioblastoma using genome- and transcriptome-wide profiling.
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,perform,performed,"aberrations in glioblastomas of long-term survivors, we performed genome-"
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,include,including,"profiling of glioblastoma samples from 94 patients, including 28 long-"
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,show,show,-wildtype glioblastomas from long-term survivors did not show distinct
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,corroborate,corroborate,mutation in glioblastoma long-term survival and corroborate the association of
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,lack,lacked,-wildtype glioblastomas in our cohort of long-term survivors lacked
Title,"""Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.""",https://pubmed.ncbi.nlm.nih.gov/25361004,mediate,mediated,"in human glioblastoma stem cells, via inhibition of clic1-mediated"
Abstract,"""Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37218946,challenge,challenging,crucial for glioblastoma treatment but may be challenging using clinical imaging alone
Abstract,"""Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37218946,receive,received,) where glioblastoma patients received high-dose rt guided by the
Abstract,"""Perspectives for immunotherapy in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25210870,grow,growing,to fight glioblastoma is growing.
Abstract,"""Perspectives for immunotherapy in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25210870,lysate,lysate,to present glioblastoma antigens (whole tumor lysate) to the immune
Abstract,"""Perspectives for immunotherapy in glioblastoma treatment.""",https://pubmed.ncbi.nlm.nih.gov/25210870,start,start,cells with glioblastoma stem-like cells will start soon.
Abstract,"""A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MRI.""",https://pubmed.ncbi.nlm.nih.gov/38305926,accord,according,astrocytoma and glioblastoma according to the 2021 who cns5 classification.
Abstract,"""A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MRI.""",https://pubmed.ncbi.nlm.nih.gov/38305926,collect,collected,and 289 glioblastomas) with histologic diagnosis was retrospectively collected from our
Abstract,"""Extent of tumor-brain interface: a new tool to predict evolution of malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11235948,target,targeted,"recurrences of glioblastoma were targeted with suicide genes, the authors developed"
Abstract,"""Extent of tumor-brain interface: a new tool to predict evolution of malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11235948,enrol,enrolled,with recurrent glioblastomas were enrolled in this study.
Abstract,"""Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study.""",https://pubmed.ncbi.nlm.nih.gov/31321614,undergo,undergoing,histologically proven glioblastoma undergoing first-line therapy were prospectively recruited.
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,compare,compared,"in primary glioblastomas compared to low-grade, anaplastic, or"
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,show,showed,"and primary glioblastoma cells showed a high membrane hsp70 expression density,"
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,show,showed,isolated from glioblastoma tissues only showed a weak staining pattern.
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,compare,compared,harbouring primary glioblastomas compared to those with secondary and low grade glioblastomas
Abstract,"""Glioblastoma stem cell HISTArionics.""",https://pubmed.ncbi.nlm.nih.gov/36332566,possess,possess,glioblastomas are lethal malignancies that possess a rapidly evolving microenvironment
Abstract,"""Glioblastoma stem cell HISTArionics.""",https://pubmed.ncbi.nlm.nih.gov/36332566,promote,promote,", and glioblastoma stem cells (gscs) that promote tumor growth"
Abstract,"""Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10079373,use,using,and 22 glioblastomas) using the avidin biotin immunoperoxidase technique.
Abstract,"""Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10079373,appear,appeared,"in glioblastomas, the survival rate appeared to be less in"
Abstract,"""Current status and recent advances in reirradiation of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33602305,recur,recur,"gliomas (glioblastomas, gbm) will recur locally within 2 years"
Abstract,"""Immune cell infiltrates in atypical teratoid/rhabdoid tumors.""",https://pubmed.ncbi.nlm.nih.gov/22931701,contain,contain,"like glioblastomas, at/rts contain brain cancer stem cells"
Abstract,"""Immune cell infiltrates in atypical teratoid/rhabdoid tumors.""",https://pubmed.ncbi.nlm.nih.gov/22931701,correlate,correlates,"noted in glioblastomas, which correlates with poor prognosis."
Abstract,"""MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/21879257,tmz,tmz,of some glioblastomas to tmz and the hypothesis that glioma stem cells
Title,"""Identifying overall survival in 98 glioblastomas using VASARI features at 3T.""",https://pubmed.ncbi.nlm.nih.gov/36417792,use,using,in 98 glioblastomas using vasari features at 3t.
Abstract,"""Identifying overall survival in 98 glioblastomas using VASARI features at 3T.""",https://pubmed.ncbi.nlm.nih.gov/36417792,classify,classify,survival in glioblastomas and to classify them into high survival and low
Abstract,"""Identifying overall survival in 98 glioblastomas using VASARI features at 3T.""",https://pubmed.ncbi.nlm.nih.gov/36417792,base,based,"survival of glioblastoma patients based on 12, 19, and 24"
Abstract,"""Identifying overall survival in 98 glioblastomas using VASARI features at 3T.""",https://pubmed.ncbi.nlm.nih.gov/36417792,have,have,classification of glioblastomas that would have a longer overall survival.
Title,"""Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities.""",https://pubmed.ncbi.nlm.nih.gov/38153923,base,based,prognostication in glioblastoma: unveiling heterogeneity based on diffusion and perfusion similarities
Abstract,"""Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities.""",https://pubmed.ncbi.nlm.nih.gov/38153923,establish,established,"survival in glioblastoma is established, prognostic models for patients are lacking"
Abstract,"""Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities.""",https://pubmed.ncbi.nlm.nih.gov/38153923,assess,assessing,"in untreated glioblastomas, assessing their prognostic significance for overall survival."
Abstract,"""Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities.""",https://pubmed.ncbi.nlm.nih.gov/38153923,undergo,underwent,patients with glioblastoma who underwent preoperative multimodal mr imaging were included.
Abstract,"""CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.""",https://pubmed.ncbi.nlm.nih.gov/25797252,respond,respond,glioblastomas respond differently to all-trans retinoic acid (
Abstract,"""CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.""",https://pubmed.ncbi.nlm.nih.gov/25797252,line,lines,"and the glioblastoma cells lines ln18, ln428 and u251 were examined"
Abstract,"""CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.""",https://pubmed.ncbi.nlm.nih.gov/25797252,improve,improve,sensitivity of glioblastoma cells to ra. dicitabine may improve the sensitivity
Abstract,"""Insulin-like growth factors (IGF) enhance three-dimensional (3D) growth of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9097982,characterize,characterized,human glioblastomas (gliomas) are characterized as rapidly growing brain
Abstract,"""Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25845427,have,have,highly malignant glioblastomas have a short median survival time mainly due to
Abstract,"""Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25845427,identify,identify,and recurrent glioblastomas by qpcr and double-immunofluorescence stainings to identify
Abstract,"""Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25845427,identify,identified,within our glioblastoma collective were identified according to the regulation of mrna
Abstract,"""Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18975243,follow,followed,"of the glioblastoma, followed a multimodal therapy including radiotherapy and chemotherapy"
Abstract,"""Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18975243,identify,identified,"such as glioblastoma, can be identified."
Abstract,"""Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18975243,manage,managed,glioblastomas in these patients should be managed like the usual
Abstract,"""Glioma stem cell maintenance: the role of the microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/21827414,provide,provide,glioblastomas are highly lethal cancers for which conventional therapies provide
Abstract,"""Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.""",https://pubmed.ncbi.nlm.nih.gov/21214925,prolong,prolong,"newly diagnosed glioblastoma can prolong survival, but it is not curative"
Abstract,"""Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.""",https://pubmed.ncbi.nlm.nih.gov/21214925,associate,associated,with recurrent glioblastoma; combination treatment was associated with an estimated 6
Abstract,"""Antiangiogenic agents in the treatment of recurrent or newly diagnosed glioblastoma: analysis of single-agent and combined modality approaches.""",https://pubmed.ncbi.nlm.nih.gov/21214925,progress,progressed,treatment of glioblastoma that has progressed following prior therapy.
Title,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,deplete,depleting,radiosensitivity of glioblastoma cell lines by depleting cd133+ tumor cells.
Abstract,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,assess,assessed,) on glioblastoma cell lines u87 and u251 were assessed by mtt
Abstract,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,sort,sorted,and cd133- glioblastoma cells were sorted by magnetic activated cell sorting (
Abstract,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,examine,examined,"cd133+and cd133- glioblastoma cells were examined, respectively, and the expression"
Abstract,"""Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/9382960,expect,expected,treating human glioblastomas has not been as effective as expected after the
Abstract,"""Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/9382960,transfecte,transfected,"six human glioblastoma cell lines stably transfected with the tk gene,"
Abstract,"""Revisiting the role of p53 in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17214319,develop,develops,glioblastoma multiforme (gbm) develops from astrocytes and is
Abstract,"""Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.""",https://pubmed.ncbi.nlm.nih.gov/8382191,improve,improve,"patients with glioblastomas, the budr li did not improve the prediction"
Abstract,"""Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.""",https://pubmed.ncbi.nlm.nih.gov/8382191,improve,improve,astrocytomas and glioblastomas did not significantly improve the prediction of survival once
Abstract,"""The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, (68)Ga-FAPI-46 PET Data, and Survival Data.""",https://pubmed.ncbi.nlm.nih.gov/38960714,treat,treated,group of glioblastomas and are treated according to the same standards.
Abstract,"""The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, (68)Ga-FAPI-46 PET Data, and Survival Data.""",https://pubmed.ncbi.nlm.nih.gov/38960714,attribute,attributed,fap in glioblastoma and a particularly strong expression in gliosarcoma attributed to
Abstract,"""The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, (68)Ga-FAPI-46 PET Data, and Survival Data.""",https://pubmed.ncbi.nlm.nih.gov/38960714,correlate,correlates,gliosarcoma and glioblastoma and how it correlates with 68ga-fap inhibitor
Abstract,"""Microtubule actin cross-linking factor 1, a novel target in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27959385,establish,established,selectively inhibited glioblastoma cell proliferation and migration in cell lines established from
Abstract,"""Microtubule actin cross-linking factor 1, a novel target in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27959385,associate,associated,and immortalized glioblastoma cell lines that were associated with downregulation of the
Abstract,"""Microtubule actin cross-linking factor 1, a novel target in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27959385,reduce,reduced,treatment of glioblastomas cooperatively reduced the proliferative capacity of glioblastoma cells.
Abstract,"""Histology-based expression profiling yields novel prognostic markers in human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16254489,provide,provided,", microdissected glioblastomas also provided prognostic information in an independent set of"
Abstract,"""Histology-based expression profiling yields novel prognostic markers in human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16254489,have,have,of 28 glioblastomas that did not all have perinecrotic palisades.
Title,"""Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35741816,treat,treated,survival of glioblastoma patients treated with radio-chemotherapy.
Abstract,"""Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35741816,treat,treated,"-type glioblastomas, treated with radio-chemotherapy."
Abstract,"""Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35741816,verify,verifies,"patients with glioblastoma, while the multivariate analysis verifies the prognostic value"
Title,"""Identification of prognostic biomarkers for glioblastomas using protein expression profiling.""",https://pubmed.ncbi.nlm.nih.gov/22179774,use,using,biomarkers for glioblastomas using protein expression profiling.
Title,"""Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules.""",https://pubmed.ncbi.nlm.nih.gov/24485463,reveal,reveals,-driven glioblastoma reveals optimized radiation dosing schedules.
Abstract,"""Intraventricular Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26773981,treat,treated,all intracranial glioblastomas treated in 2 different neurosurgical departments during the last
Abstract,"""Intraventricular Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26773981,include,included,proven intraventricular glioblastomas were included in the study.
Abstract,"""Intraventricular Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26773981,affect,affect,: intraventricular glioblastoma is extremely rare and can affect younger individuals including
Title,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,brain,brain,differentiation between glioblastomas and brain metastases and regarding their primary site of
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,challenge,challenging,differentiation between glioblastoma and brain metastasis may be challenging in conventional contrast
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,undergo,underwent,and 38 glioblastomas) underwent conventional contrast-enhanced mri including dynamic
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,mean,mean,higher in glioblastomas than in metastases (mean 3.2 ± 1.4 and
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,measure,measuring,to differentiate glioblastomas from metastases by measuring the cbv in the peritumoral
Title,"""Human gamma-delta (gammadelta) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy.""",https://pubmed.ncbi.nlm.nih.gov/37544475,overcome,overcome,therapy for glioblastoma: a novel alternative to overcome challenges of adoptive
Title,"""Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.""",https://pubmed.ncbi.nlm.nih.gov/28340100,evidence,evidenced,glioblastoma stem cell differentiation into endothelial cells evidenced through live
Abstract,"""Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.""",https://pubmed.ncbi.nlm.nih.gov/28340100,initiate,initiated,background: glioblastoma cell-initiated vascularization is an alternative angiogenesis called
Abstract,"""Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.""",https://pubmed.ncbi.nlm.nih.gov/28340100,limit,limited,formation from glioblastoma stem cells (gscs) is limited.
Abstract,"""Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.""",https://pubmed.ncbi.nlm.nih.gov/28340100,contain,containing,from human glioblastoma tissue and cd133+/sox2+ red fluorescent protein-containing
Abstract,"""Glioblastoma stem cell differentiation into endothelial cells evidenced through live-cell imaging.""",https://pubmed.ncbi.nlm.nih.gov/28340100,derive,derived,gfap coexpressing glioblastoma-derived endothelial cells (gdec) were found
Abstract,"""[Analysis of three-year survivors in patients with glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/7656829,treat,treated,"patients with glioblastomas surgically treated, there were nine patients (11"
Abstract,"""Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/28973417,represent,represent,: thalamic glioblastomas (gbms) represent a significant neurosurgical challenge.
Abstract,"""Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/28973417,perform,performed,with thalamic glioblastoma over a 10-yr period was performed.
Abstract,"""Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes.""",https://pubmed.ncbi.nlm.nih.gov/28973417,unresectable,unresectable,with thalamic glioblastoma is comparable to unresectable lobar supratentorial gbms.
Abstract,"""Tumefactive Primary Central Nervous System Vasculitis: Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging Findings With Histological Correlation.""",https://pubmed.ncbi.nlm.nih.gov/38571468,undergo,underwent,"patients with glioblastoma, 10 patients with metastasis, who underwent surgery"
Abstract,"""High mobility group A1 expression correlates with the histological grade of human glial tumors.""",https://pubmed.ncbi.nlm.nih.gov/15138557,verify,verify,astrocytomas and glioblastomas in order to verify whether the detection of these
Abstract,"""High mobility group A1 expression correlates with the histological grade of human glial tumors.""",https://pubmed.ncbi.nlm.nih.gov/15138557,compare,compared,higher in glioblastomas compared to astrocytomas.
Title,"""Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.""",https://pubmed.ncbi.nlm.nih.gov/12700121,novel,novel,alterations in glioblastoma: relevance to novel targeted therapies.
Abstract,"""Prognostic Value of BRAF Mutation in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38219188,become,become,"for treating glioblastoma (gbm) patients, has become a centre"
Abstract,"""Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas.""",https://pubmed.ncbi.nlm.nih.gov/1658684,have,had,) had glioblastomas and 48 (18%) had anaplastic astrocytomas
Abstract,"""Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas.""",https://pubmed.ncbi.nlm.nih.gov/1658684,aa,aas,) had glioblastomas and 34 (51%) had aas.
Abstract,"""Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas.""",https://pubmed.ncbi.nlm.nih.gov/1658684,have,has,are actually glioblastomas and has important implications for the design and interpretation
Abstract,"""A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P(1) signaling axis.""",https://pubmed.ncbi.nlm.nih.gov/37582160,enhance,enhancing,of u251 glioblastoma cells by enhancing signaling mediated by sphingosine-1-phosphate
Abstract,"""A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P(1) signaling axis.""",https://pubmed.ncbi.nlm.nih.gov/37582160,activate,activating,signaling promoted glioblastoma cell proliferation and survival by activating the kinases akt
Abstract,"""Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33864561,evaluate,evaluate,recurrent) glioblastomas to evaluate the mutational status of six dna repair
Abstract,"""Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33864561,correlate,correlated,in primary glioblastoma and are correlated with high tmb and mgmt promoter
Abstract,"""Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35138915,image,imaged,-wildtype glioblastomas were imaged with diffusion-weighted imaging using 13
Abstract,"""Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35138915,enable,enabled,"-wildtype glioblastomas, and its use enabled the significant differentiation of"
Abstract,"""Analysis of Olig2 and YKL-40 expression: a clinicopathological/immunohistochemical study for the distinction between subventricular zone II and III glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27179219,originate,originates,glioblastomas originates either from astrocytes that have accumulated mutations and
Title,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,treat,treated,with recurrent glioblastoma treated with laser interstitial thermal therapy (litt):
Abstract,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,assess,assess,in recurrent glioblastoma and to assess its effect in the overall survival
Abstract,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,select,selected,of recurrent glioblastoma after laser interstitial thermal therapy were selected.
Abstract,"""Survival outcomes in patients with recurrent glioblastoma treated with Laser Interstitial Thermal Therapy (LITT): A systematic review.""",https://pubmed.ncbi.nlm.nih.gov/32470780,undergo,underwent,with recurrent glioblastoma who underwent 219 laser interstitial thermal therapy treatments.
Abstract,"""[A clinical and molecular study of long-term survival glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/23711013,identify,identify,survivors of glioblastoma and to identify any prognostic factors that potentially contribute
Abstract,"""[A clinical and molecular study of long-term survival glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/23711013,undergo,underwent,: fifteen glioblastomas patients underwent surgery from june 2007 to april 2009
Abstract,"""Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.""",https://pubmed.ncbi.nlm.nih.gov/18816605,exhibit,exhibit,background: glioblastomas exhibit a remarkable tendency toward morphologic diversity.
Abstract,"""Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.""",https://pubmed.ncbi.nlm.nih.gov/18816605,predominate,predominated,adenoid' glioblastomas (a-gbm) predominated (48%
Abstract,"""Regrowth patterns of supratentorial gliomas: estimation from computed tomographic scans.""",https://pubmed.ncbi.nlm.nih.gov/3027609,truncate,truncated,astrocytomas and glioblastomas.(abstract truncated at 250 words)
Abstract,"""Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/36988300,classify,classified,glioblastoma (gbm) is classified as a stage-
Abstract,"""Performance of adjuvant treatment correlates with survival in reoperated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27901253,subject,subjected,of recurrent glioblastoma subjected to reoperation at a brazilian public healthcare service
Abstract,"""Improving morphology-based malignancy grading schemes in astrocytic tumors by means of computer-assisted techniques.""",https://pubmed.ncbi.nlm.nih.gov/9458164,identify,identified,and 164 glioblastomas (gbm) identified in accordance with the who
Title,"""Mapping the Intratumoral Heterogeneity in Glioblastomas with Hyperspectral Stimulated Raman Scattering Microscopy.""",https://pubmed.ncbi.nlm.nih.gov/33443405,stimulate,stimulated,heterogeneity in glioblastomas with hyperspectral stimulated raman scattering microscopy.
Abstract,"""Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains.""",https://pubmed.ncbi.nlm.nih.gov/7964991,explain,explained,"characteristic of glioblastomas, is not simply explained by the altered expression"
Abstract,"""Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/28956184,undergo,underwent,patients harboring glioblastoma underwent pre-operative mrs evaluation to detect 2hg
Abstract,"""Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/28956184,exhibit,exhibited,-mutant glioblastoma exhibited significantly higher accumulation of 2hg (median 3.191
Abstract,"""Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/28956184,have,have,glioblastoma with high 2hg accumulation did not have significantly longer
Abstract,"""Patterns of intracranial glioblastoma recurrence after aggressive surgical resection and adjuvant management: retrospective analysis of 43 cases.""",https://pubmed.ncbi.nlm.nih.gov/22976141,change,change,of intracranial glioblastoma may change its recurrence pattern.
Title,"""Subventricular zone-associated classification in isocitrate dehydrogenase-wildtype glioblastomas: improved prognostic value through integration of FLAIR with contrast-enhanced imaging.""",https://pubmed.ncbi.nlm.nih.gov/38941641,improve,improved,-wildtype glioblastomas: improved prognostic value through integration of flair with
Abstract,"""Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics.""",https://pubmed.ncbi.nlm.nih.gov/16990423,lead,led,discrimination of glioblastomas from oligodendrogliomas and led to the identification of 3
Title,"""Baseline multicentric tumors, distant recurrences and leptomeningeal dissemination predict poor survival in patients with recurrent glioblastomas receiving bevacizumab.""",https://pubmed.ncbi.nlm.nih.gov/30535596,receive,receiving,with recurrent glioblastomas receiving bevacizumab.
Title,"""Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.""",https://pubmed.ncbi.nlm.nih.gov/18037961,derive,derived,glioblastoma-derived stem cell-enriched cultures form distinct
Abstract,"""Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.""",https://pubmed.ncbi.nlm.nih.gov/18037961,use,using,from human glioblastomas by using conditions that select for the expansion of
Abstract,"""Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.""",https://pubmed.ncbi.nlm.nih.gov/18037961,obtain,obtain,lines from glioblastoma specimens with the goal to obtain model systems for
Abstract,"""Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26744442,identify,identifying,to characterize glioblastoma lesions by identifying mr imaging voxel-based tumor
Abstract,"""Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26744442,obtain,obtained,patients with glioblastomas were obtained from 2 independent cohorts (n =
Abstract,"""Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26744442,associate,associated,location in glioblastoma is associated with patient outcome and may have a
Title,"""CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.""",https://pubmed.ncbi.nlm.nih.gov/29642043,predict,predicts,cpeb4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.
Abstract,"""CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.""",https://pubmed.ncbi.nlm.nih.gov/29642043,evaluate,evaluated,98 primary glioblastomas) and evaluated its association with pathological grades and
Abstract,"""CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.""",https://pubmed.ncbi.nlm.nih.gov/29642043,predict,predicting,in primary glioblastoma is a novel biomarker for predicting poor outcome of
Abstract,"""Fully Automatic Brain Tumor Segmentation using End-To-End Incremental Deep Neural Networks in MRI images.""",https://pubmed.ncbi.nlm.nih.gov/30415717,have,have,"glioblastomas have four properties: different sizes, shapes,"
Abstract,"""Fully Automatic Brain Tumor Segmentation using End-To-End Incremental Deep Neural Networks in MRI images.""",https://pubmed.ncbi.nlm.nih.gov/30415717,appear,appear,"addition, glioblastomas appear anywhere in the brain."
Abstract,"""[Radiosurgery for recurrent glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/34951763,occur,occurs,", recurrent glioblastoma usually occurs within several months after resection and causes"
Abstract,"""[Radiosurgery for recurrent glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/34951763,identify,identify,with recurrent glioblastoma and to identify the factors determining its effectiveness.
Title,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,reveal,reveals,of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural
Abstract,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,subdivide,subdivided,glioblastoma is often subdivided into three transcriptional subtypes (classical
Abstract,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,feature,features,major histomorphologic glioblastoma features to deconvolute and estimate niche proportions in an
Abstract,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,provide,providing,"profiles of glioblastoma, providing potential new insights into the genetic drivers"
Abstract,"""Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma.""",https://pubmed.ncbi.nlm.nih.gov/6286891,use,using,in 10 glioblastomas and seven mixed glioma-sarcomas using the peroxidase
Abstract,"""Immunohistochemical detection of factor VIII/von Willebrand factor in hyperplastic endothelial cells in glioblastoma multiforme and mixed glioma-sarcoma.""",https://pubmed.ncbi.nlm.nih.gov/6286891,result,resulted,"all 10 glioblastomas; in five, the vascular proliferation had resulted"
Title,"""Potent predictive CpG signature for temozolomide response in non-glioma-CpG island methylator phenotype glioblastomas with methylated MGMT promoter.""",https://pubmed.ncbi.nlm.nih.gov/36444681,methylate,methylated,methylator phenotype glioblastomas with methylated mgmt promoter.
Abstract,"""Potent predictive CpG signature for temozolomide response in non-glioma-CpG island methylator phenotype glioblastomas with methylated MGMT promoter.""",https://pubmed.ncbi.nlm.nih.gov/36444681,have,have,response in glioblastomas (gbms) that do not have the glioma
Abstract,"""Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21499306,assay,assayed,"of human glioblastoma, as assayed by northern hybridization and real-"
Abstract,"""Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21499306,exacerbate,exacerbating,in human glioblastomas exacerbating the malignant phenotype.
Abstract,"""In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15328202,respond,respond,"glioblastomas, the most common primary brain cancers, respond"
Abstract,"""In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15328202,do,did,"in several glioblastoma cell lines and primary cultures, as did gene"
Abstract,"""Predictive and prognostic factors for gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21554053,remain,remain,"and malignant glioblastoma, remain devastating tumors and need a better molecular"
Abstract,"""Predictive and prognostic factors for gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21554053,refine,refines,unraveled new glioblastoma subgroups that further refines the molecular classification of these
Abstract,"""Metabolic modulation of glioblastoma with dichloroacetate.""",https://pubmed.ncbi.nlm.nih.gov/20463368,develop,develop,"brain cancer glioblastoma multiforme, develop resistance to cell death, in"
Abstract,"""Metabolic modulation of glioblastoma with dichloroacetate.""",https://pubmed.ncbi.nlm.nih.gov/20463368,show,showed,"freshly isolated glioblastomas from 49 patients showed mitochondrial hyperpolarization, which was"
Abstract,"""Metabolic modulation of glioblastoma with dichloroacetate.""",https://pubmed.ncbi.nlm.nih.gov/20463368,secure,secured,"who had glioblastoma, we prospectively secured baseline and serial tumor tissue"
Abstract,"""Recent advances in subtyping tumors of the central nervous system using molecular data.""",https://pubmed.ncbi.nlm.nih.gov/27893285,have,have,and pediatric glioblastomas have divergent biology with differing prognoses.
Title,"""IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphology.""",https://pubmed.ncbi.nlm.nih.gov/23451042,display,displays,associated primary glioblastoma in young adults displays differential patterns of tumour and
Abstract,"""IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphology.""",https://pubmed.ncbi.nlm.nih.gov/23451042,classify,classified,276 primary glioblastoma specimens were classified into their predominant cell morphological type
Abstract,"""IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphology.""",https://pubmed.ncbi.nlm.nih.gov/23451042,associate,associated,"idh1 positive glioblastomas were associated with a younger age at diagnosis,"
Abstract,"""IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphology.""",https://pubmed.ncbi.nlm.nih.gov/23451042,provide,provide,positive primary glioblastoma in young adults and provide correlative evidence for a
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,have,have,"purpose: glioblastomas, brain metastases, and pcls may have similar"
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,compare,compared,observed in glioblastomas compared with brain metastases and pcls (p <
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,consist,consisted,"to distinguish glioblastomas from nonglioblastomas consisted of adc, cs (or"
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,consist,consisted,"glioblastomas from nonglioblastomas consisted of adc, cs (or fa)"
Abstract,"""Is there pseudoprogression in secondary glioblastomas?""",https://pubmed.ncbi.nlm.nih.gov/24267971,sgbm,sgbm,between primary glioblastomas and sgbm in particular as they relate to pp
Abstract,"""[Prognostic significance of pretreatment CT scans in supratentorial astrocytomas receiving radiotherapy].""",https://pubmed.ncbi.nlm.nih.gov/3035252,review,reviewed,"and 17 glioblastomas) were reviewed, and their prognoses were analyzed"
Abstract,"""Pathological findings and prognostic factors in recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22331317,affect,affected,features of glioblastomas are affected by tumor regrowth and the influence of
Abstract,"""Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.""",https://pubmed.ncbi.nlm.nih.gov/10022821,arise,arise,astrocytomas and glioblastomas multiforme) arise mostly either from the progression of
Abstract,"""Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.""",https://pubmed.ncbi.nlm.nih.gov/10022821,identify,identified,and seven glioblastomas multiforme) with their recurrences identified two distinct subgroups
Abstract,"""Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.""",https://pubmed.ncbi.nlm.nih.gov/10022821,have,have,between malignant glioblastomas and their subsequent recurrences may have important implications for
Abstract,"""Novel vaccines for glioblastoma: clinical update and perspective.""",https://pubmed.ncbi.nlm.nih.gov/27993092,have,have,glioblastomas have a formidable tumor microenvironment that is hostile to
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,infiltrate,infiltrate,within each glioblastoma and the ability of glioma cells to diffusely infiltrate
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,tend,tend,"is that glioblastomas tend to be poorly infiltrated by t cells,"
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,direct,directed,"to induce glioblastoma-directed t cell responses, including neoantigen-"
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,develop,develop,glioblastomas may develop de novo (primary glioblastomas) or
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,constitute,constitute,subtypes of glioblastoma constitute distinct disease entities that evolve through different genetic
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,develop,develop,primary glioblastomas develop in older patients and typically show egfr overexpression
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,develop,develop,secondary glioblastomas develop in younger patients and often contain tp53 mutations
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,exist,exist,"subtypes of glioblastomas may exist with intermediate clinical and genetic profiles,"
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,occupy,occupies,-cell glioblastoma that clinically and genetically occupies a hybrid position between
Title,"""Hurdles in radiation planning for glioblastoma: Can delayed-contrast enhanced computed tomography be a potential solution?""",https://pubmed.ncbi.nlm.nih.gov/30698349,delay,delayed,planning for glioblastoma: can delayed-contrast enhanced computed tomography be
Abstract,"""Hurdles in radiation planning for glioblastoma: Can delayed-contrast enhanced computed tomography be a potential solution?""",https://pubmed.ncbi.nlm.nih.gov/30698349,treat,treated,patients of glioblastoma treated at our center between 2011 and 2014 were
Abstract,"""Intra-operative characterization of gliomas by near-infrared spectroscopy: possible association with prognosis.""",https://pubmed.ncbi.nlm.nih.gov/12836069,investigate,investigated,and seven glioblastomas with the ipsilateral cortex were investigated by nirs revealing
Abstract,"""Molecular biology of glioblastoma: Classification and mutational locations.""",https://pubmed.ncbi.nlm.nih.gov/28924284,regard,regarded,glioblastomas are regarded as the most common malignant brain tumours
Abstract,"""Molecular biology of glioblastoma: Classification and mutational locations.""",https://pubmed.ncbi.nlm.nih.gov/28924284,involve,involve,while secondary glioblastomas mostly involve younger people.
Abstract,"""Molecular biology of glioblastoma: Classification and mutational locations.""",https://pubmed.ncbi.nlm.nih.gov/28924284,follow,followed,observed in glioblastomas are loss of heterozygosity at 10q followed by epidermal
Abstract,"""Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/32280134,characterize,characterized,"glioblastomas (gbms) are characterized by four subtypes,"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,discover,discovered,"nscs with glioblastoma, since we have discovered that recurrent glioblastomas were"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,incline,inclined,that recurrent glioblastomas were inclined to be derived from subventricular zone (
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,provide,providing,"process of glioblastoma relapse, providing the basis for dealing with newly"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,help,help,"newly diagnosed glioblastoma patients, which may help postpone the recurrence of"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,preprocesse,preprocessing,recurrence of glioblastoma as far as possible through preprocessing the tumor-
Abstract,"""Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12711288,establish,established,orthotopic c6 glioblastomas were established in wistar rats.
Abstract,"""Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12711288,increase,increased,"model of glioblastoma, encapsulation of a xenogeneic packaging cell line increased"
Abstract,"""Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.""",https://pubmed.ncbi.nlm.nih.gov/33009979,show,showed,"mutations, glioblastomas showed concomitant mutations in tp53 (3/8),"
Abstract,"""Computational modeling and synthesis of pyridine variants of benzoyl-phenoxy-acetamide with high glioblastoma cytotoxicity and brain tumor penetration.""",https://pubmed.ncbi.nlm.nih.gov/37507404,focus,focused,"anti-glioblastoma drugs, we focused on specific structural modifications to"
Abstract,"""Computational modeling and synthesis of pyridine variants of benzoyl-phenoxy-acetamide with high glioblastoma cytotoxicity and brain tumor penetration.""",https://pubmed.ncbi.nlm.nih.gov/37507404,range,ranging,them demonstrated glioblastoma toxicity with ic50 ranging from 0.59 to 3.24 µm
Abstract,"""Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/11563632,contain,contained,"%) glioblastoma tumor samples contained ink4b transcripts, but only nine"
Abstract,"""Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/11563632,result,resulting,"in some glioblastomas, resulting in combined loss of p16, p15"
Abstract,"""Intratumoral arteriovenous shunting in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11220379,suspect,suspected,shunting in glioblastomas has been suspected but neither proven nor quantified.
Title,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,base,based,pathways to glioblastoma: a population-based study.
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,diagnose,diagnosed,", 715 glioblastomas were diagnosed."
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,prevail,prevailed,"novo) glioblastomas prevailed (95%), whereas secondary glioblastomas"
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,progress,progressed,whereas secondary glioblastomas that progressed from low-grade or anaplastic gliomas
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,characterize,characterized,secondary glioblastomas were characterized by frequent loh 10q (63%
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,distribute,distributed,"in primary glioblastomas, mutations were more equally distributed."
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,occur,occurs,in these glioblastoma subtypes occurs through different mechanisms.
Title,"""Cerebral glioblastomas can be cured!""",https://pubmed.ncbi.nlm.nih.gov/2987748,cure,cured,cerebral glioblastomas can be cured!
Abstract,"""Cerebral glioblastomas can be cured!""",https://pubmed.ncbi.nlm.nih.gov/2987748,remove,removed,"if glioblastomas and other cerebral gliomas are removed completely, the"
Title,"""Human glioblastoma cells produce granulocyte-macrophage colony-stimulating factor in vitro, but not in vivo, without expressing its receptor.""",https://pubmed.ncbi.nlm.nih.gov/7505398,produce,produce,human glioblastoma cells produce granulocyte-macrophage colony-stimulating factor
Abstract,"""Human glioblastoma cells produce granulocyte-macrophage colony-stimulating factor in vitro, but not in vivo, without expressing its receptor.""",https://pubmed.ncbi.nlm.nih.gov/7505398,study,studied,by human glioblastomas was studied.
Abstract,"""Human glioblastoma cells produce granulocyte-macrophage colony-stimulating factor in vitro, but not in vivo, without expressing its receptor.""",https://pubmed.ncbi.nlm.nih.gov/7505398,release,released,of 10 glioblastoma cell lines spontaneously released gm-csf (2.9
Abstract,"""Human glioblastoma cells produce granulocyte-macrophage colony-stimulating factor in vitro, but not in vivo, without expressing its receptor.""",https://pubmed.ncbi.nlm.nih.gov/7505398,secrete,secrete,human glioblastoma cells secrete gm-csf without expressing the receptor
Abstract,"""The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29036186,collect,collected,from 118 glioblastomas were collected for polymerase chain reaction (pcr)
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,constitute,constitute,"among which glioblastomas constitute the largest group, are characterized by a"
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,cure,cured,patient with glioblastoma multiforme (gbm) has been cured to date
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,exert,exerts,"to combat glioblastoma, and this drug exerts its cytotoxic activity through"
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,radiotherapy,radiotherapy,resistance of glioblastoma to radiotherapy and proapoptotic-related chemotherapy.
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,report,reported,"metastasis to glioblastomas have been previously reported, but were unsupported by"
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,have,had,foci of glioblastoma and lung adenocarcinoma had the same kras mutation which
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,diagnose,diagnosed,"thus, glioblastoma with tumor-to-tumor metastasis was diagnosed"
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,occur,occur,"metastases to glioblastoma may occur, and they should be considered in"
Abstract,"""Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro.""",https://pubmed.ncbi.nlm.nih.gov/9336158,repopulate,repopulate,scc and glioblastoma cells to repopulate during fractionated irradiation could be demonstrated
Abstract,"""Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).""",https://pubmed.ncbi.nlm.nih.gov/31369092,show,showed,-wildtype glioblastomas showed lower pfkfb3 to pfkfb4 mrna ratios (7.7:1
Abstract,"""Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).""",https://pubmed.ncbi.nlm.nih.gov/31369092,exhibit,exhibiting,-wildtype glioblastomas exhibiting loss of heterozygosity (loh) of the
Abstract,"""Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).""",https://pubmed.ncbi.nlm.nih.gov/31369092,represent,represent,wildtype primary glioblastoma and that pfkfb3 and pfkfb4 might represent promising targets
Abstract,"""Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/15986444,find,found,"overexpressed in glioblastomas but rarely found in normal tissue, ptn may"
Abstract,"""Analysis of the functional role of chromosome 10 loss in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8104691,suggest,suggesting,in human glioblastoma multiforme suggesting the presence of a glioma-associated
Title,"""Stem cell niche irradiation in glioblastoma: providing a ray of hope?""",https://pubmed.ncbi.nlm.nih.gov/25363009,provide,providing,irradiation in glioblastoma: providing a ray of hope?
Abstract,"""Stem cell niche irradiation in glioblastoma: providing a ray of hope?""",https://pubmed.ncbi.nlm.nih.gov/25363009,organize,organized,glioblastomas are organized hierarchically with a small number of glioblastoma
Abstract,"""Stem cell niche irradiation in glioblastoma: providing a ray of hope?""",https://pubmed.ncbi.nlm.nih.gov/25363009,have,have,number of glioblastoma stem cells that have unique self-renewal capacity
Abstract,"""Stem cell niche irradiation in glioblastoma: providing a ray of hope?""",https://pubmed.ncbi.nlm.nih.gov/25363009,initiate,initiate,"reservoir of glioblastoma stem cells that can initiate, promote or repopulate"
Abstract,"""Stem cell niche irradiation in glioblastoma: providing a ray of hope?""",https://pubmed.ncbi.nlm.nih.gov/25363009,offer,offers,"the putative glioblastoma stem cell in the svz, and offers a"
Title,"""Quantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.""",https://pubmed.ncbi.nlm.nih.gov/27815396,develop,develop,microenvironment of glioblastoma to develop predictive statistical models of overall survival.
Abstract,"""Quantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.""",https://pubmed.ncbi.nlm.nih.gov/27815396,show,shown,"contribute to glioblastoma progression, very few quantitative studies have shown the"
Abstract,"""TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study.""",https://pubmed.ncbi.nlm.nih.gov/29941484,match,matched,plasma of glioblastoma patients.experimental design: matched csf and plasma samples were
Title,"""Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22973019,drive,drives,transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic
Abstract,"""Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22973019,transdifferentiate,transdifferentiate,shown that glioblastoma stem-like cells (gscs) can transdifferentiate
Abstract,"""Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22973019,find,found,cases of glioblastomas and found that most of them consisted of blood
Abstract,"""Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22973019,develop,developed,patients with glioblastomas developed vigorous mural cell-associated vascular channels but
Abstract,"""Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.""",https://pubmed.ncbi.nlm.nih.gov/38702989,characterize,characterized,background: glioblastomas are characterized by aggressive behavior.
Abstract,"""Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines.""",https://pubmed.ncbi.nlm.nih.gov/38702989,determine,determine,"mechanisms in glioblastoma cells, and to determine how those mechanisms affect"
Abstract,"""1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17934521,identify,identified,in nine glioblastomas homozygous deletions at 1p36 were identified.
Abstract,"""TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28821920,undergo,underwent,"(10 glioblastomas, 1 anaplastic astrocytoma) underwent 18f-ge-180"
Abstract,"""TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28821920,show,shows,and pretreated glioblastoma and shows tracer uptake even beyond contrast enhancement on
Abstract,"""Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation?""",https://pubmed.ncbi.nlm.nih.gov/16896907,display,displayed,glioblastomas and metastases displayed either a type 1 or a
Abstract,"""Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation?""",https://pubmed.ncbi.nlm.nih.gov/16896907,show,showed,of the glioblastomas or metastases showed a type 3 curve.
Title,"""Downregulation of CTRP1 reduces radio-resistance in glioblastoma cells by inhibiting the expression of CD133 after X-ray and carbon ion irradiation.""",https://pubmed.ncbi.nlm.nih.gov/39515408,inhibit,inhibiting,resistance in glioblastoma cells by inhibiting the expression of cd133 after x
Abstract,"""Cerebral pseudocysts following chemotherapy of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/203172,report,reported,chemotherapy for glioblastomas are reported.
Title,"""Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.""",https://pubmed.ncbi.nlm.nih.gov/26910903,lead,leads,of recurrent glioblastoma leads to temporary disruption of the peritumoral blood brain
Abstract,"""Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.""",https://pubmed.ncbi.nlm.nih.gov/26910903,occur,occur,most recurrent glioblastomas (gbm) occur within the peritumoral region.
Title,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,depend,depends,mutation in glioblastomas depends on idh1 mutation.
Abstract,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,treat,treated,histologically confirmed glioblastomas treated with radiation therapy and chemotherapy were reviewed retrospectively
Abstract,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,improve,improved,indicate that glioblastomas with mgmt methylation or tp53 mutations have improved survival
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,characterize,characterized,"glioblastoma is one of the most fatal cancers, characterized"
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,have,has,patients with glioblastomas and has potential as a novel tumor biomarker.
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,understand,understood,"ykl-40 in glioblastoma development, however, are poorly understood."
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,reveal,revealed,"of human glioblastomas revealed a correlation between ykl-40, vegf, and"
Abstract,"""Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22296176,use,using,on 40 glioblastomas and normal brain using validated antibodies against dll4 and
Abstract,"""Ki-67 Proliferative Activity in the Tumor Margins as a Robust Prognosis Factor in Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/33260244,contain,contains,margin of glioblastomas (gbm) contains proliferative tumor cells difficult to
Abstract,"""Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization.""",https://pubmed.ncbi.nlm.nih.gov/31068339,leave,leaves,"care of glioblastomas leaves behind invasive, radio- and chemo-resistant"
Title,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,have,has,upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance
Abstract,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,use,using,"including 8 glioblastomas and 4 anaplastic astrocytomas, using taqman real-"
Abstract,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,multivariate,multivariate,of 39 glioblastoma patients by kaplan-meier method and multivariate analysis
Abstract,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,suggest,suggested,profiles in glioblastomas and anaplastic astrocytomas suggested that 16 mirnas were candidate
Abstract,"""Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27667176,characterize,characterized,"glioblastomas are characterized by transcriptionally distinct subtypes, but despite"
Abstract,"""Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27667176,suppress,suppressed,in primary glioblastoma stem cell-like cultures suppressed known mesenchymal master
Abstract,"""Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27667176,validate,validate,that determines glioblastoma mesenchymal transformation and validate asics as a general methodology
Abstract,"""The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24903384,analyze,analyzed,6) glioblastomas were analyzed using quantitative real-time pcr and
Abstract,"""The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24903384,compare,compared,in the glioblastoma specimens compared to the non-neoplastic brain tissue
Abstract,"""The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24903384,fold,fold,"and secondary glioblastomas, with values of up to 44-fold"
Abstract,"""Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.""",https://pubmed.ncbi.nlm.nih.gov/32328653,discuss,discussed,idhwt) glioblastomas will be discussed.
Abstract,"""Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27485530,increase,increased,patients with glioblastomas has increased.
Abstract,"""Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27485530,age,aged,study of glioblastoma patients aged 60 years old or older who were
Abstract,"""Therapeutic exploitation of apoptosis and autophagy for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20879985,correlate,correlated,suffering from glioblastomas (gbms) is strongly correlated to the intrinsic
Abstract,"""Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/17048097,associate,associated,subsets of glioblastomas (gbm) associated with different molecular genetic profiles
Abstract,"""Parameters influencing the efficiency of the thymidine kinase/ganciclovir strategy in human glioblastoma cell lines.""",https://pubmed.ncbi.nlm.nih.gov/9711725,expect,expected,treating human glioblastomas has not been as effective as expected after the
Abstract,"""Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.""",https://pubmed.ncbi.nlm.nih.gov/10485462,find,found,grade (glioblastomas multiforme) tumors and found that insulin-like
Abstract,"""[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].""",https://pubmed.ncbi.nlm.nih.gov/28665384,understand,understood,' in glioblastoma patients are not fully understood.
Abstract,"""[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].""",https://pubmed.ncbi.nlm.nih.gov/28665384,identify,identify,"patients with glioblastomas, identify clinical predictors of a favorable prognosis,"
Abstract,"""[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].""",https://pubmed.ncbi.nlm.nih.gov/28665384,follow,follows,"diagnosis of glioblastoma were as follows: young age, the supratentorial"
Abstract,"""Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/24697149,acquire,acquired,) from glioblastoma in patients who do not have acquired immunodeficiency syndrome
Abstract,"""Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/24697149,assess,assessed,) or glioblastomas (n = 41) were assessed by using
Abstract,"""Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27891815,cause,caused,enhancement of glioblastomas (gbm) is caused by the decrease in
Abstract,"""The sodium pump alpha1 subunit as a potential target to combat apoptosis-resistant glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18323016,respond,respond,conclusions: glioblastoma patients who do not respond to chemotherapy and whose
Title,"""Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.""",https://pubmed.ncbi.nlm.nih.gov/16951158,associate,associated,"in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase"
Abstract,"""Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.""",https://pubmed.ncbi.nlm.nih.gov/16951158,affect,affect,glioblastomas [glioblastoma multiforme (gbm)] and can affect up
Abstract,"""Immunohistochemical analysis of p53 and p21 in human primary glioblastomas in relation to proliferative potential and apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/10328545,assess,assessed,human primary glioblastomas in relation to tumor proliferation potential as assessed by
Abstract,"""Immunohistochemical analysis of p53 and p21 in human primary glioblastomas in relation to proliferative potential and apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/10328545,examine,examined,"all 15 glioblastomas examined, with a mean (+/-sd)"
Abstract,"""Immunohistochemical analysis of p53 and p21 in human primary glioblastomas in relation to proliferative potential and apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/10328545,induce,induced,p21 in glioblastomas may be induced by a p53-independent pathway
Abstract,"""A modality-adaptive method for segmenting brain tumors and organs-at-risk in radiation therapy planning.""",https://pubmed.ncbi.nlm.nih.gov/30952038,undergo,undergoing,risk in glioblastoma patients undergoing radiation therapy.
Abstract,"""High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29236891,grade,grade,in 30 glioblastomas (who grade iv) and compared to 10
Abstract,"""High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29236891,compare,compared,in the glioblastoma samples compared to the control samples of normal brain
Abstract,"""Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.""",https://pubmed.ncbi.nlm.nih.gov/8864999,see,seen,"% in glioblastomas, while it was seen in only 8%"
Abstract,"""Impact of levetiracetam use in glioblastoma: an individual patient-level meta-analysis assessing overall survival.""",https://pubmed.ncbi.nlm.nih.gov/39653818,inhibit,inhibiting,sensitivity in glioblastoma (gb) by inhibiting mgmt expression.
Title,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,underlie,underlie,aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,have,have,patients with glioblastoma have a high risk of developing venous thromboembolism (
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,perform,performed,of all glioblastomas was performed for diagnostic purposes and included mutational status
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,diagnose,diagnosed,"patients with glioblastoma, 25 were diagnosed with vte."
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,relate,related,deletion in glioblastoma-related vte.
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,characterize,characterized,for mesenchymal glioblastomas characterized by a greater degree of aggressiveness compared to
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,remain,remain,progression of glioblastoma remain elusive posing a challenge for rationalization of aldh1a3
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,regulate,regulates,"targeting in glioblastoma, and it is also unclear how aldh1a3 regulates"
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,stemness,stemness,aldh1a3 regulates glioblastoma cells stemness.
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,model,modelling,impacts on glioblastoma stem cells by modelling aldh1a3 expression in an otherwise
Title,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,support,support,glioblastoma hijacks microglial gene expression to support tumor growth.
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,communicate,communicate,"glioblastoma cells communicate with microglia, in part by releasing"
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,continue,continue,"microglia in glioblastoma, the tumors continue to grow, and these"
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,hijack,hijacked,"define a microgliaglioblastoma specific phenotype, whereby glioblastomas have hijacked gene expression"
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,hijack,hijacked,", whereby glioblastomas have hijacked gene expression in the neuroimmune system to"
Title,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,target,targeting,glioblastoma stem cell targeting peptide isolated through phage display binds
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,have,have,glioblastoma stem cells (gscs) have unique properties of
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,target,targeting,to isolate glioblastoma targeting peptides.
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,localize,localized,"intracranially xenografted glioblastoma, the peptide localized to the site of the"
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,target,targeted,as the glioblastoma cell surface receptor targeted by the peptides.
Abstract,"""Glioblastoma Stem Cell Targeting Peptide Isolated Through Phage Display Binds Cadherin 2.""",https://pubmed.ncbi.nlm.nih.gov/37280108,demonstrate,demonstrated,interrogation of glioblastoma databases demonstrated that cadherin 2 expression correlated with tumor
Title,"""Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/11048748,treat,treated,survival of glioblastoma in patients treated with an ecog protocol of pre
Abstract,"""Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/11048748,enter,entered,from the glioblastomas of 23 patients entered into a phase ii ecog
Abstract,"""Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/11048748,predict,predict,in the glioblastoma multiforme did not predict treatment benefit.
Title,"""A case of cervical spinal cord glioblastoma diagnosed with MR diffusion tensor and perfusion imaging.""",https://pubmed.ncbi.nlm.nih.gov/20040012,diagnose,diagnosed,spinal cord glioblastoma diagnosed with mr diffusion tensor and perfusion imaging.
Abstract,"""A case of cervical spinal cord glioblastoma diagnosed with MR diffusion tensor and perfusion imaging.""",https://pubmed.ncbi.nlm.nih.gov/20040012,report,reported,intramedullary glioblastomas in adult patients have rarely been reported.
Title,"""Brain lipid binding protein mediates the proliferation of human glioblastoma cells by regulating ERK1/2 signaling pathway in vitro.""",https://pubmed.ncbi.nlm.nih.gov/29288341,regulate,regulating,of human glioblastoma cells by regulating erk1/2 signaling pathway in vitro.
Abstract,"""Brain lipid binding protein mediates the proliferation of human glioblastoma cells by regulating ERK1/2 signaling pathway in vitro.""",https://pubmed.ncbi.nlm.nih.gov/29288341,associate,associated,expression in glioblastoma is associated with poor survival and used a double
Abstract,"""Feasibility of Targeting Glioblastoma Stem Cells: From Concept to Clinical Trials.""",https://pubmed.ncbi.nlm.nih.gov/31721715,contain,contain,discovered that glioblastomas contain a population of cells with stem-like
Abstract,"""Feasibility of Targeting Glioblastoma Stem Cells: From Concept to Clinical Trials.""",https://pubmed.ncbi.nlm.nih.gov/31721715,signal,signaling,", 'glioblastoma stem cells and wnt signaling' is an example"
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,monosomy,monosomy,karyotypes of glioblastomas are very complex with trisomy 7 and monosomy 10
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,arise,arising,"in secondary glioblastomas, the latter arising from preceding low-grade"
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,derive,derived,and secondary glioblastomas derived there- from.
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,arise,arising,"of two glioblastomas, one case arising de novo and the other"
Abstract,"""TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37863960,remain,remain,mechanisms in glioblastoma multiforme (gbm) remain unclear.
Abstract,"""TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37863960,confer,confer,"expression in glioblastoma cells confer stronger ability of migration, invasion,"
Abstract,"""TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37863960,provide,provides,"tppp3 in glioblastoma in the future, and provides new treatment and"
Title,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,detect,detecting,mutated human glioblastoma: implications for detecting idh-mutated glioblastoma with
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,establish,established,marker in glioblastomas has been established.
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,classify,classified,glioblastomas are classified by their idh mutation status under the
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,establish,established,status in glioblastoma patients have not been established so far.
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,express,expressing,we established glioblastoma cells (u251) expressing idh1 r132h and examined
Abstract,"""Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/35961053,treat,treated,744 idhwt glioblastomas were treated with radiochemotherapy per eortc-26981/22981 (tmz/
Abstract,"""Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group.""",https://pubmed.ncbi.nlm.nih.gov/35961053,serve,serve,resection in glioblastoma' are highly prognostic and may serve for stratification
Abstract,"""A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.""",https://pubmed.ncbi.nlm.nih.gov/21294158,contain,contain,glioblastomas contain stem-like cells that can be maintained
Abstract,"""A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.""",https://pubmed.ncbi.nlm.nih.gov/21294158,preserve,preserve,investigated whether glioblastoma stem-like (gs) cell lines preserve
Abstract,"""High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19774387,determine,determine,) in glioblastomas in order to determine their prognostic impact among grade
Title,"""Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/18383832,correlate,correlates,"expression in glioblastomas correlates with proliferation, but not with apoptosis."
Abstract,"""Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/18383832,seem,seem,though in glioblastomas it does not seem to correlate with outcome.
Abstract,"""Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/18383832,belong,belonging,selected viable glioblastoma areas belonging to 20 cases which were assayed for
Abstract,"""CD44 expression and tumour cell density correlate with response to tamoxifen/carboplatin chemotherapy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15015779,consist,consisting,"-operative glioblastoma therapy consisting of tamoxifen, carboplatin and radiotherapy,"
Title,"""Periventricular glioblastomas and ependymal involvement interrogated using intraoperative fluorescence - a pathological correlative study.""",https://pubmed.ncbi.nlm.nih.gov/27648634,interrogate,interrogated,periventricular glioblastomas and ependymal involvement interrogated using intraoperative fluorescence - a
Title,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,indicate,indicate,prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved
Abstract,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,apply,applied,parameters in glioblastomas that can be applied in the setting of a
Abstract,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,study,studied,107 adult glioblastomas were studied.
Abstract,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,contain,containing,conclusions: glioblastomas containing areas of oligodendroglial differentiation or showing widespread immunocytochemical
Abstract,"""MGMT Testing in Glioblastomas: Pitfalls and Opportunities.""",https://pubmed.ncbi.nlm.nih.gov/30444735,predict,predicts,markers in glioblastomas as it not only predicts response to therapy but
Abstract,"""YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.""",https://pubmed.ncbi.nlm.nih.gov/15788675,determine,determine,sets of glioblastomas and anaplastic oligodendrogliomas to determine whether this single marker
Abstract,"""YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.""",https://pubmed.ncbi.nlm.nih.gov/15788675,show,show,conclusions: glioblastomas show strikingly more ykl-40 expression than anaplastic oligodendrogliomas.
Abstract,"""YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.""",https://pubmed.ncbi.nlm.nih.gov/15788675,show,showed,of 37 glioblastomas showed completely negative ykl-40 staining in both tumor cells
Abstract,"""YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.""",https://pubmed.ncbi.nlm.nih.gov/15788675,show,showed,% of glioblastomas showed strong staining intensities of 2+ or 3
Abstract,"""Viral Control of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34209584,reside,reside,response against glioblastomas because they reside in the brain (an immunologically
Abstract,"""Viral Control of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34209584,inhabit,inhabit,glioblastomas inhabit the brain like sand in the grass and
Abstract,"""Noninvasive radiomics model reveals macrophage infiltration in glioma.""",https://pubmed.ncbi.nlm.nih.gov/37660885,cut,cut,) and glioblastomas (cut-off = 1.80) through three
Abstract,"""Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9821169,report,reported,36 primary glioblastomas reported in this series.
Abstract,"""Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9821169,have,had,"series of glioblastomas, none of these markers had any prognostic value"
Abstract,"""Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9821169,express,expressing,the primary glioblastomas expressing egfr was much lower in our study (
Abstract,"""Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9821169,cut,cut,and secondary glioblastomas is not so clear-cut.
Abstract,"""The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22948185,represent,represents,glioblastoma multiforme (gbm) represents the most common and
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,grade,grade,% of glioblastomas (who grade iv).
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,develop,developed,"in primary glioblastomas, which developed clinically de novo, and in"
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,evolve,evolved,"in secondary glioblastomas, which evolved from low-grade (who"
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,contain,contained,) primary glioblastomas contained a pten mutation and an additional case showed
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,show,showed,) primary glioblastomas showed both a pten mutation and egfr amplification.
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,contain,contained,") secondary glioblastomas contained a pten mutation, and none of them"
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,develop,developed,the secondary glioblastoma with a pten mutation developed from an anaplastic astrocytoma
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,have,have,that secondary glioblastomas have a p53 mutation as a genetic hallmark but
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,develop,develop,and secondary glioblastomas develop differently on a genetic level.
Title,"""Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/35908277,educate,educated,glioblastoma-educated mesenchymal stem-like cells promote glioblastoma
Title,"""Neuroplasticity in glioblastoma: there is more to plasticity than just low grade glioma.""",https://pubmed.ncbi.nlm.nih.gov/39668322,be,is,neuroplasticity in glioblastoma: there is more to plasticity than just low
Title,"""SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.""",https://pubmed.ncbi.nlm.nih.gov/27940247,monitor,monitored,therapy of glioblastoma and can be monitored by mri.
Abstract,"""SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.""",https://pubmed.ncbi.nlm.nih.gov/27940247,employ,employed,human g12 glioblastomas in nude mice and rat c6 glioblastomas were employed
Abstract,"""SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.""",https://pubmed.ncbi.nlm.nih.gov/27940247,employ,employed,rat c6 glioblastomas were employed as the animal models.
Abstract,"""Aquaporin-1 expression in human glial tumors suggests a potential novel therapeutic target for tumor-associated edema.""",https://pubmed.ncbi.nlm.nih.gov/14753494,suggest,suggests,aquaporins in glioblastomas suggests a pathologic role for these membrane water channels
Title,"""Auger electron therapy of glioblastoma using [(125)I]5-iodo-2'-deoxyuridine and concomitant chemotherapy - Evaluation of a potential treatment strategy.""",https://pubmed.ncbi.nlm.nih.gov/33784592,use,using,therapy of glioblastoma using [(125)i]5-iodo-2'-deoxyuridine and concomitant chemotherapy
Abstract,"""Auger electron therapy of glioblastoma using [(125)I]5-iodo-2'-deoxyuridine and concomitant chemotherapy - Evaluation of a potential treatment strategy.""",https://pubmed.ncbi.nlm.nih.gov/33784592,use,using,treatment of glioblastomas (gbm) using the auger electron emitting compound
Abstract,"""Endocan expression and localization in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19458546,characterize,characterized,glioblastomas (gbms) are highly malignant tumors characterized by
Abstract,"""Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.""",https://pubmed.ncbi.nlm.nih.gov/28675164,compare,compare,"targets in glioblastoma, and compare the efficacy and toxicity of targeting"
Abstract,"""Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.""",https://pubmed.ncbi.nlm.nih.gov/28675164,affect,affect,changes of glioblastoma that can affect the use of adc-based
Title,"""Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/21841523,progress,progresses,patients with glioblastoma that progresses during bevacizumab treatment.
Abstract,"""Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/21841523,progress,progressed,patients whose glioblastomas progressed during bv treatment requiring craniotomy with those of
Abstract,"""Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/21841523,develop,developing,"consistent with glioblastomas developing bv evasion being not intrinsically more aggressive,"
Abstract,"""Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.""",https://pubmed.ncbi.nlm.nih.gov/21841523,receive,receiving,patients whose glioblastomas progress while receiving bv leading to craniotomy exhibit shorter
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,have,have,"glioblastoma patients have poor prognosis, with an average survival"
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,remain,remain,"methods for glioblastoma, and its molecular mechanisms remain elusive."
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,base,based,pathways in glioblastoma patients based on gene expression and dna methylation datasets
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,identify,identified,pathways in glioblastoma and identified four dna methylation-based biomarkers of
Abstract,"""High dose hyperfractionated radiotherapy for adults with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8280367,treat,treated,patients with glioblastoma multiforme or anaplastic astrocytoma of the brain were treated
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,give,given,absent in glioblastoma given the lack of brain fibroblasts.
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,yield,yielded,trypsinization of glioblastoma specimens yielded cells with caf morphology and single-
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,confirm,confirmed,16 patient glioblastomas confirmed caf proximity to mesenchymal glioblastoma stem cells (
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,make,making,"to identify glioblastoma cafs and their gsc interactions, making them an"
Title,"""Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.""",https://pubmed.ncbi.nlm.nih.gov/19841865,assess,assessed,"status in glioblastoma patients, assessed by five different methods."
Abstract,"""Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.""",https://pubmed.ncbi.nlm.nih.gov/19841865,treat,treated,patients with glioblastomas treated by surgery and radiotherapy with concomitant temozolomide (
Abstract,"""Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.""",https://pubmed.ncbi.nlm.nih.gov/19841865,treat,treated,methylation in glioblastoma patients initially treated with tmz.
Abstract,"""Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.""",https://pubmed.ncbi.nlm.nih.gov/17167979,undergo,underwent,"patients with glioblastoma multiforme underwent conventional mri, proton mr spectroscopic imaging"
Abstract,"""Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.""",https://pubmed.ncbi.nlm.nih.gov/17167979,offer,offering,"delineation of glioblastomas, offering information not available with conventional mri."
Abstract,"""Increased endothelial expression of transglutaminase in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9460717,study,studied,of the glioblastomas studied.
Abstract,"""Increased endothelial expression of transglutaminase in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9460717,contribute,contribute,cells in glioblastomas may contribute to the high prevalence of vascular thrombosis
Abstract,"""Primary glioblastomas and anaplastic astrocytoma in a glioma family.""",https://pubmed.ncbi.nlm.nih.gov/16678736,die,died,"with a glioblastoma, and a son who had died with a"
Abstract,"""Primary glioblastomas and anaplastic astrocytoma in a glioma family.""",https://pubmed.ncbi.nlm.nih.gov/16678736,kindre,kindred,primary' glioblastoma and anaplastic astrocytoma in the same kindred.
Title,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,increase,increase,profile in glioblastoma and increase glioblastoma resistance to temozolomide.
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,remain,remains,"chemotherapy, glioblastoma remains incurable."
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,owe,owing,patients with glioblastoma relapse owing to various intrinsic and extrinsic resistance mechanisms
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,infiltrate,infiltrated,glioblastomas are densely infiltrated with tumour-associated microglia and
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,analyse,analysed,-derived glioblastoma spheroids with microglia at different tmz concentrations and analysed
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,include,including,"in the glioblastoma cells after co-culture with microglia, including"
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,correspond,corresponded,observed in glioblastoma cells with enhanced tmz resistance corresponded to the interferon
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,induce,induce,"glioblastomas are notorious for their capacity to induce neovascularization,"
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,associate,associated,"regulated in glioblastoma-associated endothelial cells, resulting in increased expression"
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,condition,conditioned,"cells to glioblastoma-conditioned medium or vegf, resulting in increased"
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,relate,related,"loop in glioblastoma-related angiogenesis, in which vegf inhibits the"
Title,"""Phage display discovery of novel molecular targets in glioblastoma-initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/24832468,initiate,initiating,targets in glioblastoma-initiating cells.
Abstract,"""Phage display discovery of novel molecular targets in glioblastoma-initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/24832468,display,display,glioblastomas display cellular hierarchies with self-renewing glioma-
Abstract,"""Phage display discovery of novel molecular targets in glioblastoma-initiating cells.""",https://pubmed.ncbi.nlm.nih.gov/24832468,derive,derived,to a glioblastoma xenograft in vivo then derived gics.
Abstract,"""Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33661425,grade,grade,update classifies glioblastomas (who grade iv) according to isocitrate dehydrogenase
Abstract,"""Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33661425,know,known,study included glioblastoma cases (n = 199) with known idh
Abstract,"""What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?""",https://pubmed.ncbi.nlm.nih.gov/33394262,locate,located,deal with glioblastomas (gb) located in or near eloquent areas
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,have,have,"in particular glioblastomas, have a high morbidity and mortality, mainly"
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,degrade,degraded,"upregulated in glioblastomas, can be degraded by certain proteases."
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,compare,compared,"expressions in glioblastomas in situ, compared to cultured human glioblastoma cells"
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,derive,derived,"vitro, glioblastoma-derived adamts5 degrades recombinant human brevican to several"
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,contribute,contribute,on proliferating glioblastoma cells and these proteases may contribute to their invasive
Title,"""Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.""",https://pubmed.ncbi.nlm.nih.gov/12084347,correlate,correlates,p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic
Abstract,"""Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.""",https://pubmed.ncbi.nlm.nih.gov/12084347,determine,determined,assayed primary glioblastomas for expression and subcellular localization of p53 and determined
Abstract,"""Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.""",https://pubmed.ncbi.nlm.nih.gov/12084347,correlate,correlates,"human primary glioblastomas correlates with a certain intermediate filament protein expression,"
Title,"""Two distinct tumor phenotypes isolated from glioblastomas show different MRS characteristics.""",https://pubmed.ncbi.nlm.nih.gov/18613001,show,show,isolated from glioblastomas show different mrs characteristics.
Abstract,"""The zinc finger transcription factor ZFX is required for maintaining the tumorigenic potential of glioblastoma stem cells.""",https://pubmed.ncbi.nlm.nih.gov/24831540,contain,containing,glioblastomas are highly lethal brain tumors containing tumor-propagating
Abstract,"""Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19322519,use,use,glioblastomas use both egf and vegf signaling to enhance growth
Abstract,"""Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19322519,enrich,enriched,fractions of glioblastomas are enriched for high vegf synthesizing cells so this
Abstract,"""Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case.""",https://pubmed.ncbi.nlm.nih.gov/3039475,report,reported,of multifocal glioblastoma is reported with special reference to positron emission tomography
Abstract,"""Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case.""",https://pubmed.ncbi.nlm.nih.gov/3039475,predict,predicted,"to be glioblastomas, and, as predicted by the pet findings"
Abstract,"""HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/17132220,display,display,glioblastomas frequently display loss of pten and/or epidermal growth factor
